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A b s t r a c t
This thesis sets out to examine how body iron stores may influence mucosal 
cell handling of dietary iron. It is proposed that transferrin receptors (TfR) located at 
the basolateral surface of the enterocytes serve to 'inform' mucosal cells regarding 
body iron stores. It is further postulated that mucosal crypt cells can only influence 
mucosal handling o f dietary iron after they have migrated to their final destination at 
the terminal villus architecture: a 'lag period' o f some 3-5 days. This concept o f a 'lag 
period' stem from previous iron absorption studies where changes in body iron stores 
required a period o f some 3-5 days before mucosal cells were able to 'respond' to 
changes in dietary iron.
A re-evaluation o f the 'mucosal block' hypothesis was undertaken using recent 
molecular biological techniques with TfR at the basolacteral surface o f enterocytes 
serving to 'inform' these cells regarding body iron stores. This information imparted 
to the enterocytes in turn sets up a specific L:H ferritin transcript ratio in the crypt 
cells. As these cells migrate to the terminal villus, ferritin mRNA translation will 
produce a specific heteroploymer protein that will either impede or facilitate iron 
transfer to the portal circulation based on ferritin L:H transcript ratios predetermined 
by body iron stores in crypt cells some 3 days earlier. To examine this hypothesis, an 
adaptation of a previously described method of separating crypt and villus cells was 
undertaken.
These studies revealed a reciprocal relationship between TfR and body iron 
stores such that when body iron stores were depleted, TfR expression was enhanced 
to facilitate iron entry into cells. However, when body iron stores become replete, TfR 
expression were downregulated to reduce iron entry to cells. Dietary manipulation 
revealed that mucosal cell ferritin transcripts responded to changes in luminal iron, 
but this response was observed in both crypt and villus cells within 24 hours of 
dietary manipulation and did not follow the proposed lag period of 3-5 days 
corresponding to crypt-villus cell migration.
Mucosal ferritin transcripts were also examined in subjects with primary iron 
overload i.e. genetic haemochromatosis (GH). A method of separating crypt and 
villus cells in the human intestinal mucosa had not been previously described and this 
technique was developed denovo. Mucosal ferritin expression were significantly 
lower in subjects with GH when compared to control subjects with normal iron stores. 
This observation is consistent with enhanced iron transfer to portal blood and 
probably does not indicate a defect in ferritin expression in subjects with GH.
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Iron (symbol Fe) is a transition metal with an atomic weight of 55.85 and an 
atomic number o f 26. A transition element is one with a partially filled d or f  orbital. Iron
fn A 0 A Ohas an electronic configuration consisting o f Is 2s 2p 3s 3p 3d and 4s which 
thus enables valency states from 2"^  (ferrous), 3"^  (ferric) up to a possible 5”^. The net result 
o f these valence numbers renders iron an important metal in human and animal 
physiology due its unique property to donate and accept electrons in its environment.
This transition metal is essential in biological systems mainly due its ability to 
bind reversibly with oxygen. It is incorporated into protoporphyrin to form haem in 
haemoglobin and myoglobin, a co-factor for several enzymes such as catalase, electron 
transport enzymes such as the cytochromes and many iron sulphur proteins such as 
aconitase, a key enzyme in the tricarboxylic acid cycle. In addition, iron is a co-factor for 
ribonucleotide reductase, the rate limiting enzyme in deoxyribonucleic acid (DNA) 
synthesis.
1.1.2 Natural occurrence and distribution
Iron is the fourth most abundant element in the earth's crust and the second most 
abundant metal (Crighton & Charloteaux-Wauters 1986). In nature, it exists exclusively 
in the ferric state, a state in which it is not biologically available (Home 1978). Iron is 
also the most abundant transition metal in man and is mainly present in one of its 
oxidation states (Fe^^, Fe^^).
1.1.3 Iron bioavailability
Measurements of iron intake would be of limited value in assessing the nutritional 
value o f diets if  there was no indication on iron bio availability. Iron bioavailability is
/ i i
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defined as the proportion of the total iron intake that is potentially available for 
absorption and normal body functions (Department of Health 1991). Methods to study 
iron availability have been reviewed by Fairweather-Tait (1992). Based on such studies, it 
is possible to divide foods into high, medium and low bioavailability as summarised in 
Table 1-1.
Diets too can be separated into three broad categories consisting of "low", 
"intermediate" and "high" bioavailability, (determined in individuals with very low iron 
stores but normal haemoglobin concentration) with mean iron absorption (a mixture of 
haem and non-haem iron) o f approximately 5, 10 and 15% respectively (FAO/WHO 
1988). Low bioavailable diets contain a preponderance of foods consisting of cereals and 
root vegetables that inhibit iron absorption and are dominant in many developing 
countries especially in the lower socio-economic groups. Intermediate bioavailability 
diets consist of similar foods as in the low bioavailability diets but with some meat and 
additional foods rich in ascorbic acid. High bioavailability diets contain generous 
amounts of meat, poultry and fish with high amounts of ascorbic acid and is the typical 
diet consumed by people in developed countries.
O f the two main forms in which iron can exist in foods, haem iron absorption 
appears to be relatively unaffected by dietary or physiological variables compared to 
non-haem iron (FAG/WHO 1988). The various mechanisms whereby dietary substances 
(enhancers and inhibitors) affect iron absorption will be discussed in section 1.3,2,
1.1.4 Iron toxicity
Iron poses two problems for biological systems. Firstly, in its ubiquitous state, iron is 
insoluble and inaccessible. Therefore, biological systems have had to evolve mechanisms 
to acquire iron. The absorptive mechanism(s) are not very efficient but this
" ‘■"'‘ï i a
Chapter 1 
Table 1-1
Relative bioavailability of haem and non-haem iron in food



































Key: % is mean iron absorption
is overcome to some extent by the acquisition of efficient retaining mechanisms and the 
absence of a distinct excretory pathway for iron (McCance & Widdowson 1938). 
Secondly, iron is toxic in free solution due to its ability to promote the generation of 
hydroxyl radicals (Fenton 1894, Harber & Weiss 1934). A radical is an atom or molecule 
containing one or more electrons. The following reactions summarise the generation of 
the hydroxyl radicals:
 !   : _
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Fe3+ + O 2 * -> Fe2+ + 02
(superoxide)
Fe^+ + H2 O2 “> Fe^+ + OH + OH * (Fenton reaction)
Combining the two reactions:
O2  + H2 O2  —> O2  + OH + OH * (Harber -Weiss reaction)
(hydroxyl radical)
Hydroxyl radicals cause disruption of biological membranes by lipid 
peroxidation. Peroxidation can be considered to occur in three phases namely initiation, 
propagation and termination. Initiation is brought about by the removal of a hydrogen 
atom from the methylene link (-CH2-) between two double bonds in a polyunsaturated 
fatty acid producing a carbon radical which reacts with oxygen to form a peroxy radical 
(R-00*). Peroxy radicals can then remove a hydrogen atom from another lipid molecule 
forming a lipid hydroperoxide (R-OOH). This is described as propagation and it can be 
repeated many times within the lipid bilayer. Lipid hydroperoxides behave like hydrogen 
peroxide which can interact with transition metals to form alkoxyl radicals (RO*) and are 
also capable o f initiating more lipid peroxidation. The propagation phase ends when two 
radicals interact or when a radical scavenger such as vitamin E reacts with the lipid 
radical. Various products result from lipid peroxidation, amongst them aldehyde products 
which can react with thiol and amino groups in biological membranes forming cross-links 
thus contributing to the declining function in radical damaged tissue. This autocatalytic 
chain of lipid peroxidation summarised in Figure 1-1 is the principle reason why iron has 






Autocatalytic cycle of lipid peroxidation, see text for discussion.
Key: SOD: superoxide dismutase, GPx: gluthiathione peroxidase, Fell: ferrous iron, 
OH*: hydroxy radicals; RH*: lipid or organic molecule, R: lipid radical, ROO": peroxy 
lipid radical, ROOH: lipid hydroperoxide; RH: hydrogen donner.(Termination takes place 
by the interaction of vitamin E or via the action of GPx).
Oxidative metabolism
INITIATION SOD







1.1,5 Evolution o f  protective mechanisms
There are several ways o f limiting the entry of iron into the body in an attempt to 
limit iron toxicity. For instance, only a small amount o f the dietary iron (10-15%) is 
normally absorbed but this amount can be increased to 30-40% in iron deficiency. In 
man, absorption is confined to the proximal small intestine with maximal absorption in 
the duodenum (Becker et al 1979, Johnson et al 1983, Muir & Hopfer 1985, Conrad et al
■ ■■
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1987). The physical forni o f iron also affects absorption. Ionic iron or non-haem iron is 
more poorly absorbed (10-15%) than porphyrin or haem iron (25%) but the overall 
proportion that either form contributes is dependant on dietary factors. Luminal secretions 
of the gastrointestinal tract such as gastric juice (enhancing) and pancreatic secretions 
(inhibitory) also affect iron absorption (section 1.3.2iii). Once absorbed into the body, the 
complexation of iron within all cells requires an iron storage protein to maintain iron in a 
soluble, bioavailable and non-toxic form. These conditions are fulfilled by the iron 
storage protein ferritin and this will be discussed in Chapter 4.
1,2 Iron metabolism in man
Iron metabolism in man has been summarised in Figure 1-2. The amount o f body 
iron in the healthy adult is between 3 to 4 g (Davidsion et al 1979) and is roughly 
distributed as follows: haemoglobin (2.5 g), tissue iron in myoglobin, redox proteins and 
iron enzymes (0.3 g) and in iron stores as ferritin and haemosiderin (1.0 g). However, 
non-specific iron excretory mechanisms do exist and result in losses of approximately 
1 mg/day in the healthy person. This can occur in several ways; via the urinary tract, 
during menstruation, pregnancy and lactation or desquamation of skin cells and epithelial 
cells from the gastrointestinal tract. The latter is iron retained within the enterocytes being 
shed into the gut lumen at the end o f their life cycle and can be potentially, a major iron 
loss (Green et al 1986). In addition, there is evidence that iron is also excreted via the 
globlet cells in the gastrointestinal tract (Refsum & Schreier 1980). Increased iron loss 
(up to 4 mg/day) has been reported in an iron loaded patient who had recovered from 
chronic anaemia (Crosby et al 1963) and more recently, iron-loaded thalassaemic patients 
after bone marrow transplantation show significant reduction in iron stores during a seven 
year follow up (Lucarelli et al 1993). In general, 1 mg of elemental iron (2 mg in women) 
is needed per day to replace iron losses.
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Figure 1-2
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Iron absorption has been extensively studied since McCance & Widdowson 
(1937,1938) suggested that regulation of absorption must be responsible for iron 
homeostasis as excretion was limited. However, despite intensive studies on iron 
metabolism, (Forth & Rummel 1973, Brock et al 1994), many aspects on iron absorption 
remain unclear, in particular, how the transfer of iron from the intestinal mucosa to the 
portal circulation takes place. Absorption of non-haem iron differs from haem iron. 
Non-haem iron is released from food by peptidases in the duodenum, the main site of 
absorption. On the other hand, haem iron in meat can be absorbed directly by interacting 
with specific haem receptors in mucosal cells where iron is released from the porphyrin 
ring by mucosal haem oxygenase.
Once iron is taken up by mucosal cells, it is rendered non-toxic by binding to 
proteins: either to mucosal transferrin (TfN) and then translocated across the enterocyte 
basement membrane to the portal circulation or retained within mucosal apoferritin. Iron 
bound to ferritin, sometimes referred to as the "ferritin curtain" (Chapter A) remains 
within the enterocyte and is excreted when intestinal cells are shed into the gut lumen.
In plasma, iron is bound to its transport protein, TfN. Iron is transported either as 
diferric TfN (20%), monoferric TfN (40%) or apotransferrin (40%) (Young & Bomford 
1984, Van der Huel et al 1984, Huebers et al 1983). The determinant factors for iron 
entry into cells is the presence of transferrin receptors (TfR) and the concentration and 
saturation of TfN with diferric TfN having the highest affinity for TfR. TfR are present 
on most types of cells. The majority of TfN bound iron is taken up by developing red 
blood cell precursors by receptor mediated endocytosis. TfR are embedded on the cell 
surface membranes and also as endocytic vesicles or endosomes (Ciechanover et al 1981, 
Dautry-Varsat et al 1983). The endocytic cycle o f TfN is initiated by the binding of the 
charged TfN to the exposed receptor located at the bottom of the membrane pit which is 
coated with clathrin, a protein that provides a nidus for aggregation o f receptors on cell 
surfaces (Pearse & Bretscher 1981). This clathrin-coated pit then folds into a vesicle
.1
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which is internalised into the cytoplasm, and, by means of a proton pump (Tyko & 
Maxfield 1982), the contents of the vesicle becomes acidic (approximately pH 5) thereby 
facilitating the dissociation of iron from TfN binding sites but leaving apotransferrin still 
bound to the receptor. Liberated iron equilibrates with ferritin (Klausner et al 1983, 
Bomford & Munro 1985). TfR bearing apotransferrin is recycled to the plasma 
membrane, where apotransferrin dissociates from the receptor. TfR mediated endocytosis 
for iron entry to cell has been summarised in Figure 1-3.
The liver accounts for most of the remaining TfN bound iron uptake but unlike 
erythroid cells, there is controversy about the mechanisms of iron uptake from TfN bound 
iron into hepatocytes. TfR and specific uptake of transferrin iron have been demonstrated 
in hepatocytes, albeit in small amounts (Young & Aisen 1981) but hepatocytes and 
Kupffer cells have additional mechanisms for iron uptake (Young et al 1983). A plasma 
membrane oxidoreductase mechanism has been described for hepatocytes (Thorstenson & 
Romslo 1988). Hepatocytes have receptors for circulating haemoglobin bound to 
haptoglobin and for haemin bound to haemopexin. Kupffer cells are capable o f ingesting 
intact red blood cells (Munro & Linder 1978). A hepatocyte membrane receptor for 
ferritin has also been described in rats (Mack et al 1983) and in man (Adams et al 1988). 
Ferritin is also taken up via a receptor-mediated endocytosis route dependant on a 
microtubule process (Ramm et al 1990).
Once inside the cell, free iron in the cytoplasm is maintained within physiological 
limits by ferritin which incorporates ferrous iron into the apoprotein shell accompanied 
by its oxidation (Theil 1983). Ferritin has a half-life o f 3 days in rats and one hypothesis 
suggests that the protein shell is degraded by both cytosolic and lysosomal proteolytic 
enzymes (Wixom et al 1980). Proteolytic removal of the ferritin shell within the 
lysosomal vesicles leaves the iron core which is recognised histologically as 
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histological sections. By contrast, proteolytic removal of ferritin within the cytoplasm 
releases the ferric iron which is reduced by flavin mononucleotides and re-enters the 
ferrous iron pool. It has been proposed (Ritcher 1984) that soluble cytosol ferritin is 
progressively transferred to and accumulates within the lysosomes as haemosiderin in a 
sequence of events summarised in the scheme Table 1-2,
The role o f haemosiderin is uncertain. Mossbauer spectroscopy studies have 




In secondary iron over loaded states such as p-thalassaemia (an inherited disorder in 
haemoglobin synthesis requiring multiple blood transfusions), the haemosiderin iron core 
structures are those of the crystalline goethite structure (Mann et al 1988, Ward et al
1988). However, in primary iron overload such as genetic haemochromatosis (GH in 
section 3.4), the haemosiderin iron cores are similar to the ferrihydrite structure 
associated with liver ferritin. Goethite deposits are less labile and are thought to be less 
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1,3 Mechanisms o f  iron absorption
As there is no distinct excretory pathway for iron, regulation of iron stores must 
be at the site o f absorption (McCance & Widdowson 1937, 1938). Absorption of 
non~haem iron differs from haem iron and is therefore considered separately. Although 
haem iron absorption is more efficient, the quantity of iron controlled by non-haem iron 
absorption is often much greater.
1.3,1 Non^haem iron absorption
Non-haem iron is released from food by peptidases in the duodenum. Only the 
ferrous form of non-haem iron can cross membranes and since most of the dietary 
non-haem iron is in the ferric state, it has to be reduced and made more soluble by the 
gastric juice containing hydrochloric acid or organic acids such as ascorbic acid. A 
previous study has also demonstrated that ascorbic acid is concentrated in the human 
stomach and may be secreted into the gastric juice (Sobala et al 1989). This may be a 
very important, unrecognised mechanism affecting iron absorption. Several stages are 
involved in the absorptive process. These include (i) binding o f iron to the brush border
(ii) iron uptake into the interior of the cell (iii) intracellular handling of iron (iv) 
transcellular transport and (v) release o f mucosal iron to the portal circulation.
(i) Binding o f  iron and mucosal iron uptake
At least three mechanisms for non-haem iron binding to the brush border have 
been reported (Simpson et al 1989).
(a) a non-specific low affinity binding or paracellular uptake. This mechanism is 
non-saturable and non-regulated. However, it forms a small but significant basal uptake 
o f iron and may explain the well described incomplete suppression o f iron absorption in 
iron overload (Crosby et al 1966).
12
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(b) a high affinity receptor binding which is well regulated and dependant on metabolic 
energy. The search for such a receptor has mainly been unrewarding. One of the specific 
membrane receptors identified for iron uptake was the TfR, a glycoprotein which is found 
on most cells in the body and particularly at high concentrations on cells with a high 
requirement for iron such as immature erythroid cells (Bomford & Munro 1985). Huebers 
et al., (1983) proposed that mucosal apotransferrin was secreted into the gut lumen and 
takes up luminal iron and is then absorbed into the cell. Excess apotransferrin was 
recycled via the enterohepathic circulation. However, subsequent immunolocalisation 
techniques revealed that within the small intestine, TfR are predominantly found on the 
basolateral surfaces o f enterocytes rather than in the apical microvillous brush borders 
(Levine & Woods 1990, Parmley et al 1985, Banerjee et al 1986, Osterloh et al 1988, 
Lombard et al 1990). Hence, TfR are unlikely to play a major role in mucosal iron 
uptake.
(c) binding to specific glycoproteins which presents iron to the mechanisms for shuttling 
iron into and across the enterocyte. Candidate proteins for this include an iron-binding 
protein described by Teichmann & Stremmel (1990) and mobileferrin (Conrad et al 
1992 ,1993a & 1993b). The former is an iron-binding protein isolated in the microvillus 
membrane vesicles of the proximal intestine; molecular weight 160 kDa with three 
54 kDa monomeric peptides linked by disulphide bonds forming a transmembrane 
iron-transport protein. It is present in stomach and liver but not in the oesophagus and its 
concentration in the duodenum is increased in iron deficiency and reduced in secondary 
iron overload suggesting that it is responsive to iron stores. Mobilferrin appears to be 
localised in the apical cytoplasm of the proximal small bowel but not in other organs. It is 
a water soluble protein, molecular weight of 56 kDa which can bind reversibly to iron, in 
a molar ratio of 1:1 (Conrad et al 1990, 1992). Its location in the apical cytoplasm and its 
close association with integrin, another transmembrane protein consisting of two protein 




intracellular iron transport but further work is required to confirm and extend these 
observations.
(d) A variety o f fatty acids in the brush border membrane vesicles such as oleic, stearic, 
phosphatidyl serine and phosphatidic acid also have iron-binding properties, with binding 
being pH dependant and may have a role in iron uptake into the enterocytes 
(Simpson & Peters 1987). Unlike binding in (b) and (c), this is a passive process and is 
only partially regulated (Simpson et al 1989).
(ii) Mucosal intracellular iron transport
Once iron is internalised within the enterocyte, it can be considered in two 
separate compartments (i) an iron storage compartment and (ii) an iron transfer 
compartment. Little is known about the iron transfer mechanism within the mucosa.
Excess iron taken up is diverted to the storage compartment. Once in the storage 
compartment, it is thought that only about 10 % of the iron can re-enter the iron transfer 
compartment (Wheby & Umpierre 1964b).
The mechanism(s) for transcellular iron transport remain unknown. Several 
glycoproteins have been implicated namely TfN and ferritin. Mucosal TfN has been 
suggested but supportive evidence is lacking. Studies in man reveal that mucosal content 
of TfN is not different in iron deficient subjects compared to subjects with normal iron 
stores (Whittaker et al 1989). Hypotransferrinaemic mice (Buys et a l \9 9 \ ,  Simpson et al 
1991) and the rare human syndrome of congenital atransferrinaemia (Goya et al 1972) | |
have enhanced iron absorption despite a lack of TfN in the small intestinal lumen, 
mucosa and plasma. In addition, the absence o f TfN mRNA in the rat and human 
duodenal mucosal cells (Idzerda et al 1986, Pietrangelo et al 1992) suggests that TfN is 
not synthesised within the mucosal cell and is probably derived via TfR at the basolateral 
surface o f enterocytes to supply iron for cellular growth and development (Chapter 3).
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Ferritin, an iron storage protein has long been implicated as a repository for 
excess iron (Hahn et al 1943, Granick 1946). Absorption o f radioactive iron in iron 
deficient dogs was increased compared to replete animals which absorbed little. Granick; 
(1946) proposed a "mucosal block" which prevented the absorption of un-needed iron and 
this block disappeared in iron deficiency. To explain the mechanism of this block, a 
"mucosal acceptor" for iron was postulated where physiological saturation of the acceptor 
prevented further entry of iron. This mucosal acceptor was thought to be ferritin where 
iron bound to it was lost when cells are shed from the intestinal mucosa. There is a good 
correlation between mucosal ferritin or ferritin mRNA with iron status, with low levels in 
iron deficient states and high levels in secondary iron overload in rodents and in man 
(Halliday et at 1978, Savin & Cook 1980, Whittaker et al 1989, Pietrangelo et al 1992). 
However, when it was shown that mucosal ferritin synthesis continued even in iron 
deficiency (Britten & Raval 1970), the concept o f ferritin having a regulatory effect on 
iron absorption was largely discounted.
(iii) Mucosal iron transfer to portal circulation
This is the final step in the absorptive process but information regarding its 
mechanism is scanty. Iron may exit along the basal portion o f the enterocyte or along the 
lateral spaces (Parmley et al 1978). It then has to traverse the interstitial spaces and the 
endothelial cell to enter the portal venous system. Expression o f TfR only at the 
basolateral surface o f enterocytes allows for the possibility that this may be the principal 
route for iron export to the portal circulation. However, several strands of evidence 
indicate that this is unlikely as discussed in section 3.4.3.
Most of the iron in the portal blood is in the ferrous state (Wollenberg et al 1990), 
This suggests that ferric iron is reduced to the ferrous state at the basolateral membrane 
prior to release. Ceruloplasmin, a copper binding protein may also be implicated in iron 
transfer since iron absorption is enhanced after intravenous ceruloplasmin administration.
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It is postulated that when ferrous iron diffuses to the portal circulation, it is oxidised by 
ceruloplasmin upon entry to the capillary wall producing a ferric moiety for binding to 
plasma TfN (Wollenberg et al 1990).
1.3.2 Factors affecting non”haem iron absorption
Non-haem iron absorption is affected by several factors.
(i) Non-haem iron and bioavailability
Non-haem iron is found in foods from both plant and animal origin. In plants, 
there are at least three forms; metalloproteins e.g. plant ferritin (Sczekan & Joshi 1987), a 
soluble iron source in the sap of plants and an iron complex in the form of phytates 
(Hazell 1985), In animal products non-haem iron is found in many forms such as ferritin 
and haemosiderin in meat products, phosphoproteins in egg yolk and lactoferrin in milk. 
Dietary components especially proteins and exogenous ligands (enhancers and inhibitors) 
can also influence non-haem iron bioavailability.
(a) Enhancers o f  non-haem iron absorption
The main enhancers o f non-haem iron absorption are proteins, ascorbic acid and 
organic acids. Bioavailability of iron in foods with significant amounts of ascorbic acid is 
high (Gillooly et al 1983, Ballot et al 1987). Ascorbic acid potentiates non-haem iron 
absorption by at least two mechanisms; by acting as a reducing agent in the stomach 
(ferrous iron better absorbed than ferric iron) and as a chelator in the stomach and the 
proximal small intestine by maintaining iron in a soluble state. However, ingestion of 
ascorbic acid on a long term basis can only affect iron status when the diet is poor in iron 
and when iron deficiency is present. The observation that ascorbic acid is concentrated 
and secreted in the gastric juice suggests that there may have been an important 
evolutionary mechanism to enhance iron absorption when diet was sub-optimal. 
Interestingly, in the replete state, supplemental dietary ascorbic acid does not appear to 
have any additional effect on iron assimilation (Looker et al 1988) and with further
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adaptation at the enterocyte level to limit iron absorption (Cook 1990). Several other 
organic acids notably citric, malic and tartaric acid also have an enhancing effect on 
non-haem iron absorption whereas oxalic acid in foods such as spinach, rhubarb, 
chocolates and cocoa appears to have an inhibitory effect (Gillooly et al 1983).
(b) Inhibitors o f  non-haem iron absorption
The absorption inhibitors in natural foods include the phytates, polyphenols such 
as chlorogenic acid in coffee, phosphates and tannins in plant tissue and phosphoproteins 
in animal tissue. These reduce non-haem iron absorption by forming insoluble complexes 
(Morris & Ellis 1982). Calcium also, has an inhibitory effect on non-haem iron 
absorption but the exact inhibitory mechanism is not known. One postulated mechanism 
is that calcium inhibits the enzyme phytase present in cereals during baking, leading to 
increase amounts of phytate which in turn reduce non-haem iron absorption 
(Hallberg et al 1991). It is evident that enhancer-inhibitory interactions are just as 
important as iron-chelator interactions in influencing non-haem iron absorption.
(ii) Iron valency
Reduction of ferric to the ferrous state is thought to be essential before absorption 
can occur (Brise & Hallberg 1962). Once taken up by the enterocyte, iron is oxidised to 
be stored or shuttled across the enterocyte. Prior to release from the enterocyte to the 
interstitial space, iron is reduced, diffuses into the portal circulation and is reoxidised by 
ceruloplasmin (Wollenberg et al 1990).
(iii) Luminal contents o f  the gastrointestinal tract
Patients with gastrectomy and achlorhydria develop iron deficiency due to 
diminished ability to absorb non-haem iron (Bothwell et al 1979). Gastric juice aids iron 
absorption by solubilising non-haem iron. The low pH of the gastric contents is 
neutralised within minutes on entering the duodenum. However, if  iron is maintained in a
17
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water soluble state e.g. in the presence o f ascorbic acid, absorption continues despite the 
higher pH status. This may explain the enhancing effect o f bile on iron absorption 
(Conrad & Schade 1968) although invitro studies suggest that this is due to the formation 
of mucoprotein ligands rather than iron-ascorbic acid complexes (Jacobs & Miles 1970). 
Iron can also be maintained in a water soluble chelate by taurocholate in bile further 
enhancing iron absorption (Sanyal et al 1990).
Pancreatic secretions tend to reduce non-haem iron absorption because 
bicarbonate ions raises the pH thereby decreasing solubility (Zemspky et al 1989). 
However, the overall effect o f pancreatic juice may be to enhance non-haem iron 
absorption by releasing amino acids and polypeptides from foods which can act as 
absorption ligands.
Mucus and mucins lining the intestinal mucosa also play a role in promoting 
non-haem iron absorption (Conrad et al 1991, Wien & Van Campen 1991). It is 
suggested that mucins bind iron in the acidic gastric environment thus maintaining iron in 
solution despite the rise in pH in the duodenum, and, as iron is bound relatively weakly to 
mucins, it dissociates easily to be absorbed (Conrad et al 1991).
(iv) Internal factors: body iron status and erythropoeisis
(a) Body iron status
The inverse relationship between body iron stores and iron absorption is well 
established in both animals and humans (Cook et al 1974, Walters et al 1975, 
Magusson et al 1981, Baynes et al 1987, Cook 1990). However, despite many studies, the 
precise mechanism by which the enterocytes are informed o f body iron status remains a 
mystery.
A humoral regulator has been suggested since infusion of plasma of pregnant rats 
to non pregnant rats enhanced iron absorption (Apte 1969). Increased iron absorption was
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also observed in pregnant women (Whittaker et al 1991b). However, the search for 
humoral factors has generally been unrewarding.
Studies looking at the relationship between serum ferritin or serum TfN saturation 
and iron absorption have revealed two phases o f regulation of absorption by body iron; a 
minor level of control responsible for fine adjustments at normal iron stores and a major 
level of control when iron stores are depleted. One of the more durable theories for 
internal control was a proposal by Crosby et al., (Conrad & Crosby 1963) in that the 
intestinal mucosal cell may be 'conditioned' while in the crypts by the amount of iron 
supplied from plasma (section 1,4).
A liver transplant model in rats has been used to establish whether the liver has a 
regulatory function on iron absorption (Adams et al 1989). Rat livers were loaded with 
oral carbonyl iron (iron stored in hepatocytes) or parenteral iron dextran (iron stored in 
Kupffer cells) and then transplanted to isogenic rats with normal liver iron stores. 
Significant reduction in iron absorption (studied 10 days post transplant) was observed in 
these transplanted animals (20 fold and 0.5 fold respectively) suggesting that hepatocyte 
iron content may influence a putative messenger controlling intestinal absorption.
(b) Effect o f  erythropoeisis
Increased iron absorption associated with increased erythropoiesis is evident in 
patients with haematological disorders with ineffective erythropiesis such as thalassaemia 
major and sideroblastic anaemias where these patients develop significant iron overload 
(Bothwell et al 1979, Pippard et al 1979). By contrast, if  erythropoiesis remains effective 
as in autoimmune haemolytic anaemias or hereditary spherocytosis, only modest 
increases in iron absorption are observed and it is unusual for such patients to develop 
significant iron overload. Disordered erythropoiesis thus produces conflicting signals to 
the intestinal mucosa resulting in the breakdown of the precise relationship between body 
iron reserves and intestinal absorption. Enhanced erythropoiesis may also be responsible
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for the increase iron absorption in subjects transported to high altitudes (Reynafeqe & 
Ramos 1961).
(v) Mucosal cell factors
The mucosal cell itself also influences iron absorption independent of body status. 
There were significant changes in iron absorption when small intestines from iron 
deficient rats and iron loaded rats were transplanted to isogenic iron deficient rats. Iron 
uptake by mucosal cells and iron transfer into carcass was significantly greater from 
intestines transplanted from iron deficient animals compared with the intestines from iron 
loaded animals (Adams et al 1991). Also, by raising mucosal cell iron concentration with 
a high iron containing meal led to a reduction in iron absorption from a test meal given 
subsequently(Fairweather-Tait & Wright 1984, Fairweather-Tait 1985).
The iron content of the mucosal cell may be self regulated in at least two ways; 
firstly, via TfR at the base of the enterocytes such that when mucosal cells have sufficient 
iron content, TfR are down regulated to reduce further entry o f plasma transferrin iron. 
Secondly, mucosal ferritin mRNA levels are increased such that different amounts of 
mucosal appoferritin levels are produced to sequeste excess iron within the enterocyte 
(Pietrangelo et al 1992).
1.3.3 Haem iron absorption
Dietary haem iron is mainly derived from animal tissues with haemoglobin and 
myoglobin being the main precursor proteins. It is an important qualitative source of 
dietary iron because of its higher bio availability (Martinez-Torres & Layrisse 1973). It is 
generally agreed that 20-30% of haem iron is absorbed and this is a constant figure being 
relatively unaffected by other dietary or physiological variables (FAO/WHO 1988). In 
industrialised countries, this accounts for 10-15% of the ingested iron but amounts to
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one-third of the iron absorbed because o f its higher bioavailability (Cook et al 1982, 
Bezwoda et al 1983).
1.3,4 Factors affecting haem iron absorption
Several factors are known to affect haem-iron absorption and these include:
(i) Intraluminal factors
Haem iron absorption is relatively independent o f the components of the diet 
compared to non-haem iron. However, pure haem iron is poorly absorbed due to 
formation of polymers (Conrad et al 1966) but these are theoretical considerations since 
pure haem iron is not ingested.
(ii) Mucosal uptake
Uptake o f haem is different compared to non-haem iron. As mentioned, the 
former involves interactions with specific haem receptors (Grasbeck et al 1979, 1982). 
Haem iron enters mucosal cells as microendocytic vesicles best observed at the base of 
the microvilli which are broken down by haem oxygenase within the enterocyte to release 
the iron (Raffin et al 1974) and two products biliverdin, a potent antioxidant (Tenhunen 
et al 1970, Kutty & Maines 1981, Stocker et al 1987) and carbon monoxide; a 
neurotransmitter (Verma et al 1993). This appears to be the rate limiting step in haem 
absorption (Wheby & Spyker 1981).
Haem oxygenase, molecular weight 33 kDa, is located in the endoplasmic 
reticulum, requires NADPH and molecular oxygen. This enzyme exists as two 
isoenzymes (Schacter 1988), with an inducible enzyme (HMOXl) located on 
chromosome 22 and the constitutive enzyme (HM0X2), located on chromosome 16 
(Kutty et al 1994). In rat, activity o f the enzyme is greatest in the spleen, bone marrow, 
liver, brain, kidney and lung with activity also demonstrated in the intestinal mucosa.
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Once released from haem, iron enters the same intracellular pool as non-haem 
iron. Iron from lactoferrin, (molecular weight 80 kDa), is capable o f binding 2 atoms of 
ferric iron per molecule and is thought to enter the mucosal cell by a similar way to haem 
iron as lactoferrin receptors have been isolated from the brush border membranes 
(Cox et al 1979). However, the role of lactoferrin in iron absorption remains unclear and 
lactoferrin is more generally understood to have a role in reducing bacterial overgrowth.
(iii) Internal factors: effect o f  iron status
There is also an inverse relationship between body iron stores and haem iron 
absorption although this relationship is less pronounced than for non-haem iron 
absorption (Lynch et al 1989a), At any serum ferritin level, haem iron absorption is N
greater than non-haem iron but at higher iron levels, inhibition o f haem iron absorption is
iless pronounced than inhibition o f non-haem iron absorption (Lynch et al 1989b).
1.3.5 Sites at which iron absorption can be regulated
From the discussion so far, the possible sites at which non-haem iron absorption 
can be regulated are (i) at the level of iron uptake by the enterocyte (ii) the mechanism(s) ; |
retaining iron within the enterocyte and (iii) the release of iron from the enterocyte to the 
portal circulation. All these sites can be influenced by body iron status and are important 
although it has been proposed that uptake by mucosal cell may be the main site of 
regulation (Nathanson & Mclaren 1987). By contrast, haem iron absorption is controlled 
largely at the site o f mucosal transfer to the portal circulation although luminal uptake by 
the enterocyte can be increased in iron deficiency (Wheby & Spyker 1981). The different 
sites in the control o f iron absorption may account for a greater sensitivity of non-haem 
iron absorption to changes in body iron stores. Iron absorption is a precisely regulated 
process but when this regulation becomes defective, it manifests in a condition called
: = ■*GH.
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1,3.6 Aberrant iron absorption
Insights into the control of iron may be gleaned by studying aberrant iron 
absorption as it occurs in GH. The hereditary nature of the disease was first suggested by 
Sheldon (1927, 1935) but it was much later before its occurrence in association with the 
Major Histocompatability Complex (MHC) was described (Simon et al 1977a, 1977b) 
and that the mode of inheritance was autosomal recessive. The prevalence for GH is 
between 0,1 and 0.5 percent o f the Caucasian adult population (Dadone et al 1982, 
Edwards a / 1988).
Occasionally, iron overload can be due to other causes such as excessive iron 
supplementation, alcohol, multiple blood transfusion, sideroblastic anaemia and these are 
referred to as secondary haemochromatosis. GH is due to an inborn error of iron 
metabolism resulting in an inappropriately high level o f iron absorption from the diet in 
the face of increase iron stores. Although the precise defect is still unknown, much is 
known about the genetics and effective treatment is available. Recent studies in this 
condition provide some insight into the mechanisms regulating iron absorption.
Expression of this disorder may be influenced by dietary iron intake and other 
factors probably alcohol in particular. In countries where there are sufficient quantities of 
iron in the diet, the majority o f patients homozygous for the defect will develop clinical 
and biochemical expression o f the disease by the 5th decade o f life. Excess iron 
deposition in liver, pancreas, reproductive system, joints and heart manifests as liver 
cirrhosis with an increased risk of hepatoma, diabetes mellitus, hypo gonadotrophic 
hypogonadism, athropathy and cardiomyopathy. The disease is diagnosed by 
demonstrating an increase in iron stores in liver.
In theory, the metabolic defect in GH defect could be in the enterocyte or a more 
widespread disorder affecting the liver or the reticuloendothelial system. Several studies 
by (Boender & Verloop 1969, Powell 1970, Marx 1979) seem to suggest that the defect 
in iron absorption lies both in the mucosal uptake and the release o f iron to the portal
23
Chapter 1
circulation. However, mucosal iron kinetics studies (McLaren et al 1991) concluded that 
mucosal transfer was the major determining factor. In subjects with GH, intestinal 
mucosal H and L-ferritin (different forms of ferritin with potentially different metabolic 
properties, see Chapter 4) fail to rise in parallel with serum ferritin (Francazani et al 
1989, Whittaker et al 1989) and steady state mRNA for both H and L-ferritin is also 
inappropriately low (Pietrangelo et al 1992). By contrast, TfR expression on the basal 
surface of mucosal cells in GH is increased (Banerjee et al 1986, Lombard et al 1990) as 
well as TfR mRNA (Pietrangelo et al 1992). This is in keeping with mucosal cells 
behaving as iron ‘deficient’ and their increase absorption in these circumstances would 
not be inappropriate. One possible explanation for this is that the enterocyte is not 
'informed' about body iron stores. Alternatively, a primary defect within the intestinal 
mucosa could be caused by a failure to switch from neonatal to adult control o f iron 
absorption (Srai et al 1984).
To explore how the enterocyte might be informed about body iron stores requires 
some imderstanding of cellular iron homeostasis.
1.3.7 Molecular regulation o f  ferritin and transferrin receptors
Iron enters cells via TfR and once inside cells, iron may be considered to be in 
one of three pools; (i) to be utilised for metabolic processes, (ii) sequestered as ferritin 
and (iii) a separate pool to regulate the iron regulatory element binding protein (IRE-BP) 
or IRP. In the 1970's Munro and co-workers (Zahringer et al 1976) postulated and 
subsequently demonstrated that control o f ferritin expression was mainly regulated by 
translation (Munro & Linder 1978, Rogers & Munro 1987). Deletion analysis of ferritin 
mRNA indicated that the region for translation control reside within 30 nucleotides of the 
212 nucleotides o f 5'UTR on human H-ferritin mRNA (Hentze et al 1986, 1987b). This 
30 nucleotide sequence could be folded to form a stem-loop structure. Similar stem-loop 




1987, Leibold & Munro 1987,1988) and these stem-loops function as translational control 
elements and have been termed the iron regulatory or responsive element (IRE).
For TfR, immunoprécipitation studies (Mattia et al 1984, Rao et al 1985) indicate 
that the iron-dependent alterations in TfR biosynthesis were at the level of transcription. 
The locus of iron regulation of TfR expression is within a fragment o f 678 nucleotides on 
the 3’UTR of TfR mRNA (Owen & Kuhn 1987, Casey et al 1988b). A total of 5 
stem-loop structures have been recognised within the 3'UTR which are similar and 
contain homologue sequences to the IRE within the 5'UTR o f ferritin mRNA (Cassey et 
al 1988a).
Several studies notably (Hentze et al 1987a, 1988, 1989b, Kuhn & Hentze 1992) 
have revealed the existence o f an intriguing mechanism for the control o f cellular iron 
homeostasis by modulating the translation o f ferritin and TfR mRNA. Both IRE’s on TfR 
and ferritin are capable o f being bound by a 90 kDa iron regulatory protein (IRPl). 
Binding of IRPl has the effect o f stabilising TfR mRNA facilitating translation whereas 
binding o f IRPl to ferritin mRNA impedes translation by preventing ferritin mRNA 
interactions with ribosomes.
Wlien iron stores are low, IRPl has a high affinity for the 5'UTR of ferritin 
mRNA repressing ferritin translation. However, binding of IRPl to 3'IRE TfR mRNA 
stabilises mRNA promoting translation. Enhanced TfR expression will facilitate iron 
entry into cells. However, when iron stores are high, affinity o f IRPl to IRE is reduced. 
TfR mRNA is destabilised, translation is attenuated and diminished TfR expression will 
reduce entry o f iron into cells. Simultaneously, ferritin translation is derepressed 
culminating in ample ferritin protein to sequest excess iron. This reciprocal mechanism 
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To date, there are at least two IRPs which bind specifically to the IRE's. IRP2 
unlike IRPl has a molecular mass o f 105 kDa with the highest binding activity in the 
small intestine and brain. However, the functional significance of the different IRP’s 
remain uncertain (Kim et al 1995).
Clues on how the IRPl might sense changes in cellular iron status have come 
from observations that IRPl is structurally very similar to the mitochondrial enzyme, 
aconitase (Hentze & Argos 1991, Rouault et al 1991) and possesses iron-dependant 
aconitase activity (Kaptain et al 1991, Haile et al 1992). This has been identified as 
cytosolic aconitase, the physiological 'iron sensor'. When cellular iron is low, IRPl is 
seen as in a reduced state being an avid binder for the IREs (referred to as IRE-BP-on in 
Figure 1-5) thereby repressing ferritin mRNA translation and TfR mRNA degradation. 
Similarly when cellular iron is high, IRPl is envisaged as in an oxidised state (referred to 
as IRE-BP off in Figure 1-5) with reduced avidity for the IRE thereby de-repressing 
ferritin mRNA translation and TfR mRNA degradation. The two forms of aconitase may 
not be interchangeable and denovo synthesis o f either apoaconitase, depending on cellular 
iron availability may best explain its dual function.
To date, there is no evidence for a defect of this co-ordinate regulation in GH. 
Activity of IRPl in TfR mRNA and ferritin mRNA appears to be increased in GH with 
mucosal ferritin translation in these patients being only slightly raised compared to 
control subjects but lower when compared to patients with secondary haemochromatosis 
(Pietrangelo et al 1995). Positional cloning have localised the gene for IRPl to 
chromosome 9 (Hentze et al 1989a).
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Figure 1-5
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It is known that (i) induction o f anaemia by blood loss in rats had no effect on iron 
absorption until about the 4th day (Crosby et al 1963). (ii) Induction o f an acute iron 
overload was not accompanied by a reduction in iron absorption until at least 24 hours 
(Wheby et al 1964a). (hi) Parenteral administration of radioactive iron to rats resulted in 
the accumulation of radioactivity initially in the duodenal crypt cells and only after 
3 days had lapsed were there any appreciable change in the location o f the radiolabelled 
iron (Messier & Leblond 1958). (iv) This duration coincides approximately with the 
migration o f cells from the crypts o f Lieberkuhn onto the villus architecture in the rat 
intestinal mucosa (Leblond & Messier 1958). (v) Non-haem iron absorption is influenced 
by body iron stores (Baynes et al 1987, Cook 1990). (vi) Iron absorption correlates with 
mucosal ferritin content (Charlton et al 1963, 1965). (vii) TfR mRNA expression has an 
inverse relationship to ferritin mRNA in the enterocyte (Pietrangelo et al 1992) .
It has been proposed that mucosal cells in the intestinal mucosa may have been 
conditioned while in the crypts by body iron stores from plasma iron (as reflected by the 
percentage transferrin saturation) and these proliferating cells may influence iron 
absorption as they migrate the villus cellular architecture to the tip some 3 to 5 days later 
(Conrad & Crosby 1963). If  this is correct, then changes in expression o f TfR and ferritin 
along the crypts should follow a predictable pattern with changes in dietary iron.
I set out to test the hypothesis that body iron stores influence iron regulatory 
behaviour in the mucosal cells o f the proximal small intestine by (i) conditioning the 
proliferating cells in the intestinal crypts via plasma TfN and TfR located on the 
basolateral surface of enterocytes (ii) this conditioning of the crypts sets up a specific L:H 
rich ferritin subunit transcript ratio referred to as the constitutive ratio and (iii) this 
constitutive ratio predetermined in the crypts should be consistent with the known pattern 
of iron absorption as crypt cells migrate to become functional villus cells at the tip some 
3 to 5 days later.
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i .5  Plan o f investigations and outline o f thesis
To test the first part of my hypothesis, I propose to show that L and H-ferritin rich 
subunit mRNA in the crypt and villus cells of the proximal intestine are different in 
differing states o f iron repletion. This could be tested in human intestinal biopsies 
obtained endoscopically but would require a method of separating subpopulations of pure 
crypt and villus cells o f the human intestinal mucosa. As such a method has not been 
described before, this will require the development of a new method and verification of 
the purity o f the separated cell subpopulations. Furthermore, I would require a method of 
analysing mRNA expression in the separated cell subpopulations. This will be undertaken 
using Northern hybridisation techniques and I will also require human ferritin probes and 
gene cloning techniques to generate sufficient cDNA for examining ferritin transcripts in 
subjects with disordered iron metabolism (iron deficiency and GH).
To show that L and H-ferritin rich subunit mRNA in crypt and villus cells are 
responsive to acute alterations in body iron stores, I would have to use an animal model 
where iron stores in these animals could be manipulated by dietary means. I would also 
need to develop a method o f separating these cells and also set up a method o f analysing 
and quantifying mRNA in the separated cell subpopulations. However, to demonstrate 
that L and H-rich ferritin subunits in intestinal villus cells change progressively over a 
3-5 day period in a way which can be predicted by alterations in L and H rich transcripts 
in crypt cells predetermined 3-5 days earlier, I would still be able to use the same animal 
model but to capture changes in regulatory behaviour in the intestinal mucosa, I would 
have to challenge the iron status 'acutely' in these animals by dietary means over the said 
period o f 3-5 days after the animals had been initially conditioned to an iron deficient or 
an iron supplemented diet (carbonyl iron) for 5 weeks.
As a means of'informing' the enterocytes regarding body iron stores and therefore 
programming regulatory behaviour, I postulated that this is mediated through TfR located 
on the basolateral surfaces of the enterocytes. I therefore propose to examine TfR mRNA
30
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and protein expression in the same groups of animals. The latter was achieved by 
immunohistochemical techniques using monoclonal antibodies to rats and humans.
This thesis has been divided into four experimental sections. Chapter 2 describes 
the techniques used, the development/adaptation of methods to separate crypt and villus 
cells in the rat intestinal mucosa as well as the development o f probes to examine mRNA 
transcripts (TfR and ferritin) to test my hypothesis. Chapter 3 describes experimental 
manipulation of body iron stores by diet using an animal model (rat) to study its effect on 
intestinal TfR mRNA expression in crypt and villus cells. By using immunohistochemical 
techniques, TfR protein expression was also studied in these animals. In Chapter 4, L and 
H ferritin mRNA expression was examined in the rat liver and also in crypt and villus 
cells o f the rat intestine after body iron stores were manipulated by diet and parenterally. 
Chapter 5 examined L and H-rich ferritin subunit mRNA expression in crypt and villus 
cells (separated from endoscopic biopsies) in subjects with disordered iron metabolism. 
TfR protein expression was also examined in these subjects. General discussion, 
conclusions and potential for future work are covered in Chapter 6.
I
31
■ ' .I:'-- " 1.- , > : .-y   _ _ _
Chapter 2
2. Development and adaptation of methods and techniques
2.1 Separation o f  intestinal crypt and villus cells in rat intestine
2.1.1 Introduction
The epithelium of the small intestine is maintained by a series o f stern cells at the 
base of the crypts of Lieberkuhn. As these cells migrate up the crypt-villus axis they 
undergo functional and morphological differentiation giving rise to a series o f terminally 
differentiated cells on the villus (Potten & Loeffler 1987, Trier & Madara 1981). This 
migration from the depths of the crypts to villus tip takes approximately 36-72 hours in 
rats (Messier & Leblond 1958) but 3-5 days in humans (Junqueira 1971) where these 
cells reach full maturity at the upper third o f the villus architecture. This migration is 
accompanied by the development of the well-defined apical microvillar brush borders and 
the maturation o f a number of apical (e.g. alkaline phosphatase and sucrase), basolateral 
(e.g Na+/K+-ATPase) and basal (e.g thymidine kinase) enzymes. Methods for separating 
crypt and villus cells in rodents have been described previously, the most notable is by 
the mechanical separation in chelation buffer (Weiser 1973). Initially, separation was 
undertaken at 37 °C which resulted in significant disruption of biochemical and molecular 
processes such as mRNA stability. Later, the separation technique was undertaken at 4 ”C 
which preserved mRNA integrity (Flint et al 1990). I have modified the separation 
technique o f Flint et al 1990 (section 2.1,2) to test my hypothesis in the rat model. To 
study isolated crypt and villus cells in human tissue in which tissue availability is limited, 
I have had to develop a method for separating these cell subpopulations from endoscopic 
samples (Chapter 5). Validation of these cell subpopulations were undertaken by 
histological acessment, assaying for specific enzymes such as alkaline phosphatase 
(villus cells) and 3H-thymidine incorporation (crypt cells). Below (Table 2-1), is a brief 
description of how I modified the Flint et al (1990) protocol o f crypt-villus separation in 







2.1.2 Materials and methods
(i) Reagent sources | |
All chemicals used in these studies were purchased from Sigma Chemical (Dorset,
U.K.) unless stated in the text.
(ii) Animals and tissues
Eight to 10 weeks old, male Wistar rats (Charles Rivers, Ramsgate Kent, 
England) were housed individually in polythene cages and received a standard rodent diet 
(Special diet services, Essex, U.K.). At the end of the study, the animals were sacrificed 
by carbon dioxide inhalation and the proximal small intestine (25 cm. from the pyloric 
antrum) was removed for cell separation. This was essential in order to provide 
reproducible results (Schumann et al 1990). Throughout the study, the animals had 
unlimited access to water.
(iii) Protocol fo r  crypt-villus separation in the rat intestinal mucosa
The proximal small intestine was removed and flushed with 20 mis of iced Hanks 
buffered salt solution (HBSS, low calcium and magnesium, Hyclone, UK) in 0.5 mM 
dithiothreitol. Tissues were everted using a blunt-ended spinal needle by a 'sleeve pull 
through' technique as shown in Figure 2-1. The everted bowel was divided into 
approximately 2 cm segments and in a sequential series o f incubations and inversions at 
4 “C, various sediment were removed to obtain cell fractions designated Vw, V I, V2, V3, 
C l and C2. After separation, cells were concentrated by centrifugation (Mistral 6L 
Fission instruments) at 2000 rpm for 10 minutes at 4 ”C. The pellet was resuspended in 
0.5 mis chelation buffer and stored at -80 °C until RNA extraction or biochemical 
analysis were undertaken.
Figure 2-1
Eversion o f the rat intestinal m ucosa for separation o f crypt-villus cells
Key: 1: spinal needle with end made blunt, 2: small intestine treaded through and one end 




Isolation of rat intestinal mucosa along the crypt-villus axis
Evert small intestinal mucosa 
Cut specimens into 1-2 cm pieces. Incubate in 30 mis Hanks buffer with 0.5mM 
DTT at 4 “C for 5 minutes under constant stirring with a magnetic flea 
Transfer small bowel tissues to 60 mis of *chelation buffer in a sterilin container 
Incubate at 4 °C with constant stirring for 25 minutes 
Obtain supernatant and pellet cells at 2000 g for 10 minutes 
This fraction is labelled Vw
Transfer small bowel tissues to 60 mis of chelation buffer 
Invert sterilin container gently by hand, approximately 30 inversions 
Obtain supernatant and pellet cells at 2000 g for 10 minutes at 4 °C 
Repeat twice in 60 mis o f cold chelation buffer. Pellet cells as before 
This gives fractions labelled Vi, V 2  and Vs
Transfer tissues to 60 mis chelation buffer 
Incubate at 4 °C for 10 minutes with constant stirring 
Discard suspension
Transfer small bowel tissues to 60 mis of chelation buffer 
Invert sterilin container gently by hand (approximately 30 inversions) 
Obtain supernatant and pellet cells as before 
This fraction is labelled Ci 
Repeat above until tissues float to the surface 
This fraction is labelled C 2




(iv) Validation o f  cell subpopulations
The purity and character o f the cell fractions obtained by this separation technique 
was assessed histologically, enzymatically (villus cells) and by 3H-thymidine
incorporation (crypt cells).
îîl(a) Alkaline phosphatase assay .,:3
Villus cells were identified by activity of constituent enzymes i.e. alkaline I'
phophatase. For alkaline phosphatase measurements, cells were disrupted with a sonicator 
(MSB Soniprep 150) for 6 seconds at 10 pm wavelength. The suspension was centrifuged 
at 4 °C (Eppendof 5402R) at 10,000 g for 5 minutes. 200 pi o f supernatant was then 
incubated at 37 °C with enzyme substrate (0.23 mM p-nitrophenylphosphate in 0.3 mM 
ZnCh and 10 mM MgCl^ in 0.5 M Tris-HCl, pH 7.4, total volume 1.1 mis) for 15 
minutes and the reaction terminated with 0.5 mis of 0.5 M NaOH. Enzyme activity was 
determined by the release of p-nitrophenol detected spectrophotometrically at 420 nm. 
Results (Figure 2.3[top]) were expressed as the amount o f p-nitrophenol per mg protein 
determined by the Lowry method (1951) as described below.
The Lowry protein assay utilised the following reagents 
Solution A: Na2C0^ (20 g/1) in 0.1 M NaOH (4g /I)
Solution B: CuS04 5 H 2 O (0.5 g/100 ml) in 1% sodium citrate
Solution C: 50 mis o f A + 1 mis o f B
Folins reagent was diluted with distilled water (1:1).
The standard stock solution used is BSA (100 mg/100ml in 0.9% saline)
One ml o f solution C was introduced to either 200 pi of test solution or standard 
solution. The mixture was vortexed and left to stand for 10 minutes at room temperature. 
Then 100 pi of diluted folin reagent was introduced and the mixture left at room 
temperature for a further 30 minutes. Absorption was read at 750 nm with saline as a 
blank and samples were analysed in duplicates.
a:
■ ' I
 ^   ■  : L. _ ............ ..................
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Construction o f  a standard curve
This was undertaken as described below (200 \il total volume)
Blank A B C D E F
Cone (|ig/ml) 0 50 125 250 500 749 1000
Stock (|il) 0 10 25 50 100 150 200
0.9% saline 200 190 175 150 100 50 0
Figure 2-2
Standard curve for protein assay
1 .2  “1
Sample range13 0.6 -IIÔ 0 .4 -I
0.2 -
100 200 300 400 5000
Protein concentration ng/ml
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(b) Incorporation o f  3H-thymidine
Crypt cells were identified by 3H-thymidine uptake (Leblond & Messier 1960). 
Male Wistar rats (100 g body weight) were injected intraperitoneally (ip) with methyl- 
3H-thymidine (Amersham, Buckinghamshire, U.K.) specific activity 79 Ci/mmol at 1 
pCi/g 1 hour to label proliferative cells. At the end of the experiment, the animals were 
sacrificed by cervical dislocation. Isolation of cell subpopulation was undertaken as 
described previously in Table 2-1.
Two hundred pi of the resuspended cells was precipitated with 5 % trichloroacetic 
acid and the precipitate dissolved in 200 pi 0,1 mM NaOH and neutralised with an equal 
volume of 0.1 mM HCl. Radioactivity in the samples was determined by liquid- 
scintillation counting (10 ml of scintillant, LKB, Loughborough) on a LKB 1219 Rack 
Beta counter. Results (Figure 2.3[bottom]) were expressed as dpm per mg protein 
(Lowry et al 1951).
(c) Histological verification o f  separation technique
At each sequential stage o f the isolation procedure, a small bowel remnant was 
removed and processed for histological examination after staining with haematoxylin and 
eosin (Figure 2-4).
2*13 Comment
The present study of alkaline phophatase activity and thymidine incorporation in 
the segregated cells reveal a gradient o f 4 and 8 fold difference respectively of 
activity/incorporation between crypt and villus cells (Figure 2-3). This compares 
favourably (also a gradient o f 4 and 8 fold difference respectively) to previous studies 
(Weiser 1973, Flint et al 1990). Histological assessment o f cell loss suggest that serial 





Alkaline phophatase activity (top) and SH-thymidine incorporation (bottom) in 
segregated cell subpopulations following segregation of rat intestinal cell 
subpopulation. Note that enzyme activity is highest in villus cells (Vw) and lowest in 
crypt cells (C2 ) and incorporation is highest in crypt cells (C2 ) and lowest in villus cells 
(Vw)
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Histological verification of separation technique for crypt and villus cells
Key: Vo: longitudinal section of rat small bowel, Ve: everted small intestine,
Vw: after 25 minutes in chelation buffer, V3 : after 90 inversions, Ci: after further 




2,2 Cloning and development o f  DNA probes ■f
2,2.1 Introduction
MThe techniques available for examining molecular expression evolved rapidly 
during the period of the thesis. Accordingly, in the course of these studies, I utilised a 
variety o f techniques in my attempt to find suitable probes. These are described here both 
as evidence of my efforts and also as a testament to the rapid progress in development of 
techniques during the relatively short course o f these studies.
To investigate the hypothesis, I wished to examine ferritin transcripts (L and H 
ferritin) in crypt and villus cells of the proximal rat intestinal mucosa over a 3-5 day 
period after manipulation o f body iron stores with diet. I will require L and H-ferritin 
probes. Initially I had planned to use oligonucleotide ferritin probes and selected 
sequences (30 mers) for rat L and H-ferritin verified using Genbank database. These 
sequences (shown in the appendix at the end of this chapter) were synthesised by Dr. 
Barraclough in the Department of Biochemistry, University of Liverpool. When these 
probes were tested on rat tissues, the hybridisation signal for L-ferritin (Figure 2-5a) was 
located in the predicted position below the 18S rRNA but the hybridisation signals for 
H-ferritin (3 different sequences selected) were on 28S rRNA (Figure 2-5b) where the 
predicted hybridisation signal is below the 18S rRNA. This observation could be 
explained by complementarity between ferritin and 28S rRNA which has been reported 
previously (Swatantra et al 1985). This is thought to affect the stability and/or the 
translatability o f ferritin mRNA. My search for a rat ferritin cDNA probe was 
unrewarding and mouse ferritin cDNA probes were examined in rats tissues.
Mouse L (578 bp) and H-ferritin (347 bp) were a generous gift from Dr. Andrew 
McKie, in the Department o f Molecular Medicine, ICings College, University of London.
These probes were generated by the polymerase chain reaction (PCR). When I tested 
these probes on rat tissues (liver and small intestinal RNA), the hybridisation signal was 
in the predicted position below the 18S rRNA (Figure 2-6a & b). Furthermore, sequence
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verification between mouse and rat ferritin was confirmed using Genbank database. There 
was sufficient mouse ferritin cDNA for subsequent experiments and further manipulation 
was not required.
Preliminary experiments also reveal that mouse ferritin probes were not 
compatible with human tissues which I also wanted to examine (Chapter 5). Human 
ferritin probes (cDNA) probes were a kind gift from Dr. Antonello Pietrangelo, 
Department of Internal Medicine, Modena, Italy. The pFr and Pr3 clones containing the 
L-ferritin gene (approximately 850 bp) and the H-ferritin gene (approximately 900 bp) 
respectively had been incorporated into the plasmid PBR 322. To generate sufficient 
cDNA for subsequent experiments, further manipulation (gene cloning) was required.
The gene cloning experiments were undertaken by me in the School of Tropical 
Medicine, Liverpool, by which the plasmid PBR 322 containing the ferritin gene 
sequence were transformed to DH5 1-a competent cells (Promega, Biotech, Liverpool, 
U.K.). Furthermore, since PBR 322 is a relatively ‘primitive’ plasmid and as such the 
yield of plasmid DNA is low, amplification using chloramphenicol (an inhibitor of 
protein synthesis and chromosomal replication but not plasmid replication) was used to 
increase its copy number. Plasmid DNA was obtained using the Large-Prep alkaline lysis 
method and fragment DNA of interest obtained using restriction enzymes as described 
below.
TfR protein and mRNA expression was examined (Chapter 3), in crypt and villus 
cells o f the rat intestinal mucosa. The latter was achieved using an oligonucleotide probe. 
This is a 30 base oligonucleotide antisense to TfR30i-33i (Kuhn et al 1984) with the 
following sequence (5'-GCT-CAT-CTG-GGG-ACA-GGT-GAC-CCT-TAC-ACA-3'). 
Sequence verification to rat TfR was again confirmed using Genbank database and 
preliminary experiments have shown this oligonucleotide to hybridise liver and small 





A utoradiogram  for L-ferritin (oligonucleotide probe)
Key: lane 1 : rat liver RNA (20 |ig), lane 2: rat intestinal RNA (20 pg) 





A utoradiogram  for H-ferritin (oligonucleotide probe)
Key; lane 1 ; rat liver RNA (20 pg), lane 2: rat intestinal RNA (20 pg) 
Note that the hybridisation signal is on 28S rRNA
1 2
? H-ferritin on 28 S rRNA
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Figure 2-6 (a)
Mouse L-ferritin (cDNA probe)
Key: lane I: rat liver RNA (20 pg), lane 2: rat intestinal RNA (20 pg) 





Mouse H -ferritin (cDNA probe)
Key; lane 1 : rat liver RNA (20 pg), lane 2: rat intestinal RNA (20 pg) 
Note hybridisation pattern is below 18S rRN A
i 2
0 0 1  ---------- 18S rRNA
5-----—— H-ferritin mRNA
Figure 2-7
Com parison of ra t and hum an TIR mRNA in small bowel and liver
Key: lane 1: liver RNA (20 pg), lane 2: mucosal RNA (20 pg), lane 3: human liver RNA
(20 pg) and lane 4; mucosal RNA from one endoscopic biopsy





(i) Preparation o f  nutrient broth medium |
Nutrient broth No.2 (containing beef extract powder, peptone and sodium 
chloride) obtained from Difco, East Molesey, U.K. was rehydrated by suspending 25 g of 
medium to 1 litre of deionised water and heated to boiling to dissolve completely. Media 
was autoclaved at 15 Ib/sq. in. in a liquid cycle for 20 minutes and stored at 4 until 
required.
Agar base No.2 dehydrated (containing protease peptone, liver digest, yeast 
extract, sodium chloride and agar) obtained from Difco, East Molesey, U.K. was 
rehydrated by suspending 39.5 g of medium in 1 litre of deionised water and heated to 
boiling to dissolve completely. This was autoclaved under the same conditions and 
allowed to cool in a fume cupboard. Ampicillin (50 pl/ml medium) was introduced to the 
medium and then transferred to petri dishes. Agar plates with and without ampicillin were 
labelled and stored inverted at 4 °C until required.
(ii) Transformation and plasmid preparation
Competent cells DH5 1-a (500 pi) were thawed, stored in ice (10 minutes) where 
10 pi of plasmid DNA was introduced (the volume of plasmid DNA solution should not 
be more than 5 % of the volume of the competent cells). In general, approximately 50 pi 
of competent cells are usually sufficient to be saturated by 1 ng of plasmid DNA. The 
mixture was left in a water bath (42 °C) for 2 minutes with care not to shake the 
eppendorf tube followed by ice (30 minutes) and 800 pi of nutrient broth. Reaction 
mixture was then placed in a shaking water-bath (37 °C) for 60 minutes and plated onto 
agar plates containing ampicillin (50 pl/ml) to select out transformed cells. Agar plates 
were incubated at 37 °C for 12-16 hours to obtain bacterial colonies. For the pFr and Pr3 
clones (L and H-ferritin) in plasmid PBR 322, after transformation onto bacterial DH5
1-a competent cells, amplification was undertaken to increase its copy number.
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(Hi) Amplification
Ten mis of bacterial culture carrying the plasmid pBR322 was grown to the late 
log phase (optical density o f 0.6 at 600 nm). Five hundred mis o f nutrient broth medium 
(prewarmed to 37 °C) containing ampicillin (50 pl/ml) was introduced in a 2-litre flask to 
2 mis of the late-log phase culture. Incubation was undertaken for approximately 3 hours 
at 37 with vigorous shaking on a rotary shaker or until the optical density of the 
culture was approximately 0.4. Chloramphenicol (2.5 mis o f 34 mg/ml in ethanol) was 
introduced (final concentration in the culture is 170 pg/ml). The culture was incubated for 
a further 12-16 hours at 37 °C with vigorous shaking in a rotary shaker.
(iv) Harvesting and recovery o f  plasm id DNA
Bacterial cells were harvested by centrifugation (400 rpm for 15 minutes at 4 °C) 
in a Sorval GS3 rotor centrifuge. The supernatant was discarded. Bacterial pellet was 
resuspended in ice-cold STE buffer* and bacterial cells obtained by centrifugation as 
before. Alkaline lysis and ethidium bromide-caesium chloride gradient centrifugation was 
utilised to separate plasmid from chromosomal DNA following the method described by 
Ish-Horowica & Burke (1981).
Bacterial pellet was resuspended in 10 mis of Solution 1*. The suspension was 
incubated for 10 minutes (room temperature) followed by 20 mis o f Solution 2* (freshly 
prepared). Contents were thoroughly mixed by inverting the bottle several times and left 
in ice (5 minutes) followed by 10 mis of ice-cold Solution 3* and stored in ice for at least 
20 minutes. A flocculent should form consisting of chromosomal DNA, high molecular 
weight RNA and potassium/SDS/membrane complexes. Bacterial lysate was centrifuged 
(7000 rpm for 10 minutes at 4 °C) and supernatant divided into 35 mis centrifuge tubes 
with 12 mis isopropanol and left for 10 minutes at room temperature. Plasmid DNA was 
recovered by centrifugation (10,000 rpm for 10 minutes at 20 ®C). Pellet was rinsed in
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70 % ethanol at room temperature and excess ethanol removed by a vacuum deciccator. 
Plasmid DNA was obtained by centrifugation in a caesium chloride-ethidium bromide 
gradient.
(v) Centrifugation in a caesium chloride-ethidium bromide gradient
Plasmid DNA (pellet) was dissolved in 13 mis of TE buffer* with 13.9 g of 
caesium chloride and 1.3 mis (5 mg/ml) ethidiun bromide. The tube was inverted to 
dissolve caesium chloride and centrifuged (10,000 rpm for 10 minutes at 20 °C) to pellet 
proteins and to remove the pellicle layer on the surface. The density of the mixture was 
adjusted if necessary to 1.56 g/ml by adding caesium chloride or TE buffer. The solution 
was transferred to an ultracentrifuge tube, filled with paraffin and centrifuged at
42,000 rpm (T865 fixed angle rotor) for 20 hours at 18 ^C. Two bands of DNA, located in 
the centre of the gradient will be visible (the upper band consisting of contaminating 
bacterial chromosomal DNA and linear open-nicked plasmid DNA [discarded] and the 
lower band consisting of supercolied plasmid DNA collected with a hypodermic needle).
(vi) Removal o f  ethidium bromide from purified plasmid DNA
An equal volume o f saturated isoamyl alcohol was introduced to the DNA 
solution and the two phases mixed by vortexing. A Pasteur pipette was used to transfer 
the lower aqueous phase to another tube. The above procedure was repeated (6 times) or 
until all the pink colour had disappeared from the aqueous and organic phase.




(vii) Removal o f  caesium chloride from  purified plasmid DNA
This was undertaken by dialysis for 24-48 hours against TE buffer* and buffer 
was changed several times during the dialysis period. The expected yield is 2-10 mg of 
plasmid DNA per 500 mis culture. DNA concentration was determined 
spectrophometrically at 260 nm and estimates of purity obtained by the ratio of 
absorption at 260 and 280 nm as described in section 2.3.2.
(viii) Restriction enzyme digest
Restriction endonucleases were used to cleave double-stranded DNA. By 
convention, one unit o f restriction enzyme is defined as the amount o f enzyme needed to 
cut 1 pg o f DNA in 1 hour. Restriction digest was performed in the following way:
DNA solution (in a sterile eppendorf tube) was mixed with sufficient water to give a 
volume o f 18 mis with 2 mis o f 10 X restriction buffer and 1-2 units of restriction 
enzyme. Incubation at 37 °C was undertaken for the required period and the reaction 
terminated by adding 0.5 M EDTA (pH 8.0) to a final concentration o f 10 mM.
(ix) Analysing the products o f  a restriction digest
Restriction digest will result in a number o f DNA fragments of varying sizes 
where these fragments are separated by agarose gel electrophoresis. DNA fragments can 
be visualised by staining with ethidium bromide under ultraviolet irradiation provided 
sufficient DNA (not less than 25 ng) is present. A representative restriction digest is 
illustrated in Figure 2-8.
2.2.3 Comment
Modem biological techniques such as gene cloning have only been recently 
introduced and many of the techniques which I have used have already been superseded 
by more efficient ways o f making DNA probes which were unavailable to me at the time
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of study. Furthermore, molecular signal amplification teclmiques have evolved such that 
quantitative mRNA can now be undertaken more easily than heretofore. However, I 
believe that some of the techniques I have adapted such as the separation of human crypt 
and villus cells (Chapter 5) could be much more informative using the more sensititive 
assays.
Figure 2-8
Agarose gel electrophoresis for a restriction digest for human L and H- ferritin with 
PsTl. (DNA stained with ethidium bromide, lane 1: digested L-ferritin, lane 2: uncut 
L-ferritin, lane 3: markers, lane 4: uncut H-fenitin and lane 5: digested H-fenitin). The 
cDNA fragments (arrows) were collected, concentrated and used for hybridisation 
(Chapter 5).







The molecular biological techniques employed in the current thesis are now described.
2.3.1 Single step RNA extraction
RNA separation was undertaken as described by Chomycznski & Sacchi (1987), a 
robust method which enables completion o f RNA extraction within 4 hours. All 
chemicals used for RNA extraction were obtained from Sigma unless stated otherwise 
and solutions made up with 0.1 % diethylpyrocarbonate (DEPC) water and autoclaved.
Tissue or cells were homogenised in 0.5 mis o f solution D (0.36 mis of
2-mercaptoethanol/50 mis solution C) which is stable for at least 1-3 months at room 
temperature. Solution C consists o f 250 g guanidinium thiocynate in 293 mis water,
7.6 mis 0.75M sodium citrate and 26.4 mis 10 % sarcosyl. This was followed by the 
addition of 50 pi 2M sodium acetate (pH 4), 500 pi phenol and 100 pi chloroform- 
isoamyl alcohol (49:1). The mixture was vortexed for 10 seconds and cooled in ice for 15 
minutes and centrifuged (12000 g for 20 minutes at 4 °C). The supernatant was obtained 
and introduced to 0.5 mis of isopropanol. Great care was taken to avoid transferring 
contaminating material (proteins and phenol) located in the lower region of the 
supernatant. Samples were left overnight at -20 or 1 hour at -80 “C to precipitate the 
RNA which was recovered by centrifugation (12000 g for 20 minutes at 4 °C). RNA was 
dissolved in 0.3 mis of solution D with an equal volume of isopropanol and left -20 °C for 
another hour or overnight. (From experience, RNA yield was greater if  precipitation was 
carried out overnight). RNA was recovered by centrifugation (12000 g for 10 minutes at 
4 ^C), washed in 1 ml 75 % ethanol, dried at room temperature for 5 minutes, (vacuum 
drying of the RNA pellet from experience was not necessary) and finally dissolved in 
50 pi 0.5% sodium dodecyl sulphate (SDS) at 65 for 10 minutes. Samples were stored 
at -80 °C until required.
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2,3.2 Spectrophometric determination o f  RNA and DNA
Determination o f the absorption spectrum at 260 nm allows quantification of the 
amount of nucleic acid in the sample. By definition, an optical density o f 1 is equivalent 
to 50 pg/|xl for double stranded DNA, 40 pg/pl o f single stranded DNA or RNA and 
20 pg/pl o f oligonucleotides. In addition, the ratio of the absorption at 260 nm to 280 nm 
allows an estimate o f the purity o f the nucleic acid. Pure DNA preparations have values 
o f greater than 1.8 and pure RNA preparations have values greater than of 2.0. 
Contamination by phenol or proteins will lead to lower ratios. Oligonucleotides, however, 
do not observe this rule. The ratio of absorption at 235 nm to 280 nm is used, with a ratio 
of 1 regarded as being fi*ee firom contaminants. A representative absorption spectrum of 
rat liver RNA is shown in Figure 2-9.
Figure 2-9
Absorption spectrum of rat small intestinal RNA.
Ratio o f optical density at 260 nm to 280 nm can be used to estimate the purity o f RNA
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2.3.3 RNA separation by formaldehyde SX MOPS-agarose gel electrophoresis
RNA molecules are biological compounds that carry a negative electrical charge. 
Therefore, when subjected to an electrical field, they will migrate towards the positive 
pole. Agarose gel electrophoresis can therefore be used to separate RNA molecules 
according to their size. Composition of formaldehyde gels and conditions for 
electrophoresis have been summarised in the appendix. RNA can be visualised with 
certain stains such as ethidium bromide which intercalates with these molecules and 
fluoresces under ultraviolet irradiation. Figure 2-10 illustrates the presence of the 28S and 
18S ribosomal RNA (rRNA) stained with ethidium bromide. Messenger RNA (mRNA) 
cannot be visualised by this technique as they contribute less than 1 % of the total RNA. 
A more sensitive method of detection is autoradiography. In this, a complementary DNA 
sequence (double stranded) or an oligonucleotide sequence (single stranded) is labelled 
with a radioactive marker such as ^MCTP. This will hybridise to complementary 
sequences of specific mRNA's of interest that have been separated by agarose gel 
electrophoresis, transferred to nylon membranes by capillary blotting (Northern blotting) 
and fixed to these membranes by ultraviolet radiation. The mRNA of interest can be 
visualised by placing an X-ray sensitive photograph over the nylon membranes 
(autoradiography); the intensity o f the signals reflecting the population of the transcripts 
and are quantified by desitometery.
2.3.4 Northern blot transfer
The technique for RNA transfer to nylon membranes by capillary blotting is as 
described in Sambrook et al Molecular Cloning manual (1989). Briefly, the filter paper 
(Whatman chromatography paper, Maidsione, England) and membranes (Amersham UK) 
were cut to the same size as the gel, in 0.1% DEPC water and capillary transfer was set 
up as shown in Figure 2-11. The sides of the gel were sealed with parafilm (American
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10 X SSC for 16-18 hours.
Following transfer, membranes were dried at room temperature sandwiched 
between 2 filter papers for 5 minutes and covered in saran wrap (Dow chemical 
company). RNA was fixed to the membranes by exposing to UV light for 3 minutes 
where membranes were kept at 4 °C until required or stored at -80 °C if not to be used 
immediately.
Figure 2-10
A garose gel electrophoresis show ing rat liver 28S and 18S ribosom al R N A  stained  
with ethidium  brom ide. Note that mRNA cannot be visualised by this technique
28S rRNA  
18S rRNA
Figure 2-11
Northern transfer o f R N A  by capillary blotting
paper towels
nitrocellulose filter 
or nylon m em brane










2.3.5 Preparation and use o f  DNA probes
Both cDNA (mouse and human ferritin) and oligonucleotide probes (TfR) were 
utilised in the experiments. However, in order to normalise for RNA loading, two 
additional oligonucleotide ribosomal probes (oligonucleotide sequences corresponding to
Irat 18S rRNA (Torczynski et al 1983) and human 28S rRNA (Barbu and Dautry 1990) 
were used. The oligonucleotide sequences for TfR, 18S and 28S rRNA were synthesised 
by Dr. Barraclough, in the Department o f Biochemistry at the University of Liverpool,
Probes were labelled by different enzyme systems, cDNA with a random priming 
kit utilising Klenow enzyme (Promega, Biotech) and the oligonucleotides with a terminal 
transferase kit (Boehringer, Manheim, Biochemica, East Sussex, England).
(i) Labelling o f  cDNA sequences by random priming
Complementary DNA was labelled with the prime-a-gene kit based as described 
by Finneberg and Vogestian (1983). Table 2-2 summarises labelling reactions by random 
priming. Six pi of cDNA (approximately 25 ng) in 6 pi TE buffer was boiled and cooled 
in ice (5 minutes) followed by 2 pi o f dNTP (obtained from mixing 2 pi o f dATP, dTTP 
and dGTP), 2 pi bovine serum albumin (BSA), 2 pi Klenow enzyme, 19 pi sterile water,
10 pi 5 X buffer and 3 pi ^^dCTP (Amersham) introduced sequentially. The mixture was 
incubated for 3 hours at room temperature, boiled for 5 minutes to separate double 
stranded DNA and cooled in ice (5 minutes) before hybridisation.
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Table 2-2
Random Priming with hexamer cDNA





then add random hexamer and dCTP
'Filling in' with Klenow enzyme
0-0-0- o-o-o-o-
Boil again to separate DNA strand
0-0-0- o-o-o-o O-O-OOO-
0 - 0-  0- 0 - 0-0  0 - 0— —  0-0
'Labelled' probe for hybridisation
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(ii) Prehybridisation and hybridisation conditions fo r  cDNA probes
Quickhyad^ approximately 6 mis (Stratagene, Cambridge, U.K.) was activated by 
incubating at 37 °C for 10 minutes in a hybridisation oven. Prehybridisation was carried 
out at 68 for 20 minutes. The probe was introduced (gently to avoid splashing) and 
hybridisation carried out at 68 °C for 1 hour.
(Hi) Washing conditions fo r  cDNA probes and autoradiography
Membrane was washed in the following solutions with increasing stringency :
2 X SSC/0.1% SDS (15 minutes at room temperature), 2 x SSC / 0.1% SDS (15 minutes 
at 60 °C) and finally twice in 0.1 x SSC / 0.1% SDS (15 minutes at 60 °C). In between 
washings, the membrane was checked with a Geiger counter for intensity o f background 
activity before proceeding to a higher stringency wash. Membrane was placed in X-ray 
film (Kodak) and left -80 '^ C for varying periods to generate an autoradiogram. 
Autoradiograms were developed and the intensity of the signals quantified using a 
Schimadzu C5 9000 dual chamber flying spot scanning densitometer.
(iv) End labelling o f  the oligonucleotide sequences by terminal transferase
Labelling conditions were carried out in accordance to the manufactures 
instructions (Boehringer). The mixture, 5 pi 5x buffer, 4.5 pi C0 CI2 , 1.5 pi 
oligonucleotide (approximately 10 ng), 1 pi terminal transferase enzyme and 3 pi 32dCTP 
was left to incubate at 37 °C for 1 hour and the reaction terminated with 5 pi 2M EDTA, 
pH 8. Excess radioactive material was removed with a Sephadex G-50 column prepared 
as follows:
Two grams o f Sephadex G50 (Pharmacia, Fine Chemicals, Milton Kynes, U.K.) 
was dissolved in 100 mis of 6 x SSPE at room temperature and left for at least 24 hours 
before use. A plastic Pasteur pipette (top end removed and the bottom secured with glass 
wool, autoclaved previously) was filled with Sephadex G50. Labelling reaction mixture
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was introduced with 200 pi aliquots of 6 x SSPE collected onto eppendorf tubes (16 
altogether). In this way, preliminary experiments reveal that the first 6-12 fractions 
contained the labelled probe with later fractions containing excess radioactive material. 
The eppendorf tubes were placed in scintillation vials and radioactivity determined on a 
LKB 1219 Rackbeta counter (counted for 1 minute).
(v) Prehybridisation and hybridisation o f  oligonucletide sequences
Prehybridisation was carried for 12 hours at room temperature (ribosomal probes) 
and at 42 ”C (transferrin receptor probe) in 20 mis prehybridisation ^buffer. A higher 
temperature for TfR was utilised to reduce non-specific binding where preliminary 
experiments reveal this to be the optimal temperature for hybridisation. Labelled 
oligonucleotide sequence was introduced and hybridisation carried out for a further 16-18 
hours in 10 mis hybridisation *buffer.
(^details o f buffers can be obtained in the appendix at the end o f this section) .
(vi) Washing conditions and autoradiography o f  oligonucleotide sequences 
The following conditions were used with increasing stringency:
TfR probe
1 X SSC/0.1 % SDS, O.lx SSC/0.1 % SDS (both for 15 minutes at room temperature),
0.1 X SSC/0.1 % SDS (15 minutes at 30 T ) .
Ribosomal probes( 18S and 28S)
1 X SSC/0.1 % SDS (15 minutes at room temperature), 1 x  SSC /O.l % SDS (15 minutes 
at 60 °C) and finally twice in 0.1 x  SSC/0.1 %SDS (15  minutes at 60 °C).
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(vii) Determination o f  specific activity ofprobe
This is essential to find the minimum volume o f the labelled probe required for 
hybridisation and was determined as follows. One pi o f the labelled cDNA or 
oligonucleotide was mixed to 9 pi o f water by gentle shaking. One pi was placed onto 6 
Whatman DE 81 filter paper o f which 3 o f 6 filter papers were washed in 20 mis o f 0.5 M 
NaPO^ for 5 minutes. This represents the labelled counts and the other 3 unwashed filter 
paper represents the total counts. Filter papers were allowed to dry at room temperature 
and with 5 mis scintillant in each vial, radioactivity was recorded (5 mis o f scintillant was 
used as a blank for background). Percentage labelling was determined by taking the ratio 
of the means o f the labelled samples (washed filter papers) to the means of the total 
counts (unwashed filter paper).
The volume of the probe required for hybridisation was calculated as follows :
Percentage labelling (x) = mean counts o f the washed samples x 100
mean counts of the unwashed samples
If the mean counts for the unwashed samples is Y cpm
The activity of the probe is Y x 10 = Z cpm / pi
For 1 ml o f hybridisation buffer, the required counts would be 1.25 x 10*^  cpm /ml 
Hence the volume of the probe required in 6 mis hybridisation buffer is:
1. 25 X 6 X 10  ^ per ml 
Z cpm
(viii) Expression o f  results
A representative autoradiogram is shown (Figure 2-12) for rat H-ferritin mRNA 
and 18S rRNA at different RNA concentrations. The intensity of these signals were 
quantified by densitometery (Figures 2-13a & 2-13b ) and results were expressed as a 




(ix) Histology and immunohistochemical illustration
All the illustrations (haematoxylin, neutral red and immunohistochemistry) in this 
thesis have a magnification of X I00 unless stated otherwise.
(x) Statistics
All data are shown as mean ± SEM unless stated otherwise. Food intake, body 
weight were analysed using the nonparametric Mann Whitney test. A significance level 
ofp<0.05 was chosen for any differences revealed. All statistical procedures were carried 
out using the Arcus-Pro II™ statistical package (Medical Computing Ltd.; Aughton, 
Lancs, U.K.)
Figure 2-12
Autoradiogram of H-ferritin mRNA and 18S rRNA in rat liver
Rat liver RNA at 2.5 pg, 15 pg, 30 pg with the H-ferritin mRNA normalised for RNA 
loading with 18S rRNA
Amount of RNA (pg)
H-ferritin mRNA
2.5 5.0 15 30
18 S rRNA » #
H-ferritin mRNA *. 18S rRNA: 0.77 0.75 0.72 0.68
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Summary of densitometer readings for ferritin and 18S rRNA in rat liver










2.5 9658 12478 0.77
5.0 23604 31417 0.75
15 44462 61774 0.72
30 71542 105624 0.68
2,4 Histology
2.4,1 Immunohistochemistry fo r  TfR
Immunohistochemical studies were undertaken using specific monoclonal 
antibodies to TfR in rat OX 26 [Serotec, Oxford, England; 1:10 dilution in phosphate 
buffer solution (PBS)] and human OK T9, (Ortho Pharmaceuticals, Raritan, New Jersey; 
1:10 dilution in PBS) in small intestinal tissues. The second (labelling) antibody was 
peroxidase conjugated rabbit anti-mouse immunoglobulin (Dakopatts, Glostrup, 
Denmark; 1:50 dilution in PBS).
Tissues were fixed in OCT (Miles Scientific, Elkhart, Ind.) and sectioned to 6 pm 
thickness using a microtome cryostat (Cryotome 620, Anglia Scientific, U.K.). Sectioned 
tissues were dried in air (20 minutes), fixed in acetone (15 minutes) and further dried in 






PBS, pH 7.6) was placed onto each tissue section in a humid chamber for either 30 
minutes at room temperature or 10 minutes at 37 °C. This is to minimise non-specific 
binding. Rabbit serum was then carefully removed but ensuring that tissues remain well 
hydrated. The primary antibody was next placed onto tissue sections and incubated either 
for 1 hour at room temperature or 37 °C for 30 minutes or overnight at 4 °C in a humid 
chamber. As a control, incubations were undertaken without the primary antibody. Tissue 
sections were washed 3 times in PBS, 5 minutes for each wash. The second antibody was 
introduced and incubation undertaken at either 1 hour at room temperature or at 37 °C for 
30 minutes. Tissue sections were washed as before. Approximately 5 mg of 
diaminobenzidine [DAB] (freshly prepared by dissolving in 9.97 mis PBS and 33 pi 
hydrogen peroxide) and kept away from light until used. Tissue sections were covered 
with DAB for approximately 2-5 minutes until a brown colour develops (Weir et al 
1974), washed in distilled water for 5 minutes, counterstained with haematoxylin (BDH 
Chemicals, England) for 10 seconds, soaked in water bath for a further 5 minutes and 
finally immersed in the following: 70% ethanol (2 minutes), 90% ethanol (2 minutes), 
100% ethanol (5 minutes) and xylene (twice for 5 minutes). The final immersion is 
crucial to obtain a clear slide. A small drop of distrene plasticizerxylene (BDH 
Chemicals) was placed onto each tissue section and the slide mounted with a cover slip 
with care so as not to introduce any air bubbles. The slide was allowed to dry before 
viewing under light microscopy.
2,4.2 Perisprussian blue staining fo r  haemosiderin
This stains haemosiderin deposits in tissues blue. Peris potassium ferricyanide 
(BDH Chemicals, Poole, U.K.) approximately 4 g was dissolved in 25 mis of distilled 
water until a pale yellow coloured solution was obtained followed by 25 mis of 2 % 
concentrated hydrochloric acid in a Caplan jar (Solution A). Then tissue sections were 
taken from 100 % ethanol (in a series o f decreasing concentrations of ethanol) to water. 




was removed by washing in distilled water and tissue sections were counterstained with 
1 % neutral red. Tissue sections were quickly dehydrated in increasing concentrations of 
ethanol (70 %, 90 %, 100 %) and the slide mounted in DPX as before.
2.5 Appendix
Section 1: Ctypt-villus separation
Chelation buffer fo r  crypt/tip separation (pH 7.3)
2 7mM trisodium citrate; 5mM Na2HP0 4 ; 96mM NaCl; 8mM KH2PO4; l.Sm M  KCl; 0.5 
m M  dithiothreitol (DTT); 55 mM  D-sorbital and 44mM sucrose.
Section 2: Ferritin sequences 
L-ferritin sequence
5'-GCFGAA~GAT~GAG~TGG~GGFAAA-ACC-CCA-GAC-3'




No hybridisation signal was obtained from  this sequence
Sequence 2: 5'-AAG-AAC-TTT-GCC-AAA-TAC-TTT-CTT-CAC-CAA-3'
Sequence 3: 5'-GCA-TGT-TGG-GGT-TTC-CTT-3'
Both sequences produced hybridisation signals on the 28S rRNA
Solution 1
50 mM  glucose, 25 mM Tris.Cl (pH 8.0), 1% SDS, 10 mMEDTA (pH 8.0)





Solution 2 was prepared fresh each time before use.
Solution 3
5M  Potassium Acetate 60 mis
Glacial Acetic acid 11.5 mis
Water 28.5 mis
The resultant is 3 M  with respect to potassium and 5 M  with respect to acetate. Solution 3 
was not autoclaved 
TE Buffer
lO m M Tris Cl (pH 8.0), 1 mMEDTA (p H 8.0)
TE Buffer was also autoclaved.
STB buffer
0.1 M NaCl, 10 mM Tris.Cl (p H 8.0), 1 mMEDTA (pH 8.0)
This buffer was also autoclaved.
DNA minigel
For a 1.2 % agarose gel, 0.5 g  o f  agarose in 5 ml 5x TBE buffer and 35 mis o f  DEPC  
water was brought to boil and then cooled fo r  1 hour to allow the gel to set.
5 X  TBE buffer
The running buffer is 5 x  TBE buffer prepared by dissolving 54 g  o f  Tris base, 27.5 g  o f  
boric acid and 20 ml o f  0.5M ETD (pH 8.0) in 1 litre o f  DEPC water. This buffer was 
autoclaved. The working solution is 0.5 x  TBE.
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Sample buffer
The sample buffer consists o f  equal volumes o f  0.25 % bromoblue, 0.25 % xylene cyanol, 
30%  glycerol and ethidium bromide.
Agarose gel electrophoresis
Gel electrophoresis was under taken at 100 volts in 0.5 x  TBE buffer fo r  1-2 hours or 
until the markers have migrated to three-quarters the distance down the gel.
Section 3: Molecular biochemistry 
RNA Agarose gel
Large 1 % agarose gel Small 1 % agarose gel
1.5 g  agarose 0.25 g  agarose
13.5 mis 5 X MOPS 2.5 mis 5 x  MOPS
110 mis 0.1 % DEPC water 20 mis DEPC water
21.5 mis formaldehyde 4 mis formaldehyde
Protocol fo r  making gel
Agarose was dissolved in 0.1 % DEPC water and 5 x  MOPS in a water-bath and the 
mixture cooled to 50 °C followed by the addition o f  formaldehyde in a fum e cupboard. 
The gel was then allowed to set. This takes approximately 45 minutes fo r  a mini gel and 2 
hours fo r  a large gel.
RNA Running buffer (5 XM O PS) p H  7.0
(3-N-morpholino propanesulfonic acid)
20.6 g  o f  3-N-morpholinopropanesulfonic acid was dissolved in 800 mis 0.1 % DEPC  
water containing 3.28 g  o f  sodium acetate (40 mM). The p H  was adjusted to 7.0 with 2M  
sodium hydroxide. Then, 1.86 g  o f  EDTA in 10 mis o f  DEPC water p H  8.0 (0.5M) was
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added and the fina l volume adjusted to 1 litre. This buffer should not be autoclaved and 
has to be protected from  light. The working solution is 1 x MOPS.
Denaturing solution (DS) Loading Buffer
0.5 mis deionised formamide 1 ml 50 % glycerol
162 p.1 formaldehyde 12 p i 5 % bromophenol 0.05 g/ml
100 p i 5 X M O P S 2 p i (10 pg/pl) ethidium bromide
7 p i IM N aO H
Blotting Buffer (20 x  SSC)
175.3 g  o f  sodium chloride and 76.2 g  sodium citrate was dissolved in 1 litre o f  0.1 % 
DEPC water and then autoclaved. Working solution is 10 x SSC.
Prehybridisation and hybridisation buffers fo r  oligonucleotide probes
Pre-hybridisation buffer Hybridisation buffer
6 mis 20 X SSPE 6 mis 20 x  SSPE
0.2 mis 10 % SDS 0.2 mis 10 % SDS
0.2 mis tRNA (10 mg/ml) 0.2 mis tRNA (10 mg/ml)
1 ml 100 X Denhardts 1ml 100 x Denhardts
12.6 mis 0.1 % DEPC water 2.6 mis 0.1 % DEPC water
100 X  Denhardts solution 10 x SSPE
2 g  Bovine serum albumin 175.5 g  NaCl
2 g  Ficoll 27.6 g
2 g  Polyvinylpyrrolidone 7.4 g  EDTA
Denhardts solution was filter sterilised using a size 0.4 mm pore filter and then stored in 
aliquots o f  1 ml at -20 ^C.
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3 Examination o f transferrin receptor expression in rat
3,1 Introduction
Three proteins, namely TfN the major iron transport protein in plasma, TfR on 
cell surfaces and ferritin, the main intracellular iron storage protein are essential in 
regulating the availability of iron for cellular requirements (Bomford & Munro 1985). 
These proteins are expressed by most cells in the body and are co-ordinately regulated 
with a view to ensure sufficient iron delivery and availability for cellular requirements 
whilst at the same time avoiding delivery of excessive iron and preventing toxicity 
(section 1.3.7). Previous studies have reported and confirm a relationship between body 
iron stores and the regulation o f iron absorption in the proximal intestine 
(section 1.3.2 iv). However, it is not yet clear whether these three proteins play a role in 
regulating iron supply to the body in response to demand.
Human TfN is a glycoprotein (molecular weight 80 KD) with two iron binding 
sites (Fletcher & Huehns 1968). The liver is the major site o f TfN synthesis (Aisen 1984) 
but is not the exclusive site because other cells such as lymphocytes (Morgan & Peters 
1971), Sertoli, (Skinner et al 1984) muscle and brain cells (Levine & Seligman 1984) are 
also known to synthesise transferrin. However TfN is not synthesised in the intestinal cell 
(Pietrangelo et al 1992). A role for TfN in iron absorption involving secretion of 
apotransferrin into the gut lumen to bind luminal iron has been postulated (Huebers et al 
1983) with TfN iron absorbed onto mucosal cell via TfR. To avoid depletion, excess 
apotransferrin was thought to recycle via the enterohepatic circulation. However, the 
inability to demonstrate TfR on the luminal brush border discounted this hypothesis.
Living cells require iron for growth and iron is delivered to cells by TfN 
interacting with specific receptors (TfR) that reside on cell surfaces (Aisen 1980). Like 
TfN, the TfR gene ia located on chromosome 3. To utilise TfN iron, cells must express 
this receptor. TfR is found on most cells in the body especially on cells that have a high 
requirement for iron such as immature erythroid cells and some malignant cells. It is a
68
_________  ____  _ ___
Chapter 3
glycoprotein with two identical subunits, 95 KD each (Schneider et al 1982). Besides 
being embedded on cell surface membranes, TfR are also found in endocytic vesicles or 
endosomes (Dautry-Varsat et al 1983). Within intestinal epithelial cells, these receptors 
are most prominent on the basal, lateral and intercellular membranes (Banerjee et al 
1986, Anderson et al 1990) where the most likely function is to supply iron to developing 
cells. Cell cultures have demonstrated a direct relationship between iron requirement and 
cellular TfR expression (Rouault et al 1985) and immunohistochemical studies have 
revealed greater receptors density in proliferating crypts cells compared to villus cells in 
the small intestine (Anderson et al 1990, Levine & Woods 1990). In addition, there 
appears to be a close relationship between TfR expression and cell division/migration in 
the intestine o f the neonatal rat (Anderson et al 1994). Consistent with this observation is 
the inverse relationship between TfR receptor expression in the small intestine in relation 
to body iron stores (Anderson et al 1990).
Despite this growing knowledge on receptor distribution and regulation, there is 
relatively little quantitative data on receptor expression invivo especially on the response 
to changes in iron stores on regulatory adaptation at the mucosal level.
Physiological studies on iron absorption in animals revealed that iron absorption 
does not increase or decrease for some 3-5 days following artificially induced acute 
anaemia or iron overload (Bannerman et al 1962, Crosby et al 1963, Wheby et al 1964a). 
It has been suggested that cells in the crypts have been "conditioned" in accordance to 
body iron stores where they may later influence iron uptake as they migrate the villus 
architecture some 3-5 days later (Bannerman et al 1962, Conrad & Crosby 1963). An 
obvious candidate to mediate this mechanism was ferritin (Hahn et al 1943, Granick 
1946) but subsequent demonstration o f ferritin synthesis in the presence of iron 
deficiency (Britten & Raval 1980) discounted this hypothesis. However, recent insights 
into the molecular regulation o f ferritin allow for this observation and ferritin as a 
mediator merits further consideration. It has also been hypothesised that TfR at the
69
  :  . .. .
Chapter 3
basolateral surface o f enterocytes may also serve to 'inform' enterocytes regarding body 
iron stores (Fairweather-Tait & Wright 1984, Lombard et al 1997).
3,2 Plan o f  investigations
In the present study, I have adapted and utilised a method o f segregating intestinal 
epithelial cells to provide quantitative data on some characteristics o f TfR under different 
dietary iron conditions. By this, I hoped to determine whether TfR behaves in a way 
which would allow it to influence the control of mucosal iron uptake by informing the 
enterocytes in the crypts and villus regarding body iron stores. To determine whether TfR 
influenced the ability of both crypt and villus cells to respond to changes in iron store, it 
was important to separate the cell types.
TfR protein and TfR mRNA expression in the proximal small intestine was 
examined in the four groups o f animals; iron replete, iron deficient, anaemic and iron 
loaded animals. The iron replete group served as the control, carbonyl iron group as iron 
overload, iron deficient and anaemic groups served as depleted iron stores. Two 
additional studies were undertaken. After the iron loaded animals had received the 
carbonyl iron supplemented diet for 5 weeks (steady state conditioning), these animals 
were switched to an iron deficient diet and immunohistochemical studies of mucosal TfR 
receptors examined at day 0, 1, 3 and 5 after the switch. Similarly, in the iron deficient 
group which had received the iron deficient diet for 5 weeks, these animals were switched 
to the carbonyl iron diet and studied at day 0, 1, 3 and 5 after the switch. The ‘switch diet’ 
model/conditioning was adopted to see if  the change in TfR expression occurred 
differentially in a ‘crypt-villus’ cell fashion.
This chapter has two experimental sections. Section 3-1 examined TfR mRNA 
expression in crypt and villus cells of the rat intestinal mucosa after iron stores were 
manipulated by dietary means. Crypt-villus cell separation was undertaken by adapting a
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previously described method (section 2.1.2). Section 3-2 examined TfR protein 
expression in the proximal intestine using a monoclonal antibody to rat TfR.
3,3 Quantitative distribution o f  transferrin receptor mRNA along the 
crypt-villus axis o f  the rat small intestine: Relationship to body iron stores 
and response to dietary alterations
3.3.1 Materials and methods
(i) Animals and diets
Male Wistar rats (Charles Rivers, Ramsgate) were used for all experiments. The 
experiments were conducted in accordance with Animals Scientific Procedures Act 1986 
code of practice for the care and use o f animals at the University o f Liverpool. Animals 
received diets from the time o f weaning and were housed individually in plastic bottom 
cages and kept at 22 ±  2 in a room with a 12 hour light-dark cycle (0900-2100 hrs). 
Diet was provided in excess o f normal intake (50 g) and deionised water was provided ad 
libitum with iron removed by dialysis with conalbumin. Food intake and general 
condition were checked daily. Animals were studied in four groups, six animals per 
group.
(a) Control group: (n=6, mean weight 338 ±  9.2 g) receiving a standard rodent pellet diet 
(Special diet services, Essex) for 5 weeks. The determined iron content of this diet was 
110 mg/kg diet.
(b) Iron deficient group: (n=6, mean weight 267 ±  9.5 g) consisting of animals 
maintained on an iron deficient diet (iron content of diet was less than 10 mg/kg diet) for 
5 weeks from the time of weaning.
(c) Anaemic group: (n=4, mean weight of 44.2 + 1.6 g) These were rats that had just been 
weaned and the study undertaken immediately where the maternal animal had received 
the standard rodent diet.
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(d) Iron-supplemented group: (n=6, mean weight 265 ± 12.6 g) received the standard 
rodent diet supplemented with 2.5 % wt/wt (dry) carbonyl iron for 5 weeks. This has been 
previously shown to produce hepatic parenchyma cell iron loading (Bacon et al 1983).
(ii) Intestinal crypt and villus separation
Intestinal crypt-tip separation were undertaken by the chelation/mechanical 
method detailed in section 2.1.2.(iii). Briefly, at the end o f the dietary manipulation, 
animals were sacrificed by carbon dioxide inhalation and the proximal small intestine 
(25 cm) from the pyloric antrum was removed and flushed with iced HBSS containing 
0.5mM DTT. Tissues were everted using a blunt-ended spinal needle by a 'sleeve-pull 
through’ technique. In a series o f incubations and inversions at 4 °C, various sediment 
were removed to obtain cell fractions designated Vw,Vi,V2,V3,Ci and C2  (mixture of 
villus and crypt cells). After separation, cells were obtained by centrifugation (Mistral 6L, 
Fission instruments) at 2000 rpm for 10 minutes at 4 ‘^ C. The pellet was resuspended in 
0.5 mis chelation buffer and stored at -80 °C until RNA extraction or biochemical 
analysis were undertaken.
(Hi) Characterisation o f  cell subpopulation
The purity and character o f the cell fractions obtained by this method was 
assessed histologically, enzymatically for alkaline phophatase (villus cell) and by 311- 
thymidine incorporation (crypt cell) detailed in section 2.1.2 iv).
(iv) RNA extraction and Northern hybridisation
•  Northern hybridisation for TfR mRNA were undertaken from the segregated 
crypt and villus cells in the above four groups o f animals. In addition, TfR was 
also studied in RNA extracted from cells segregated sequentially (Vw, Vi,




Total RNA was extracted from cells using acid guanidinium thiocynate- 
chloroform technique (Chomcynski & Saachi 1987) as detailed in section 2.3.1.
A 30 base oligonucleotide sequence, antisense to TfR30i-33i (Kuhn et al 1984) 
was utilised where sequence verification to rat TfR was confirmed using Genbank 
database. Preliminary experiments have reveal this oligonucleotide sequence to 
hybridise to both human and rat TfR transcripts (Figure 2-9). A 32-base 
oligonucleotide sequence (5'-TTT-CTC-AGG-CTC-CCT-CTC-CGG-AAT- 
CGA-ACC-CT-3') previously shown to bind to rat 18S rRNA (Torczynski 1983) 
was used as a RNA control. The latter was chosen as a control because as far as it 
is known, 18S rRNA expression is unchanged between crypt and villus cells 
compared to 'standard' probes such as a-tubulin, actin or histone. Oligonucleotide 
sequences were labelled with ^^dCTP using a terminal transferase enzyme kit 
(Boheringer) with excess radioactivity removed using a Sephadex G-50 column as 
described in section 2.3.5 (iv).
Prehybridisation, hybridisation and washing conditions were as detailed in 
section 2.3.5 (iv). After washing, membranes were exposed to Kodak 
autoradiographic film (Amersham) at -80 °C to generate an autoradiogram. 
Autoradiographs were quantified using densiometery. Results are expressed as a 
ratio of TfR mRNA to 18S rRNA.
Peris potassiun ferricyanide and counter stain 1% neutral red (Williams et al 
1962) to stain haemosiderin deposits in the small intestine and liver to access 
iron storage contend. This has been described in section 2.4.2.
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• Haemoglobin determination was undertaken in 5 mis of blood with an 
Automated STKS Coulter Counter (Miami,Florida).
3.3,2 Results and commentary
(i) Body weight and food  intake
Compared to control animals o f similar age, body weight was significantly 
reduced in animals receiving the carbonyl iron (338 + 9.2 g vs 265 ±  12.6 g p<0.001; 
Figure 3-1) but no significant difference in food intake (Figure 3.2). The effect o f chronic 
iron treatment on body weight is variable. Some studies (Pietrangelo et al 1990) reported 
no change while others (Bacon et al 1983) reported a significant increase. This 
discrepancy may be ascribed to differences in experimental protocol, different strains of 
animals used, source of carbonyl iron and the age of animals used (Pietrangelo et al
1990).
The iron deficient group had significantly greater food intake compared to 
controls (p<0.01) but body weight was significantly reduced (338 ±  9.2 g vs 267 ±  9.5 
g; p<0.001). This may be the effect o f iron deficiency stimulating food intake. There was 
no difference in body weight between the iron deficient and chronic iron treatment group 
although food intake in the iron deficient group was significantly greater than the chronic 
iron treatment group (p< 0.01).
(ii) Iron stores in animals
Peris potassium ferricyanide staining was used to access iron loading. Rats 
receiving the carbonyl iron diet for 5 weeks had substantial haemosiderin deposits in the 
mucosa o f the small intestine and liver (Figure 4-10a & 3-6a). However, no haemosiderin 
was observed in either the mucosa of the small intestine or liver in the iron deficient, 
anaemic and control animals.
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The iron deficient group had significantly greater haemoglobin compared to the 
anaemic group (11.9 ± 0.3 g/dl vs 5.5 ±  0.02 g/dl, p<0.001) but significantly lower 
when compared to controls (11.9 ±  0.3 g/dl vs 13.0 + 0.2 g/dl, p<0.05). Iron loaded 
animals had significantly greater haemoglobin compared to controls (15.0 ±  0.7 g/dl vs 
13.0 ±  0.2 g/dl, p<0.01). Body weights and haemoglobin concentration in the different 
groups have been summarised in Table 3-1.
Table 3-1
Body weights and haemoglobin concentration of rats under different iron regimes 
(data n=6 mean ±  SEM)
Group Control Carbonyl Anaemic Deficient
Haemoglobin
(g/dl)
13.0 ± 9 .2 **15.0±0.7 ***5.5 ± 0 .2 *11.9±0.2
Body weight 
(g)
338 ± 9 .2 ***265 ±12.6 + 44.2 ± 1 .7 ***267 ±9.5
*p<0.05, **p<0.01, ***p<0.001 when compared to control 
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RNA was extracted from the segregated cell populations and TfR mRNA 
expression examined using a 30 mer-oligonucleotide probe. Two studies were 
undertaken. TfR expression in various cell fractions (Vw, Vi, V2,V3, Ci and C2  ) were 
determined in animals maintained on a standard rodent diet. This revealed a progressive 
increase (three fold) in expression from villus to crypt cells (Figure 3a & b).
Secondly, TfR was also determined at different iron states in the intestinal 
mucosa. Autoradiograms for TfR mRNA in rats fed on a standard rodent diet, an anaemic 
group, an iron deficient diet and an iron loaded group are shown in Figure 3-4.
In anaemic animals a significant increase in TfR mRNA expression was observed 
in both crypt (p<0.01) and villus (p<0.05) cells when compared to control animals 
(Figure 3-5). However, this increase (p<0.01) was only observed in the villus cells in the 
iron deficient group. By contrast, there was a significant reduction in TfR mRNA 
expression in the iron loaded animals but this difference was confined to crypt cells
(p<0.01).
(iv) Comment
It was not possible to study TfR mRNA expression in the ‘switch diet’ model as I 









V „V ,V ,V ,C ,C 2
&  ' - v ' l i
Sum m ary of TfR mRNA : 18 S rRNA V, V, V3 C,
(mean of 4) 0.55 0.49 0.60 0.57 **0.96**1.41
Figure 3-3(b)
Sequential T tR  mRNA expression in crypt and villus cells

















Autoradiogram  of TfR  mRNA in crypt and villus cells under different iron regimes 
(data n= 3 + SEM)
(a) Villus cell
TfR mRNA
control anaemic carbonyl deficient
18S rRNA
(b) C rypt cell
TfR mRNA
18S rRNA
control anaemic carbonyl deficient
Sum m ary of results
TfR mRNA: 18S rRNA
(Mean of 6 ± SEM)
V
Villus cell
control 0.17 ± 0.03
V^ ,^imaemic **0.55 + 0.03
V^ ,^ carbonyl 0.21 ± 0.01




**0.29 ± 0.03 
1.09 + 0.08




TfR mRNA expression under different iron regimes (data n=6 ±  SEM and statistical 
significance was as compared to control. Receptors were up-regulated in iron deficient 
state and down-regulated in iron replete state. Note that the gradient of expression 
between crypt and villus (crypt greater than villus) was retained throughout but was least 
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3,4 Immunohistochemical study o f  TfR along the crypt-villus axis o f  the 
rat small intestine: Relationship to alterations and response to body iron 
stores,
3.4.1 Methods
A  murine monoclonal antibody to rat TfR (MRC OX-26) obtained from Serotec, 
Oxford was used in the following experiments. Immunohistochemical procedures were 
undertaken as described in section 2.4.1. Rat small intestinal tissues were mounted in 
OCT (BDH chemicals, Poole) and isopentane in liquid nitrogen. Isopentane was essential 
to preserve cell morphology during mounting. To ensure uniform and comparable 
conditions o f staining, several cryostat tissue sections (6 pm) from all animals in each 
group were mounted in a grid fashion on glass slides. A subjective assessment of staining 
intensity for the receptor was made by two independent observers and graded from 0 
(none), +1 (mild), +2 (moderate) to +3 (intense) staining.
3.4.2 Results
(i) Peris stain
(a) Carbonyl iron (5 weeks) to iron deficient diet and studied at day 0, 1, 3 and 5
In liver tissue, no difference in haemosiderin staining was observed until day 5 
from the switch in iron deficient diet (Figure 3-6 a & b). In the small intestine however, 
haemosiderin deposits were absent by day 3 fi:om the switch to the iron deficient diet 
(Table 3-2).
#
(b) Iron deficient diet (5 weeks) to carbonyl iron and studied at day 0, 1 ,3  and 5
In liver tissue, haemosiderin deposits were only present in liver tissues at day 5 
on the carbonyl iron diet (Figure 3-6c). However, in the small intestine, haemosiderin 
remained absent at day 5 on the carbonyl iron diet. These observations have been 





Peris staining in rat small intestine and liver under different iron 











0 +++ + - -
1 not assessed +++ + not assessed — —
3 not assessed '1 jw, - not assessed -
5 not assessed ++ - not assessed +
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Figure 3-6
Liver stained for haemosiderin
(a) On standard rodent diet (top left); (b) Carbonyl iron for 5 weeks (top right);
(c) b followed by an iron deficient diet at day 5 (note reduced haemosiderin deposits; 
bottom left); (d) Iron deficient diet for 5 weeks followed by carbonyl iron at day 5 
(bottom right)
>
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(ii) Immunohistochemistry fo r  TfR
TfR expression in crypt and villus cells after dietary iron manipulation have been 
summarised in Table 3-3.
Table 3-3
TfR expression in rat crypt and villus cells under different iron regimes and 











0 ++ + + +++ + + +++ ++
1 not assessed + not assessed •+•++ ++
3 not assessed + not assessed ++ +
5 not assessed ++ + not assessed ++





(a) Control, iron deficient, anaemic and iron loaded animals
Within the villus epithelium o f control animals, TfR are only confined to the 
basolateral surface of enterocytes, principally in the crypts (+2) with reduced receptor 
expression (+1) up the villus architecture (Figure 3-7a). However, this crypt-villus 
gradient of receptor expression is no longer apparent in both iron deficient and anaemic 
group, with more intense staining observed in crypt (+3) and villus cells (+2) (Figure 3- 
7b & 3-7c). In the iron loaded animals, TfR were only confined to crypt cells (+1) and 
were virtually absent in villus cells (0) (Figure 3-7d)
(b) Iron loaded animals switched to an iron deficient diet
Receptor staining was only confined to the crypt cells (+1) but when these 
animals were switched to an iron deficient diet, TfR staining observed in the basal villus 
architecture by 24 hours (+1) and by day 3 on the iron deficient diet, TfR staining was 
observed up to the villus tip (+1) with decreasing receptor gradient from crypt to villus 
still apparent (Figure 3-8a-c).
(c) Iron deficient animals switched to an iron loaded diet
In iron deficient animals, TfR staining was observed to the villus tip (+2) but, by 
day 3, down regulation to mid to basal villus could be observed (Figure 3.9b). By day 5 
from the switch to an iron loaded diet, receptor staining was mainly confined to crypt 




(a) TfR expression in control rats (top left; (b) TfR expression in anaemic rats (top 
right); (c) TfR expression in rats on an iron deficient diet (bottom left) and (d) TfR 





















































Polypeptide receptors can be classified into two categories on the basis of function 
(Kaplan 1981). Class I receptors, e.g. p-agonists function mainly to transmit information 
whereas class II receptors, e.g. TfR requires internalisation of ligand to provide the cell 
with a certain required factor. TfR is regulated by a complex mechanism involving 
several factors such as haem, protoporphyrin and certain growth factors which modulate 
receptor synthesis (Testa 1985). However, it is generally believed that expression of TfR 
is directly correlated with the rate o f cell growth (Trowbridge & Omary 1981, 
Pelosi-Testa et al 1986) and inversely related to the amount o f iron accumulated in cells 
(Ward et al 1982, Louache et al 1984, Pelosi et al 1986, Testa et al 1985). The 
correlation with cell growth may be partly explained by the absolute requirement for iron 
by ribonucleotide reductase; a key enzyme in DNA synthesis (Thelander & Graslund 
1983, Kucera et al 1983).
The amount o f iron entering the cell is dependant on receptor population which 
can be modified by several mechanisms; a short-term but rapid change via translocation 
of receptors between the cell surface and the endocytic pool; and secondly, a longer but 
slower change which involves changes in receptor synthesis and breakdown (Bomford 
& Munro 1985). This has been reported in Hela cells (Ward et al 1982), K 562 cells 
(Mattia et al 1984) and haematopoietic cell lines (Louache et al 1984).
Within the small intestine, due to its localisation on the basolateral surface 
(Banerjee et al 1986), TfR seemed to be the ideal candidate for the final pathway by 
which iron was transferred to the portal circulation. However, current evidence do not 
support this role. It is well recognised that in the iron deficient state, both mucosal uptake 
o f iron and TfR expression are increased whereas in the iron replete state, mucosal uptake 
and TfR expression are reduced. However, when TfR density was measured in rats from 
the neonatal period and up to 50 days old, receptor density was found to be greatest in 




with increased iron absorption but increased again at the time of weaning (Anderson et al
1991). Furthermore, administration o f phenylhydrazine to rats (induces an acute 
haemolysis) resulted in enhanced mucosal iron absorption but not TfR expression 
(Anderson et al 1990). Expression o f TfR was interpreted in these studies as signifying 
increased cell proliferation and therefore increased iron requirement rather than TfR 
having a role in iron absorption. Perhaps more importantly, for iron transfer to take place 
from enterocyte to portal blood via TfR, this would require a "reverse endocytosis" 
mechanism which is not feasible on kinetic grounds (Baker & Morgan 1994). The most 
likely role for TfR is to facilitate iron entry to mucosal cells from plasma by internalising 
plasma-derived diferric TfN (Pietrangelo et al 1992). To support this, TfN mRNA could 
not been detected in rat nor in human intestinal mucosa by Northern hybridisation 
(Idzerda et at 1986, Pietrangelo et al 1992) and mucosal TfN endocytosis has also been 
described in rats (Anderson et al 1994).
The present immunohistochemical data supports previous immunohistochemical 
studies (Baneijee et al 1986 , Anderson et al 1990) on the inverse relationship between 
body iron stores and TfR expression. TfR were up regulated in anaemic and iron-deficient 
rats and down regulated during iron supplementation. Furthermore, by changing iron 
loaded animals to an iron deficient diet, increased TfR density in villus cells (initially 
confined to the basal portion o f the villus architecture) was observed by day 1 from the 
switch in diet implying that mucosal TfR was also sensitive to changes in luminal iron as 
body iron stores were unlikely to be depleted in this time period. Conversely, TfR density 
was reduced (observed on day 5 from the change in diet), with expression virtually 
confined to crypt cells during the change from an iron deficient to an iron loaded diet. It 
would seem that TfR expression can be influenced by body iron status as well as changes 
in environmental (luminal) iron. The above system illustrates a fundamental 
physiological concept in that when cells become iron replete, TfR are down regulated to 




iron, TfR are upregulated to permit accumulation o f cellular iron. This system is vital to 
cells as iron is required for cell growth and the synthesis o f haem containing compounds.
Using Northern hybridisation technique, I was able to demonstrate an increasing 
gradient of TfR mRNA expression in a ‘villus to crypt cell manner' and confirmed the 
reciprocal relationship between TfR mRNA expression and body iron stores. Mucosal 
TfR mRNA were significantly lower in iron loaded animals compared to control animals 
but significantly higher when compared to the anaemic and iron deficient animals. TfR 
mRNA expression was also consistently higher in crypt than villus cells in the four 
groups o f animals studied. This may be reflected in crypt cells having a higher 
requirement for iron due to their rapid cell turnover.
TfR mRNA expression has also been examined in the human intestinal mucosa 
and in mice, although crypt and villus cells were not segregated (Pietrangelo et al 1992, 
McKie et al 1996). These studies have also supported the inverse relationship between 
TfR mRNA and body iron stores. However, the ability of crypt and villus cells to respond 
by altering TfR transcripts to environmental iron remains to be determined.
The present study, together with previous invivo (Pietrangelo et al 1992, McKie et 
al 1996) and invitro studies on a variety of cell types such as fibroblasts (Ward et al
1982), leukaemic cell lines (Louache et al 1984), lymphocytes (Pelosi et al 1986) and 
hepatoma cells (Zucherman et al 1979) indicate that TfR expression is mediated by iron 
through a negative feedback mechanism. There is reduced receptor expression by the 
addition o f iron and enhanced receptor synthesis by treatment with iron chelators. This 
negative feedback system is mediated by the regulation of the post-transcriptional 
mechanisms through IRP and ferritin (section 1.3.7). However, in conjunction with 
previous invitro studies (Mattia et al 1984, Louache et al 1984, Rao et al 1986), the 
present study also suggest that transcriptional control of TfR by iron may be important. 
Transcription appears to be maintained in crypt cells as well as the more mature villus 
cells coming towards the end of their life span.
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Other mechanisms o f TfR regulation may be present since in cultured human 
monocytes-macrophages (Testa et al 1989) and more recently, insitu hybridisation 
analysis using iron loaded rat small intestinal tissues (Jeffrey et al 1996), have revealed 
persistent TfR and TfR mRNA expression. This may be a protective mechanism against 
iron toxicity. Increased TfR may allow macrophages and mucosal intestinal cells to store 
large amounts of iron whose toxic effects is neutralised by simultaneous synthesis of 
ferritin such that iron retained in cells are lost when cells are shed from the intestinal 
epithelium.
Although TfR does not appear to have a direct role in mucosal iron uptake, the 
ability o f both crypt and villus cells to respond to changes in body iron stores support the 
notion that TfR may subserve an indirect role by conveying information regarding iron 
stores to the enterocytes in the depths o f the crypt such that when these cells mature and 
migrate to their functional positions at the villus tip (some 3 days later) mucosal cells 
may influence the handling o f dietary iron. However, to translate this information into 
‘action’ requires a second mediator o f which the most promising is ferritin. Using the 





4, Examination o f ferritin expression in rat liver and small 
intestine
4,1 Introduction
Iron in free solution is toxic to biological systems due to its ability to generate free 
radicals resulting in destruction of lipid membranes by oxidation (Bacon & Britton 1990). 
Chronic iron overload is also associated with organ injury. In liver, it leads to fibrosis, 
cirrhosis and hepatomas (McLaren et al 1983). The mechanism of liver injury also 
involves the generation o f reactive hydroxyl radicals (Freeman 1982), perferryl and 
ferryl ions (Tien 1981) from the interaction of iron with oxygen. To limit iron toxicity, it 
is essential that the absorbed iron is complexed to a protein which is easily available in 
times of need and this role is fulfil by the iron storage protein ferritin.
Ferritin is the major iron storage protein in eukaryotic cells. The ferritin 
apoprotein shell (molecular weight approximately 480 kDa) is a heteropolymer with a 24 
subunit structure which has a vast storage capacity for iron with more than 4000 atoms of 
iron per molecule (Harrison 1986, Harrison et al 1987). Two immunologically distinct 
sized subunits of ferritin have been described (Arosio et al 1978) which differ in 
molecular weight, share 55 % peptide sequence homology and appear to have similar 
folding (Jain et al 1985). These have been characterised as heavy (H) and light (L) chain 
ferritin. In cells, these are expressed in different proportions to generate families of 
isoferritins or heteropolymers which are L-rich (basic) or H-rich (acidic) ferritin 
(Harrison et al 1987). L rich-subunit ferritin (molecular weight 19 kDa) predominates in 
liver, spleen and placenta (Bomford et al 1981). H-rich subunits (molecular weight 21 
kDa) predominate in tissues such as heart (Powell et al 1974 & 1975a & 1975b), 
pancreas, cancers and red blood cells (Arosio et al 1976 , Kohgo et al 1980, Peters et al
1983).
In principal, 25 ferritin isomers could be expected by the different assembly of the 
two chains: L^^Hg, Lg^H^, ..... , L0 H2 4  and possibly many more if  they occupy
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non-equivalent positions on the molecule. However, it is unknown whether the 
distribution of H and L chains in the ferritin molecule is random or follows a particular 
pattem. There are metabolic differences in these isoferritins. This will be discussed in the 
next section as they may have important consequences on mucosal iron absorption.
The chromosomal location of ferritin genes has been examined in humans using 
cell fusion and insitu hybridisation. Cell fusion studies reveal ferritin genes at 2 
chromosomal sites, L-ferritin subunit on chromosome 19 (Caskey et al 1983) and 
H-ferritin subunit on chromosome 11 (Cragg et al 1985). However, insitu hybridisation 
techniques have demonstrated the existence of H-type sequences on at least seven 
chromosomes (1,2,3,6,11,13, and X) and L-ferritin genes and related sequences on at 
least 3 chromosomes (19,20 and X) (McGill 1987).
On reflection o f the hypothesis, I postulated that body iron stores (of which liver 
is the main storage organ) relays information regarding iron status through serum TfN 
and TJQR. located on the basolateral surface of enterocytes to ‘condition’ crypt cells such 
that it will set up a constitutive ratio that will be primarily L-rich subunit ferritin or 
H-rich subunit ferritin which will impede or facilitate the transfer o f iron from mucosal 
cells to the portal circulation. I therefore set out (i) to examine whether ferritin transcripts 
in liver could be altered by diet and (ii) if  so, whether dietary manipulation affected 
predominantly a specific ferritin subunit transcript.
■ " ' ■ I
4.2 Plan o f investigations
Body iron stores were manipulated by dietary and parenteral iron. At the end of 5 
weeks, the carbonyl group was switched to an iron deficient diet for 1, 3 and 5 days. The 
iron deficient group was switched to the carbonyl iron supplemented diet for similar 
periods. After four IP injections o f iron sorbitol, the parenteral group, (initially 
maintained on a standard rodent diet) was switched to an iron deficient diet for 6  hours, 1
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and 3 days. Animals were sacrificed and liver tissues obtained for RNA extraction and 
Peris staining. It was necessary to use the ‘switch model’ to determine if changes in 
luminal iron (intestinal iron) could affect ferritin expression in liver.
This chapter has been divided into 2 experimental sections. The first section 
(section 4.3) examined L and H-ferritin gene expression in liver after iron stores have 
been manipulated by oral and parenteral iron. The second section (section 4.4) examines 
ferritin expression in the small intestine along the crypt-villus axis when iron stores have 
been manipulated by similar means.
4.3 Effect o f  chronic dietary iron overload, iron deficiency and parenteral 
iron overload on ferritin mRNA expression in the rat liver
4.3.1 Methods and materials
(a) Animals and diets
Male Wistar rats (Charles Rivers, Ramsgate) were used for all experiments. 
Housing conditions were as previously described in section 3.3.1. Animals were divided 
into control, iron deficient and iron loaded groups with six animals per group as 
previously described and the data has been summarised in Table 3-1.
An additional group for these experiments were rats who were loaded with iron 
parenterally using ip injections of iron sorbitol (Astra Pharmaceuticals Limited, Langley, 
U.K), 25 mg per week for 4 weeks (mean weight 359 + 11.9 g). This has been shown to 
produce higher mucosal ferritin associated with reduced mucosal iron absorption (Savin 
& Cook 1980). Animals could only tolerate injections when their body weight exceeded 
200 g and were maintained on a standard rodent diet (Special diet services) while 
receiving weekly iron injections. On the fourth injection, these animals were switched to 
an iron deficient diet and studied at 6  hours day 1 and 3.
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(b) RNA extraction and Northern hybridisation
Total RNA was extracted from liver tissues using the acid guanidinium 
thiocynate-chloroform protocol described in section 2.3 as was RNA transfer by capillary 
blotting and fixation to membranes.
(c) Probes and hybridisation conditions
Mouse L (578 bp) and H-ferritin cDNA (347 bp) were a generous gift from Dr. 
Andrew McKie, Kings College, University of London. Preliminary experiments on rat 
tissues (liver and small intestinal RNA) revealed the hybridisation pattem was in the 
predicted position below the signal o f 18S RNA. (Figure 2-8a & 2-8b). In addition, 
sequence verification between mouse and rat ferritin was confirmed using Genbahk 
database. An oligonucleotide sequence (30 mer) for rat 18S RNA (Torczynski et al 1983) 
was used an RNA control to normalise for RNA loading. Labelling (random priming for 
ferritin, end labelling for oligonucleotide), hybridisation and washing conditions were 
undertaken as described in section 2.3.5.
(d) Other methods
Blocks o f rat liver were mounted in OCT in isopentane and 6 pm cryostat sections 
were prepared and stained with Peris Pmssian blue stain for haemosiderin to assess 
storage iron content as described in section 2.4,
4.3.2 Results
(i) Assessment o f  hepatic iron loading
After 5 weeks on oral carbonyl iron, macroscopic inspection o f livers from these 
animals appeared darker compared to control animals (Figure 4 -la). By contrast, livers of 
animals on the iron deficient diet appeared lighter (Figure 4-lb). There was no difference 
to controls in the animal liver receiving parenteral iron (Figure 4-lc)
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Parenteral iron sorbitol resulted in hepatic iron overload with iron deposition 
evenly distributed throughout the hepatic lobule (both parenchyma and RE cells). By 
contrast, dietary iron overload produced iron deposition in parenchyma cells in a 
periportal distribution (Figure 4-2a and 4-2b).
There were no detectable differences in haemosiderin staining when diet of the 
parenteral group was changed to an iron deficient diet after 3 days. However, on changing 
from a carbonyl iron supplemented diet to an iron deficient diet, diminished haemosiderin 
staining was observed at day 5. Similarly, haemosidem deposits could be observed on 
changing animals initially on the iron deficient diet to the carbonyl iron diet at day 5. 






Macroscopic appearance of livers under different iron regimes
(a) Carbonyl iron. Note that liver is much darker than control animals (top)
(b) Iron deficient diet. Note that liver is much lighter than control animals but after day 5 
on the carbonyl diet, liver was darker than control animals (middle)





Peris stain in liver under different iron regimes
(a) In parenteral iron loading haemosiderin staining is situated throughout the hepatic 
lobule (top)
(b) Oral iron (carbonyl) loading result in staining in a periportal distribution (bottom)
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(ii) Effect o f  iron loading and iron deficiency on hepatic ferritin expression
Five animals from each group were analysed. In both iron loaded groups (oral 
carbonyl and IP sorbitol), L and H-ferritin subunit mRNA tended to be greater than 
control animals although this was not statistically significant. Similarly, in the iron 
deficient group, both L and H-ferritin subunit mRNA tended to be lower compared to 
controls although this was not statistically significant (Figure 4-4 & Figure 4-5).
Figure 4-4
Autoradiogram of ferritin mRNA expression in liver under different iron regimes




Ferritin mRNA: 18S rRNA
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1.22 ± 0.09 
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Ferritin mRNA expression in liver under different iron regimes
(data n=5 ± SEM) Con=Control, Car=Carbonyl iron, Def=Iron deficient diet, and 
IP=Intraperitoneal iron sorbitol.
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* Switch diet^ conditioning
(Hi) Effect o f  an iron loaded diet (carbonyl iron) fo r  5 weeks followed by an iron 
deficient diet at day 0,1, 3 and S on hepatic ferritin expression
Within 24 hours of changing to an iron deficient diet, there was a significant 
reduction in L-ferritin subunit mRNA expression (p<0.01) maintained up to day 5 on this 






Autoradiogram showing effect of a carbonyl diet to an iron deficient diet at day 0, 1, 
3 and 5 on hepatic ferritin expression




L-ferritin mRNA: 18S rRNA 2.63 ±0.13 **1.20 + 0.03 **1.26 + 0.10 **0.68 + 0.05 
(mean of 5 + SEM)
H-ferritin mRNA: 18S rRNA 1.89 + 0.08 **1.15 ±0.13 **1.15 ±0.08 ** 0.64 ±0.06





Effect of a carbonyl diet to an iron deficient diet at day 0, 1, 3 and 5 on hepatic 
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(iv) Effect o f  an iron deficient diet fo r  5 weeks followed by an iron loaded (carbonyl) 
diet at day 0,1, 3 and 5 on hepatic ferritin expression
On changing the diet from a iron deficient to a loaded diet, there was no change in 
L and H-ferritin until day 5 where a substantial and significant rise was observed for 
L-ferritin (p<0.01). There was also a tendency for H-ferritin to rise by the day 5 on the 
iron loaded diet although this did not reach statistical significance (Table 4-1 & Figure 4- 
8).
Table 4-1
Densitometer readings (a.u.) on the effect of iron deficient diet to a carbonyl diet at 
day 0 ,1 ,3  and 5 on hepatic ferritin expression(data n=5 + SEM)













0 1.85 1.92 1.60 1.16 1.20
1.62 1.73 1.37 1.19 1.26
1.74 1.89 1.44 1.21 1.32
1.80 1.90 1.52 1.18 1.25
1.81 1.89 1.63 1.11 1.16
mean ± sem 1.17 + 0.03 1.20 ±0.03
1 1.33 1.38 1.15 1.16 1.20
1.80 1.92 1.59 1.13 1.21
1.74 1.81 1.69 1.03 1.07
1.60 1.75 1.67 0.96 1.05
1.73 1.82 1.75 0.99 1.04
mean + sem 1.05 + 0.04 1.11+ 0.05
3 1.68 1.84 1.70 0.99 1.08
1.49 1.59 1.69 0.88 0.94
1.80 1.77 1.70 1.06 1.04
1.60 1.76 1.45 1.10 1.21
1.75 1.88 1.62 1.08 1.16
mean ± sem 1.02 + 0.04 1.10 ±0.05
5 2.01 2.82 1.47 1.37 1.92
2.48 2.96 1.46 1.70 2.03
2.66 3.29 1.77 1.50 1.86
2.03 2.65 1.03 1.97 2.57
2.50 3.39 1.60 1.56 2.12





Effect of an iron deficient diet to a carbonyl diet at day 0, 1, 3 and 5 on hepatic 
























(v) Effect o f  IP  iron sorbitol followed by an iron deficient diet at 68 hoursy day 1 and 3 
hepatic ferritin expression
Within 6 hours of changing the diet, there was initially a significant rise in 
L-ferritin subunit mRNA (p<0.05) which then decreased. This was also observed for 
H-ferritin although the initial rise did not reach statistical significance. (Table 4-2 & 
Figure 4-9).
Table 4-2
Densitometer readings (a.u.) on the effect of IP iron sorbitol to an deficient diet at 6 
hours and at day 1 and 3 on hepatic ferritin expression(data n=5 ±  SEM)













0 3.42 4.36 4.95 0.69 0.88
1.90 2.31 5.14 0.37 0.45
1.91 2.15 5.80 0.33 0.37
1.79 3.28 4.97 0.36 0.66
4.34 4.26 7.75 0.56 0.55
mean + sem 0.46 ± 0.07 0.58 + 0.09
1/4 2.74 6.10 8.84 0.31 0.69
4.22 6.48 7.53 0.56 0.86
2.99 4.41 6.49 0.46 0.68
3.25 4.22 3.35 0.97 1.26
4.50 6.46 7.26 0.62 0.89
mean + sem 0.58 + 0.11 *0.88± 0.11
1 3.62 6.53 10.05 0.36 0.65
3,78 5.95 9.44 0.40 0.63
3.55 5.27 9.09 0.39 0.58
2.70 3.69 8.99 0.30 0.41
4.90 7.01 11.13 0.44 0.63
mean ± sem 0.38 + 0.02 0.58+0.04
5 5.04 5.17 12.3 0.41 0.42
2.72 2.91 4.77 0.57 0.61
4.80 4.98 5.86 0.82 0.85
3.53 4.76 8.21 0.43 0.58
2.80 2.62 4.59 0.61 0.57




Effect of IP iron sorbitol to an iron deficient diet at 6 hours, day 1 and 3 on hepatic 
ferritin expression (data n=5 ±  SEM and statistical significance as compared to day 0) 
Rats were given IP iron sorbitol (25 mg weekly for 4 weeks) and maintained on a 
standard rodent diet. On the 4th IP injection, diet was switched to an iron deficient diet 













L-ferritrin n=5 (SEM) 
H-ferritin *P<0.05
0 1/4 1 3  0 1/4 1 3
Days after switch
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4,3*3 Discussion
Dietary iron overload was achieved by supplementing carbonyl iron which is an 
extremely pure form of elemental iron (greater than 98 %), prepared by reacting iron at 
high temperatures with carbon monoxide. This forms gaseous iron pentacarbonyl, where, 
after further heating is deposited as metallic iron submicroscopic crystals less than 5 pm 
in size (Carbonyl iron powders, GAP Corporation). Carbonyl iron was supplemented to 
the standard rodent diet (2.5 % wt/wt) rather than iron deficient diet as the latter produced 
intense diarrhoea when introduced to animals. As shown, supplementation of the diets 
with carbonyl iron produced predominantly hepatocellular iron deposition which is very 
similar to that observed in patients with GH. Prolonged administration of greater than 6 
weeks will cause staining in Kupffer cells, endothelial cells and macrophages but the 
periportal to centrilobular gradient is still maintained (Bacon et al 1983). However, 
parenteral administration o f iron sorbitol produced a more homogenous deposition of iron 
throughout the hepatic lobule in both hepatocytes and Kupffer cells.
A similar study on ferritin expression in hepatocytes had been undertaken by 
Pietrangelo et al., (1990). However, the present study differs from Pietrangelo’s study in 
several ways. Firstly, in animals on chronic carbonyl iron and parenteral iron sorbitol, 
L-ferritin subunit mRNA tended to rise although this did not reach statistical significance 
whereas Pietrangelo demonstrated enhanced L-ferritin subunit mRNA expression in 
chronic iron overload (parenteral iron was not examined). Secondly, H-ferritin subunit in 
the present study also tended to change whereas H-ferritin subunit mRNA was unaffected 
by iron treatment in Pietrangelo studies. There are several reasons for this discrepancy. 
The animals in the present study were maintained on the diet for 5 weeks by contrast to 
Pietrangelo's animals for 10 and 30 weeks. It seems unlikely (although cannot be entirely 
excluded) that the mouse ferritin probes used may account for some of the discrepancy 
even though verification o f mouse L and H-ferritin sequences were shown to be
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compatible to rat L and H-ferritin using Genbank Database and by preliminary Northern 
hybridisation experiments.
On switching diets (carbonyl iron to iron deficient and iron deficient to carbonyl 
iron for specific time periods) a corresponding fall and rise (respectively) in ferritin 
mRNA expression (L and H) was observed. In the parenteral group, there was an initial 
rise in ferritin mRNA expression (L greater than H) within 6 hours following ip injection 
of iron sorbitol, (due to elevated plasma iron sorbitol by declining by 24 hours; Charlton 
et al 1965) followed by a decline in ferritin mRNA expression as the animals were 
subjected to and ate the iron deficient diet. The present study suggests that ferritin mRNA 
in liver is predominantly L-subunit ferritin mRNA; the resulting isoferritins more suitable 
for long-term iron storage.
Ferritin gene expression can be regulated by iron at both transcription and 
translation (White & Munro 1988). In addition, iron may also be involved in other steps 
of ferritin gene regulation including the assembly and maintaining the stability of the 
ferritin shell (Drysdale 1983). The ability o f iron to stimulate ferritin synthesis was first 
describe some 30 years ago (Drysdale and Munro 1965) suggesting that there is usually a 
surplus of ferritin mRNA within cells where translation is repressed until iron is present. 
However, in the present study, the changes observed in both L and H-ferritin mRNA in 
animals with chronic hepatic iron overload and switching to an iron deficient diet or vice 
versa suggest that (i) control o f ferritin gene expression at the level o f transcription may 
be also important (ii) luminal iron may also influence the synthesis o f ferritin. However, 
it is difficult to reconcile the fact that the steady state (after 5 weeks) there is little 




4*4 Effect o f  manipulating body iron stores on L and H-ferritin mRNA 
expression on crypt and villus cells o f  the rat intestinal mucosa
4.4.1 Introduction
As mentioned previously (Chapter 3) the major proteins implicated in the cellular 
control of iron metabolism are TfN, TfR and ferritin. Ferritin, in particular has been 
viewed as the key protein in controlling duodenal iron absorption. Body iron stores are 
controlled by a feedback mechanism which limits its absorption at the proximal intestine. 
However, the precise mechanism(s) remain a mystery. Over half a century ago, Hahn et 
al (1943) and later Granick (1946) proposed that ferritin may have a role in controlling 
body iron balance by acting as a mucosal "acceptor" for iron which can impede 
absorption of unwanted mucosal iron by retaining iron within the mucosal cells. Iron was 
lost when mucosal cells were shed onto the gut lumen. In an iron deficient state, this 
mucosal acceptor disappeared to permit the absorption o f luminal iron.
As described in Section 4-3, two immunologically distinct ferritin subunits have 
been described designated L and H- subunit ferritin (Arosio et al 1978). Both L and 
H-ferritin are also found in the mucosal cells (Halliday et al 1978, Whittaker 1989). 
L-rich subunit ferritin in mucosal cells correlate with storage iron status, with raised 
duodenal concentration after oral iron administration thus reflecting increased amount of 
iron entering these cells (Halliday et al 1978). L-rich isoferritins function mainly as an 
iron storage protein as it is preferentially synthesised with iron loading (Bomford et al 
1981). However, the role of H-rich ferritin is less well understood. It may be involved in 
immunosupression (Matzner et al 1979), regulating myelopoeitic activity (Dezza et al 
1986) and the synthesis o f haem (Blight & Morgan 1983). Perhaps more importantly, 
H-rich ferritin subunit appear to incorporate and release iron more readily than L-rich 
ferritin (Wagstaff et al 1978, Jones et al 1978, Levi et al 1988 ) i.e it serves a short-term 
storage for iron (a cellular house-keeping function) and is the ideal candidate protein for 
the intracellular shuttling o f iron to the portal circulation. Structural and functional
111
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relationships o f these ferritins (deduced from cDNA clones) suggest that hecteropolymers 
containing H and L subunits have essentially the same three dimensional structure. 
However, several amino-acid substitutions at certain sites on the H-chain especially the 
amino-acids that form the channel through which iron gain access to the interior of the 
ferritin shell may be responsible for the metabolic and functional differences between 
H-rich and L-rich ferritin (Boyd et al 1985),
Previous physiological studies on iron absorption in rodents demonstrated that 
iron absorption did not increase or decrease for 3-5 days following artificially induced 
acute anaemia or iron overload respectively (Crosby et al 1963, Pollack 1964, Wheby 
1964a). This interval corresponds to the time taken for proliferating crypt cells to migrate 
to the villus tip (Messier & Leblond 1958). Conrad and Crosby (1963) proposed that 
information regarding body iron stores may have conditioned crypt cells whereby these 
cells could later modulate the absorption o f dietary iron following migration to the villus 
tip. Fairweather-Tait (1984) further postulated that TfR at the basolateral surface of 
enterocytes may perform this function o f relaying information on body iron stores to the 
enterocyte. This may be achieved via a mucosal endocytic mechanism based on plasma 
transferrin saturation (Anderson et al 1994).
When body iron stores are replete and plasma transferrin is saturated, TfR is down 
regulated at an early stage and conversely whereas ferritin synthesis is un regulated. In 
crypt cells, this would set up a constitutive transcript ratio which is predominantly L- 
rich ferritin which would retain iron and impede iron transfer to plasma. Retained iron is 
lost when mucosal cells exfoliate into the gut lumen. Similarly, in an iron deficient state, 
TfR are persistently expressed and the information 'imparted' to enterocytes will favour a 
constitutive ratio which is predominately lower in L-rich ferritin transcripts, whereby, a 
predominantly H-rich ferritin protein is translated. This protein will retain iron less avidly 
thus allowing iron transfer to plasma when mucosal cells are presented with luminal iron. 
Hence, within the enterocyte, changing the proportions of L and H-rich ferritin subunits
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could be exploited respectively to reduce or increase transfer o f dietary iron to mucosal 
cells/plasma depending on whether iron stores were high or low.
I therefore set out to determine if  alterations in body iron stores will influence 
ferritin expression in crypt and villus cells that is consistent with the 'lag period' o f some
3 days, the time for crypt-villus migration that correspond to the previously noted time 
interval o f alteration in iron stores and the response of mucosal cell to dietary iron. To 
explore this hypothesis, a 'switch diet model' and segregation of crypt and villus cells 
would need to be undertaken.
4.4.2 Methods and materials
(i) Animals and diet
Male Wistar rats were used for all experiments. Animals were divided into 4 
groups, 6 animals per group. These have been described previously in Chapter 4 
consisting of (a) Rat pellet fed animals, (b) Carbonyl iron-supplemented animals (c) An 
iron deficient group and (d) An iron loaded group given IP iron sorbitol (25 mg/week for
4 weeks).
(ii) Molecular biochemistry
RNA was extracted from segregated cells, Northern capillary transfer, labelling of 
cDNA and oligonucleotide ribosomal sequences by random priming and terminal 
transferase respectively, hybridisation conditions, washing conditions, generation of 
autoradiograms and quantification by densitometery were carried out as described in 
section 2. 3.
(in) Plan o f  investigations
Body iron stores were manipulated by diet and by parenteral iron as described in 
the previous section. After 5 weeks, the oral carbonyl group was switched to an iron 
deficient diet and studied at day 1, 3 and 5, the iron deficient group was switched to the 




sorbitol, the parenteral group (maintained on a standard rodent diet) was switched to an 
iron deficient diet and studied at 6 hours, 1 and 3 days. Animals were sacrificed and crypt 
and villus cells segregation undertaken as described in section 2.1.
4.4.3 Results
(i) Peris potassium ferricyanide staining in intestinal mucosa
Haemosiderin deposits in intestinal cells were observed with Peris potassium 
ferricyanide after 5 weeks on oral iron and only 6 hours following iron sorbitol injection 
(Figure 4-10a and 4-10b). No haemosiderin deposits were observed in the intestinal 
mucosa o f control animals and animals on the iron deficient diet nor at day 5 after the 
switch firom the iron deficient diet to the carbonyl iron diet (Table 3-3, section 3.4.2). 
Haemosiderin deposits were also absent in the small intestine by day 3 from switching 
carbonyl iron loaded animals to an iron deficient diet.
Steady state conditioning
(ii) Effect o f  iron loading (oral carbonyl and IP iron sorbitol) and iron deficiency on 
ferritin expression in the rat intestine
(a) Villus cells
In both the iron loaded groups (oral and IP), no significant increase in either L or 
H-ferritin subunit mRNA was observed. However, in the iron deficient group, both 
L-ferritin (p<0.01) and H-ferritin (p<0.05) subunit mRNA were reduced compared to 
control animals (Figure 4-1 la  and Figure 4-12a).
(b) Crypt cells
No significant change in either L or H-ferritin subunit mRNA was observed 





Peris staining for haemosiderin in the rat small intestinal mucosa




Autoradiograms showing the effect of oral carbonyl iron, IP iron sorbitol and iron 







control carbonyl deficient sorbitol
V. V . V. V . V . V . V. V. V. V . V . V. V. V . V . V, V. V . V . V .
Ferritin mRNA: 18S rRNA
(Mean o f 5 + SEM)
L-feritin 
V . 0. 50 ± 0 .05  
carbonyl 0.49 i  0.09 
V^ deaclem **0.20 ±0.01
V sorbitol 0.46 4" 0.07
H-ferritin 
0.80 ±0.13  
0.55 ± 0.06 
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L-ferritin H-ferritin
Ferritin mRNA: 18S rRNA





0.54 ± 0.03 
0.52 ± 0.21 
0.52 + 0.11 
0.69 + 0.14
0.72 ± 0.09 
0.58 ±0.19  





L and H-ferritin mRNA expression in villus cell under different iron regimes
(data n=5 + SEM and statistical significance as compared to controls)
Key: Con=Control, Def=Iron deficiency, Car=Carbonyl iron, IP=Intraperitoneal iron
sorbitol
(a) Villus cell
Q L-Ferritln * P<0.05
I H-Ferritin ** P<0.01 
n=5 (SEM)
0Ç 0.8
CON CAR DEF SCR
Iron Regimes (VILLUS CELL)
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Figure 4-12
L and H-ferritin mRNA expression in crypt cells under different iron regimes
(data n=5 + SEM and statistical significance as compared to controls)
Key: Con=Control, Def=Iron deficiency, Car=Carbonyl iron, IP=Intraperitoneal iron 
sorbitol
(b) Crypt cell
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Iron Regimes (CRYPT CELL)
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Switch diet conditioning
(Hi) Effect o f  oral carbonyl iron fo r  5 weeks followed by an iron deficient diet at day 0, 
1, 3 and 5 days on ferritin expression in the rat intestinal mucosa
Six animals were used for each group (4 groups altogether). On each 
autoradiogram, there were 2 animals from each group at day 0, 1, 3 and 5 after changes in 
diet.
(a) Villus cell
Within 24 hours on switching to an iron deficient diet, a significant reduction in 
L-ferritin subunit mRNA expression (p<0.01) was observed and maintain to day 5 while 
on the iron deficient diet (p<0.01). However, this was not observed in H-ferritin subunit 
mRNA which intended to rise although not statistically significant. (Figure 4-13 and 
Figure 4-14a & b)
(b) Crypt cell
Similarly, L-ferritin subunit mRNA expression in crypt cells was reduced within 
24 hours on changing to the iron deficient diet (p<0.05) and up to day 5 (p<0.05). There 
was no significant change in H-ferritin subunit mRNA expression (Figure 4-13 and 
Figure 4-14 a & b).
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Figure 4-13
Autoradiogram on the effect of changing from a carbonyl iron diet to an iron 
deficient diet at day 0, 1, 3 and 5 on ferritin expression in the rat intestinal mucosa
Days after switch 0 day I day 3 days 5 days
Cell subpopulation Ci Ci C± Cz Cz Cz Cz Cz
L-Ferritin
18S rRNA
L-ferritin mRNA: 18S rRNA 0.34 + 0.05 **0.11 +0.03 **0.16 + 0.02 **0.14 + 0.02
(mean of 6 + SEM) Cz 0.33+0.10 *0.08 ±0.02 *0.07 + 0.02 *0.09 + 0.03
Days after switch 0 day 1 day 3 days 5 days
Cell subpopulation Cz Ci Cz C* C. Cz Cz Cj
H-ferritin
18S rRNA
H-ferritin mRNA: 188 rRNA 1.41 +0.19 1.54 + 0.23 1.66±0.33 1.96±0.42 
(mean o f 6 ±  SEM) C% 1.94 ±031 1.39 ±0.14 1.27 ±0.24 1.72 ±0.51




L-ferritin expression in crypt and villus cell from a carbonyl iron diet to an iron
deficient diet at day 0, 1, 3 and 5 (data n=6 ± SEM and statistical significance as








0 1 3 5 0 1 3 5
Days after switch Days after switch





H-ferritin expression in crypt and villus cell from a carbonyl iron diet to an iron
deficient diet at day 0, 1, 3 and 5 (data n=6 ± SEM and statistical significance as
compared to day 0 before the change in diet)
3.0-1 n=6 (SEM)
œ  2 .0 -
I
X  0.5
0 1 3 5 0 1 3 5
Days after switch Days after switch 





(iv) E ffect o f  an iron deficient diet fo r  5 weeks followed by an iron loaded (carbonyl) 
diet at day Of i ,  3 and 5 on ferritin expression in rat intestinal mucosa
(a) Villus cells
There was no difference between L and H-ferritin subunit mRNA expression in 
villus cells during dietary manipulation from an iron deficient diet to an iron loaded diet 
up to day 5 (Table 4-3 and Figure 4-15 a & b).
(b) Crypt cells
There was also no difference in L-ferritin subunit mRNA expression in crypt cells 
during dietary manipulation although there was a tendency for L-ferritin to rise by day 5 
but this was not statistically significant (Figure 4-15a). Similarly^ there was no significant 
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Figure 4-15 (a)
L-Ferritin expression in rat intestinal cells from an iron deficient diet to a carbonyl 
iron diet at day 0 ,1 , 3 and 5 (data n=6 ±  SEM and statistical significance as compared 
to day 0 before the change in diet)
I
CO00




Days after switch 
Crypt cell
0 1 3 5 0 1 3 5
Days after switch Days after switch 





H-ferritin expression in rat intestinal cells from an iron deficient diet to a carbonyl
iron diet at day 0 ,1 , 3 and 5 (data n=6 + SEM and statistical significance as compared
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(v) Effect o f  parenteral iron sorbitol followed by an iron deficient diet fo r 6 hours, 1 
and 3 days on ferritin expression in rat intestinal mucosa
(a) Villus cells
Reduced expression of L-ferritin subunit mRNA (p<0.01) was observed within 6 
hours of changing the diet and is maintained up to day 3 (p<0.01). H-ferritin subunit 
mRNA expression also tended to fall but only significant at day 3 on the iron deficient 
diet (p<0.01) (Table 4-4 and Figure 4.16 a and b).
(b) Crypt cell
L-ferritin subunit mRNA in crypt cells also tended to fall but is only significant at 
day 1 (p<0,05) from changing to the iron deficient diet. Similarly, H-ferritin subunit 
mRNA expression also tended to fall and only significant at day 1 (p<0.05) and 
maintained to day 3 (p<0.01) from the change in diet (Table 4-4 and Figure 4-16a and b).
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L-ferritin expression in crypt and villus cell on the effect of IP iron sorbitol to an
iron deficient diet at 6 hours, 1 and 3 days (data n=6 + SEM and statistical
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H-ferritin expression in crypt and villus cell on the effect of IP iron sorbitol to an
iron deficient diet at 6 hours, 1 and 3 days (data n=6 ±  SEM and statistical
significance as compared to day 0 before the change in diet)
n=6 (SEM) 
* P< 0.05 
** P< 0.01I
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4.4.4 L to H  subunit transcript ratio or constitutive ratio
On reflection o f the hypothesis (section 1.4), it has been postulated that body iron 
stores conditioned the crypt cells in the intestinal mucosa. This 'conditioning' sets up a 
specific constitutive transcript ratio which may influence the handling of luminal iron. 
The L:H transcript ratios in the various regimes have been summarised in Tables 4-5a & 
4-5b.
4.4.5 Summary o f  results
(i) Steady state conditioning 
Regime 1 (iron loading in animals)
In animals loaded with iron (oral carbonyl and IP iron sorbitol), there is a 
tendency to transcribe more o f the L-rich ferritin in both villus and crypt cells compared 
to controls, although this was only statistically significant in crypt cells in the IP iron 
sorbitol group.
Carbonyl iron:
(villus; 0.91+ 0.07 vs 0.67 ± 0.09; p>0.05; crypt; 0.86 + 0.07 vs 0.79 ±  0.09; p>0.05)
IP iron sorbitol:
(villus; 0.88 + 0.06 vs 0.67 ± 0.09; p>0.05; crypt ; 1.45 + 0.09 vs 0.79 + 0.09; p<0.05)
In the iron deficient group, there was also a tendency to transcribe a lower L-rich 
ferritin in both crypt and villus cell although this did not reach statistical significance.
Iron deficient:
(villus ; 0.46 ±  0.04 vs 0.67 ± 0.09; p>0.05; crypt ; 0.74 ±  0.05 vs 0.79 ±  0,09; p>0.05)
(ii) Switch diet model
(a) Regime 2 (carbonyl iron to iron deficient diet at day Oy 1 ,5 and 5)
In the switch diet model from an iron loaded diet to an iron deficient diet, there 
was a tendency to transcribe less L-rich feritin in both villus and crypt cell by day 1 and
132
______________ _ __________ ______
Chapter 4
maintained to day 5 although this was only statistically significant in villus cells (Table 
4-5a).
(b) Regime 3 (iron deficient diet to a carbonyl diet at day 0 ,1 , 3  and 5)
In this regime, there was a tendency to transcribe predominately L-rich ferritin 
(only observed in crypt cells) but this did not reach statistical significance (Table 4-5b).
(c) Regime 4 (IP iron sorbitol to an iron deficient diet at day 0, l/4y 1 and 3)
This produced observations very similar to regime 2, with predominately lower 





Densitometer ratios of L and H-ferritin in the rat intestinal mucosa
Regime 1 : Animals maintained on different iron regimes for 5 weeks (data n=5 + SEM) 
Regime 2: Changing from a carbonyl iron diet to an iron deficient diet at day 0 , 1 , 3  & 5 
(data n=6 ± SEM) *p<0.05, **p<0.01 (statistical significance as compared to day 0 from 














Control 0.55 1.15 0 0.26 0.09
0.51 0.75 0.18 0.09
0.51 0.73 0.38 0.48
0.91 0.66 0.18 0.26
0.89 0.65 0.18 0.10
0.32 0.09
mean + SEM 0.67 ± 0.09 0.79 + 0.09 m ean± SEM 0.25 ±0.03 0.19 + 0.07
Carbonyl 1.10 1.00 1 0.02 0.05
0.91 0.74 0.03 0.05
0.83 1.02 0.07 0.09
0.78 0.88 0.18 0.15
0.94 0.67 0.09 0.13
0.08 0.09
mean+ SEM 0.91+0.07 0,86 ± 0.07 mean + SEM **0.08 + 0.03 0.09 + 0.02
Deficient 0.39 0.91 3 0.12 0.01
0.37 0.70 0.11 0.02
0.34 0.67 0.08 0.35
0.68 0.83 0.05 0.10
0.54 0.61 0.19 0.03
0.14 0.04
mean + SEM 0.46 + 0.06 0.74 ± 0.05 mean+ SEM *0.12 + 0.02 0.09 + 0.05
IP sorbitol 0.86 1.15 5 0.05 0.11
0.65 1.08 0.13 0.07
1.06 2.18 0.10 0.19
0.91 1.42 0.07 0.13
0.90 1.41 0.04 0.03
0.04 0.12
m ean+ SEM 0;88 + 0.06 *1.45 ±0.09 m ean± SEM **0.09 + 0.02 0.11+0.02
1
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Table 4-5b
Densitometer ratios of L and H-ferritin in the rat intestinal mucosa
(data n=6 ±  SEM)
Regime 3: Changing from an iron deficient diet to a carbonyl iron diet at day 0 ,1 , 3 & 5 
Regime 4: Changing from IP iron sorbitol to an iron deficient diet at day 1/4, 1 and 3 
*p<0.05, **p<0.01 (statistical significance as compared to day 0 from the change in diet)
Regime (3) 













0 0.56 0.43 0 0.50 0.62
0.52 0.45 0.49 0.46
0.64 0.92 0.85 0.21
0.60 0.54 0.51 0.16
0.51 0.43 0.94 0.36
0.47 0.81 1.31 0.41
m ean± SEM 0.55 ±0.02 0.60 + 0.09 mean+ SEM 0.77 ±0.13 0.37 ± 0.08
1 1.12 0.81 1/4 0.76 0.05
0.57 0.79 0.95 0.05
0.50 0.41 0.48 0.09
0.62 0.34 0.45 0.15
0.72 0.43 0.22 0.13
0.56 0.48 0.10 0.09
mean + SEM 0.68 ±0.10 0.54+ 0.08 mean + SEM 0.49 ±0.13 0.09 ± 0.02
3 0.63 1.61 1 0.29 0.80
0.73 0.91 0.42 0.82
0.56 0.17 0.24 0.11
0.53 0.20 0.23 0.21
0.44 1.36 0.20 0.17
0.51 0.59 0.25 0.23
mean+ SEM 0.56 ± 0.04 0.73 + 0.20 mean+ SEM **0.27 ±0.03 0.39+ 0.13
5 0.46 0.49 3 0.55 0.75
1.04 0.58 0.53 0.59
0.26 0.43 0.28 0.62
0.32 0.81 0.37 0.48
0.52 1.72 0.19 0.27
0.74 0.92 0.28 0.50







Ferritin synthesis is regulated mainly by a post-transcriptional mechanism 
(Harford & Klausner 1990) and to a lesser extent by transcription (White & Munro 1984). 
Little is known o f transcriptional control other than that it occurs in response to 
increasing iron availability (Bomford et al 1981). Post transcriptional control of ferritin is 
mediated by the action of IRP with surplus ferritin mRNA in cells being repressed until 
iron is available such that when cellular iron is increased, ferritin synthesis also increases.
The concept o f body iron stores influencing iron absorption by conditioning 
proliferating crypt cells in the intestinal mucosa is intriguing for a number of reasons. 
There is no other micronutrient known to have a similar mechanism. There is a delay in 
the effect of some 3 days before these cells are able to ‘respond’ and alter luminal iron 
absorption. Thirdly, this 'delay' corresponds to the time for crypt to villus migration. 
Using the current separation and molecular biological techniques it was possible to 
explore some of these mechanisms.
Contrary to expectations, steady state conditioning in the present study, revealed 
that rats supplemented with oral (chronic loading) or parenteral iron (acute iron loading) 
did not significantly alter either L or H-subunit ferritin mRNA in both villus and crypt 
cells. This was also reported recently by McKie et al; (1996) in the intestinal mucosa of 
mice although crypt and villus cells were not segregated (published while the current 
studies were undertaken). However, the L:H transcript ratios in the present study, do 
indicate a tendency towards an L-rich ferritin, which was observed in both crypt and 
villus cell (but was only significant in crypt cells in the IP iron sorbitol group). Upon 
translation (not studied here), this will produce isoferritins more suited to retain iron 
within the enterocytes and reduce iron influx to the portal circulation. Conversely, in the 
iron deficient group, a significant reduction in both L and H subunit ferritin mRNA was 
observed in only villus cells. This was also reflected in the L:H transcript ratio of villus 
cells although not statistically significant. It is difficult to explain the why this
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phenomena was only observed in the villus cells. It may be an adaptive response 
following iron deficiency to conserve iron for proliferative crypt cells rather than the 
‘mature’ villus cells coming towards the end of their life-span. Following on to this, it 
would appear that body iron stores do not have the tendency to stimulate the production 
of specific ferritin-subunit ferritin transcripts in mucosal cells by contrast to the well 
recognised association between body iron stores and serum ferritin (Addison et al 1972, 
Jacobs et al 1972, Lipschitz et al 1974, Powell et al 1975a).
The purpose of the 'switch model conditioning' (from an iron loaded diet to an 
iron deficient diet and from an iron deficient diet to an iron loaded diet) was to explore 
whether ferritin could be the mediator in the 'mucosal block' responding to information 
imparted to the enterocyte regarding body iron stores.
In the oral carbonyl group, a significant reduction in L-ferritin subunit mRNA 
expression was observed in both crypt and villus cells within 24 hours of changing to the 
iron deficient diet and maintained to day 5. This was also reflected in the L:H transcript 
ratio (a reduction) although this was only statistically significant in the villus cell. A 
similar observation has been reported (Topham et al 1992) on iron uptake by 
brush-border membrane vesicles whereby transfer of control rats to a low-iron diet 
resulted in a 2-fold increase in iron uptake after only 24 hours.
A number of inferences can be drawn from the current study: firstly, ferritin is 
unlikely to be the mediator since villus cells were able to 'respond' within 24 hours by 
altering (decreasing) L-ferritin subunit mRNA expression. If ferritin had been the 
mediator, one would predict an initial response in crypt cells followed by a response 
(reduction in L-ferritin subunit expression) in the cells along the crypt-villus axis over 
next 3-5 days with villus cells at the tip, perhaps demonstrating the most delayed 
response following from a change in diet. Secondly, this response in L-ferritin expression 
observed in both villus and crypt cells was more likely due to changes in luminal derived
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iron rather than alterations in body iron stores as it is unlikely for body iron stores to be 
depleted within 24 hours.
Interestingly, the above findings were not observed for H-ferritin subunit mRNA. 
This may reflect that the two subunits of ferritin protein are co-ordinately regulated at the 
translational level but differentially regulated at the transcriptional level (Munro & Linder 
1978). A third possibility would be that crypt cells are ‘programmed’ not by body iron 
stores but by a microcirculation governed by dietary iron supply i.e. the amount of iron 
absorbed in the villi will have an immediate effect on villus cells, such that when iron is 
scarce, the animal need not wait for iron stores to be reduced in order to ‘relax’ the 
control on the regulation o f iron absorption. This is supported by a previous study 
(Topham et al \99l )  using brush-border membrane vesicles demonstrating an increase in 
plasma iron and iron incorporation into mucosal ferritin (following intragastric dose of 
Fe) in rats subjected to a short-term and long-term iron depletion suggesting that 
mucosal cells were capable of processing of iron prior to major changes in body iron 
status.
However, there were no demonstrable differences in ferritin mRNA expression in 
the iron deficient group switched to an iron loaded diet although, the ability of inorganic 
iron to stimulate synthesis o f basic isoferritin protein in the intestinal mucosa (after 5 
days on iron) has been described in patients with iron deficiency anaemia given oral iron 
(Halliday et al 1978). Several explanations are possible for the current observation. 
Northern hybridisation technique may not be sensitive enough in detecting mRNA 
changes compared to solution hybridisation (White & Munro 1988). This may be 
reflected in the L:H subunit transcript ratio especially in crypt cells which tended to rise 
by day 3 and 5 after the introduction o f the carbonyl iron diet although this did not reach 
statistical significance. Furthermore, the duration of iron treatment was 5 days whereas 
Pietrangelo et al., (1990) was able to demonstrate a preferential change in hepatic L 
ferritin subunit mRNA expression in rats maintained on an iron loaded diet for at least 10
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weeks. Furthermore, in studies on iron uptake using brush-border membrane vesicles 
(Topham et al 1992), the transfer o f iron-deficient rats to a control diet resulted in a 
progressive decrease in iron uptake which only reached that of control rats in 2 weeks.
Parenteral iron produces an acute iron overload. Rather than synthesising basic 
isoferritin transcripts (L-rich ferritin) which will retain iron in mucosal cells, both crypt 
and villus cells responded by reducing ferritin expression which was observed within 6 
on introduction to the iron deficient diet. This was also reflected in the reduced L:H 
transcript ratio especially in the villus cell. This is perhaps a further illustration that 
mucosal cells were responding to changes in luminal iron rather than body stores. 
Reduced ferritin expression was observed for both L and H ferritin subunits by contrast to 
the oral iron loaded group where H-ferritin subunit mRNA expression was relatively 
unaffected by the subsequent dietary change. This difference could be reflected in the 
different iron preparations used to load animals (carbonyl iron vs iron sorbitol) and iron 
administration (oral vs ip injection).
In conclusion, the present study has revealed that body stores do not have the 
tendency to stimulate the production of specific subunit ferritin transcripts in mucosal 
cells. However, mucosal cells themselves were capable of responding to changes in 
luminal iron by synthesising specific ferritin transcripts independent o f body iron status. 
Furthermore, this response in mucosal cell did not follow the lag-period that will account 
for crypt-villus migration. Nevertheless, the concept of the body iron stores conditioning 
the crypt cells which can subsequently influence mucosal handling o f dietary iron as they 
migrate to functional cells at the terminal villus remains attractive although the present 
data does not support that this is mediated by ferritin.
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5 . Iron protein expression in human intestine in relation to body 
iron stores
This chapter has been divided into three sections. Section 5.1 describes the 
development o f a method for isolating subpopulations of crypt and villus cells from 
human intestinal mucosa obtained endoscopically. Section 5.2 utilises this separation 
technique to examine L and H-ferritin mRNA expression in crypt and villus cell from 
patients with disordered iron metabolism. Section 5.3 examined expression o f TIR using 
a monoclonal antibody to human TfR in subjects with disordered iron metabolism.
5.1 Development o f  a technique fo r separating crypt and villus cell in the 
human intestinal mucosa
5.1.1 Introduction
The absorptive surface of the small intestine is lined by epithelial cells which have 
their origin as stem cells in the crypts o f Lieberkuhn. As mentioned in section 2.1, when 
these cells migrate out o f the crypts onto the architectural villus support structure in the 
small intestine, they undergo differentiation to give rise to a variety of metabolically 
active functional cells specialised for absorption. However, factors controlling 
proliferation, cell migration and terminal differentiation of these cells are incompletely 
understood. In addition, in terminally differentiated cells, the homeostatic mechanisms 
influencing absorption o f particular substrates have been difficult to study because of the 
intricate relationship between different epithelial cell subtypes lining the villus structure.
The initial development of methods to isolate relatively pure cell subpopulations 
along the crypt-villus axis reviewed by Remke et a i,  (1988), have made it possible to 
study aspects of the life cycle and differentiation o f these cells. However, in most of these 
reports, little histological or morphological evidence were provided about the segregated 
cell subpopulations. The most successful of these methods have been described by
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Weiser (1973) more recently, Flint et aL, (1991) used a low temperature at 4 °C to 
demonstrate that intact RNA could be isolated from the relatively pure subpopulations of 
cells obtained. These methods were developed using rat and mouse small intestine where 
sample size is not a problem. The utilisation o f methods for isolating RNA from human 
small intestine from endoscopic biopsies as a routine presents a challenge because of the 
limited amount o f tissue that would normally be available.
-f'S
'"IlI
5,1.2 Materials and methods
Hanks balanced salt solution (HBSS: low calcium and magnesium) was obtained 
from Hyclone, U.K. Methyl(3H)-thymidine (specific radioactivity 79 Ci/mmol) was 
obtained from Amersham, and media for incubating endoscopic biopsies from Gibco- 
Betsada Research Laboratories, U.K. which consisted of Gibco-Trowells T8 (65% vol), 
Gibco-NTC-135 (20%vol), Gibco-foetal calf serum (15% vol), Gibco-L-Glutamine 
200mM, benzylpenicillin (600 mg/ml) and streptomycin sulphate (167 mg/ml). 
Incubating conditions for biopsies are in section 5.1.2 (ii).
(i) Isolation o f  crypt and villus cells from human duodenal mucosa
Human small bowel tissues were obtained from patients who were undergoing 
routine endoscopy for dyspepsia at Aintree Hospitals Liverpool. Approval for this study 
has been granted by South Sefron Ethical Committee. Endoscopic duodenal biopsies 
(n = 4 to 6), each weighing between 15-20 mg were obtained using an Olympus IT 20 
endoscope and large FB 13K biopsy forceps. These biopsies were amalgamated in HBSS 
with 0.5mM DTT on ice and epithelium was isolated as described in Table 5-1.
Essentially, the separation technique entails serial processing of tissue samples for 
progressively longer duration in chelation buffer and with progressively more vigorous 




stored at -80 “C until required for extraction of RNA or biochemical analysis. RNA can 
be reliably isolated from such material stored for up to two weeks.
(ii) Validation o f  segregated cell population subtypes
The purity and character o f the cell fractions obtained were then determined. 
Serial removal of different cell types was assessed histologically by staining the biopsy 
remnant at each step with haematoxylin and eosin, assessing enzyme activity (villus cells) 
and by 3H-thymidine incorporation (crypt cells).
Enzyme activity (alkaline phophatase) was determined as described in section
2.1.2 (iv) using absorption spectrophotometry to detect the release o f p-nitrophenol at 420 
nm. Results (Figure 5-1 [top]) are expressed as standardised units per mg protein assayed 
by the modified Lowry technique (1951) as described in section 2.1.2 (iv).
Crypt cell enrichment of all cell fractions were identified by 3H-thymidine uptake. 
Endoscopic biopsies were incubated in Falcon culture dish (Figure 5-3) for 6 hours at 
37 °C in 95 % oxygen, 5 % carbon dioxide containing 0.9 mis o f media (section 5,1.2) 
and 2 pi of 3H-thymidine (specific activity 79 Ci/mmol). Under these culture conditions, 
preliminary experiments have shown these endoscopic small bowel biopsies to be viable 
for up to 48 hours. Following incubation, biopsies were washed six times in 10 mis 
chelation buffer. Separation o f cell subpopulations was then undertaken. Segregated cells 
were recovered as described in section 2.1.2 (iv) and results, (Figure 5-1 [bottom]) 
expressed as dpm per mg protein also assayed by the Lowry method (1951).
At each sequential stage o f the isolation procedure, a biopsy remnant was 




' " " M g
Chapter 5
Table 5-1
Isolation of human duodenal mucosa along the crypt-villus axis
Incubate endoscopic biopsies (four to six ) in 5 mis Hanks buffer 
in 0.5mM DTT at 4 °C for 1 minute 
Discard supernatant 
Transfer biopsies to 10 mis of *chelation buffer 
Incubate at 4 °C with constant stirring for 25 minutes. Remove biopsies 
Pellet cells at 10,000g for 10 minutes 
This cell fraction is Vw
Transfer biopsies to 2 mis *ehelation buffer 
Shake by hand, approximately 30 inversions 
Collect supernatant 
Repeat twice in 2 mis of cold *chelation buffer 
Pellet cells as before. This gives cell fractions Vi, V 2 and V3
Transfer biopsies to 10 mis *chelation buffer 
Incubate at 4 °C for 10 minutes with constant stirring 
Discard supernatant 
Transfer biopsies to 4 mis o f cold *chelation buffer 
Shake by hand (approximately 60-90 inversions) or until tissues float 
to the top on standing. Remove biopsy remnant. Pellet cells as before
This cell fraction is C 2





(Hi) RNA extraction, separation and Northern hybridisation
RNA was extracted from endoscopic duodenal cells using acid guanidinium 
thiocynate-phenol-chloroform method (section 2.3.1). RNA separation and capillary 
transfer o f RNA were undertaken as described in section 2.3.3 and 2.3.4.
Two probes were available to examine mRNA expression whose proteins have a 
predilection for either proliferating cells in the crypts i.e. TfR (Anderson et al 1990, 
Pietrangelo et al 1992) and sucrase-isomaltase for absorptive functional cells in the villus 
architecture (Green et al 1987). Sucrase-isomaltase cDNA (300 bp) was a generous gift 
from Drs. X. Wang and D. Swallow, University College, London. This was labelled using 
a random primer kit as described in section 2.3.5 (i). TfR probe is a 30 base single 
stranded oligonucleotide, labelled using a terminal transferase enzyme kit as described in 
section 2.3.5 (iv). As a control to normalise for RNA loading., a 26-base oligonucleotide 
the sequence (5’-AAC GAT CAG AGT AGT GGT ATT TCA CC-3') corresponding to 
human 28S rRNA (Barbu & Daultry 1987) was used. This ribosomal sequence was 
labelled using terminal transferase as for TfR. For both oligonucleotide probes (TfR and 
28S rRNA), excess label was removed using a Sephadex G-50 column which was 






Alkaline phophatase activity and 3H-thymidine incorporation in segregated cells on 
the human intestinall mucosa
Note that enzyme activity is highest in villus cell (Vw) and lowest in crypt cell (C2) and 
thymidine incorporation is highest in crypt cells (C2) and least in villus cell (Vw)
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Figure 5-2
Histological verification of separation technique
Key: Vo: longitudinal section of rat small bowel, Vw: after 25 minutes in chelation 
buffer, VI: after 30 inversions, V3: after 90 inversions. C l: after further incubation and 





Falcon culture dish for incubating intestinal biopsies
Note the larger duodenal biopsies (top) obtained from FB 13 biopsy forceps compared to 
smaller duodenal biopsies (bottom) from conventional biopsy forceps
(iv) PrehybridisatioHy hybridisation and washing conditions
For sucrase-isomaltase, membranes were prehybridised at 68 °C for 20 minutes in 
6 mis of Quickhyb'^ (Stratagene, Cambridge). Hybridisations were then carried at 68 °C 
for 1 hour. After hybridisation, membranes were washed in the following solutions with 
increasing stringency: 2x SSC / 0.1 % SDS (15 minutes at room temperature), the same 
solution (another 15 minutes at 60 °C) and finally twice in Ix SSC/O.I %SDS (15 minutes 
at 60 '’C). For TfR, optimal conditions for pre-hybridisation, hybridisation and washing 
conditions were carried out at 42 ®C as described in section 2.3.5 (iv). For 28S rRNA 
control, prehybridisation and hybridisation reagents were similar to TfR but hybridisation 
was carried at room temperature. Washing conditions were undertaken as for sucrase- 
isomaltase. Autoradiographs were quantified by scanning densitometery and results 




Biopsies were obtained using an Olympus IT20 endoscope which can 
accommodate the larger FB 13K biopsy forceps. Each endoscopic biopsy obtained weight 
approximately 15-20 mg compared to 5 mg biopsies obtained using conventional 
endoscopic biopsy forceps. I require between 4 to 6 such biopsies to obtain sufficient 
RNA for mRNA detection by Northern blotting. To reduce RNA degradation, all 
equipment were autoclaved and washed in 0.1 % DEPC water and RNA extraction were 
undertaken within 2 weeks o f cell separation after being stored at -80 °C.
The study of alkaline phosphatase expression and 3H-thymidine incorporation 
(Figure 5-1) in segregated cells reveal a 3 fold gradient of activity/incorporation between 
crypt and villus cells. This compares favourably to previous reports (Weiser 1973, Flint 
et a l l9 9 l)  on segregation in the intestinal mucosa of rats and mouse.
Study of mRNA expression revealed that sucrase-isomaltase mRNA expression is 
high at the villus and low in the crypt cells, a 4 fold difference (Figure 5-4a). This is 
consistent with the enzymatic location o f sucrase-isomaltase, a family o f disaccharides, 
which occurs in the brush-border membrane o f enterocytes catalysing the breakdown of 
dietary di and oligosacharides. A cDNA probe for human jejunal brush border 
sucrase-isomaltase has been isolated (Green et al 1987) where mRNA expression has 
been demonstrated in the human jejunum and in the enterocyte cell-line Caco-2. By 
contrast, utilisation o f the TfR oligonucleotide probe reveal TfR mRNA expression to be 
greater (a six fold difference) in crypt than villus cell (Figure 5-4 b). This is consistent 
with previous immunohistochemical studies on TfR expression in mucosal cells of 
rodents and humans (Banergee et al 1986, Lombard et al 1990, Anderson et al 1990) with 
greater receptor expression in crypt to villus cells and is also consistent with proliferative 
crypt cells having a higher requirement for iron. Relative densitometer ratios for 
sucrase-isomaltase and TfR mRNA illustrating higher mRNA expression of
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sucrase-isomaltase mRNA in the villus and TfR mRNA in the crypt have been 
summarised in Figure 5-5.
Figure 5-4 
(a) Sucrase-isomaltase
Sucrase-isomaltase mRNA normalised for RNA loading with 28S rRNA. Lane 1, Vw 
fi'om 6 amalgamated biopsies (0.5 pg RNA/mg tissue); lane 2, C2 (0.25 pg RNA/mg 
tissue) ; lane 3, Vw from 6 biopsies from conventional forceps (0.5pg/mg tissue) lane 4, 
C2 from 6 biopsies from conventional biopsies (0.25pg/mg tissue). Note the higher 
expression of sucrase-isomaltase mRNA in Vw (lane 1) compared to C2 (lane 2). Note 
also sucrase isomaltase mRNA was not detected in biopsies obtained from conventional 
small forceps in both Vw and C2 (lane 3 and 4)
1 2  3 4 
—  Sucrase-isomaltase mRNA
.W#' /' ' : -j  — 288 rRNA
mRNA : rRNA ratio Vw 1.41
C2 0.34
(b) TfR
TfR mRNA normalised for RNA loading with 288 rRNA in 6 amalgamated biopsies 
obtained from large FB 13K biopsy forceps. Note the higher expression of TfR mRNA in 
C2 [0.25 pg RNA/mg tissue] (lane 2 ) compared to Vw [0.5 pgRNA/mg tissue] (lane 1)
1 2 
 TfR mRNA
H n 288 rRNA
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The base of the intestinal mucosa contains crypt cells which are undifferentiated, 
mitotically active cells. Differentiation occurs as the cell moves up the villus architecture. 
The initial methods developed to segregate these cells provided little histological and 
morphological evidence for the different cell subpopulations. Weiser (1973), however, 
isolated crypt and villus fractions from adult rat small intestine using a bivalent 
cation-chelating agent at 37 “C and provided biochemical evidence for the different cell 
subpopulations. Fractions were analysed for certain brush-border enzymes (e.g. sucrase 
and alkaline phophatase activity in villus cells, thymidine kinase in crypt cells) and 
incorporation o f 3H-thymidine into the primitive undifferentiated crypt cells. Weiser was 
able to demonstrate an apparent gradient o f functionally villus cells (Vw) from primitive 
undifferentiated crypt cells (C2 ).
Isolation of epithelial cells at 37 °C, however, did not preserve cell integrity as 
internalisation o f certain surface receptors e.g. insulin and epidermal growth factor 
receptors to intestinal cells can occur within an hour at body temperature (Gallo-Payet & 
Hugon 1984,1985), In addition, isolation at 37 °C can result in a loss of mRNA 
transcripts and their protein products (Weiser et al 1987). These deleterious effect could 
be overcome to some extent if  isolation was carried out at 4 °C and this has been achieved 
in the rat and mouse intestinal mucosa where tissue availability is not a problem (Flint 
et al 1991).
I have developed a technique by which a purified population o f proliferative and 
terminally differentiated epithelia o f the human intestinal mucosa could be obtained at 
4 °C. This method produced initial fractions (Vw) of relatively pure villus cells which 
express characteristics of terminally differentiated enterocytes found on the villus but not 
in the crypt. Similarly, fractions obtained at the end of the separation (C2 ) consisted of an 
enriched suspension of crypt cells.
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Relatively pure subpopulations o f crypt and villus cells can be obtained by this 
low temperature method and the yields are suitable for mRNA studies. Morphological 
integrity is maintained in these cells. This separation technique will also be potentially 
useful to study changes in the control of proliferation, cell migration, terminal 
differentiation in the human intestinal mucosa.
5.2 Ferritin expression in crypt and villus cells in subjects with iron 
deficiency anaemia and genetic haemochromatosis
5.2.1 In  traduction
Having adapted and verified the separation technique for crypt and villus cells in 
the human intestinal mucosa, I then proceeded to examine ferritin mRNA expression in 
these cell subpopulation in patients with iron deficiency anaemia (IDA) and GH. Iron 
absorption is a carefully regulated biological process which is able to respond by 
increasing iron absorption in the proximal small intestine in iron deficiency or blood loss 
but to decrease uptake from the intestinal mucosa when iron stores become replete. In 
GH, an autosomal recessive inherited defect, the regulating mechanism is no longer intact 
resulting in excessive iron absorption from the diet despite raised body iron stores. 
Unrecognised and untreated, GH leads to a lethal accumulation o f body iron. The 
pathogenesis o f GH remain unclear. It is thought to involve defect(s) in the control of 
duodenal iron absorption either on the luminal site, which would result in raised iron 
deposition in the enterocytes; and/or defects on the serosal iron transfer which will result 
in enhanced release o f adsorbed iron to the portal circulation.
Several proteins have been implicated in the control of cellular iron metabolism. 
Three o f these TIN, TfR and ferritin have been discussed in Chapter 3 and 4. Ferritin, the 
major iron storage protein has been viewed as the key factor in controlling mucosal iron 
uptake, The mucosal block’ which has been discussed in Chapter 4 with two
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immunologically distinct ferritin chain, with different affinity to accept and release iron 
(Arosio et al 1978). Recent molecular biological techniques have provided some insights 
on iron metabolism specifically in the regulation of expression o f TfR and ferritin by the 
interaction of mRNA elements like the IRE and the cytoplasmic IRE-BP or IRP as 
discussed in section 1.3.7. Potentially, these may provide new insights into the metabolic 
abnormalities in GH.
Using the technique for separating crypt and villus cells in the human intestinal 
mucosa, I undertook a study to examine the relationship between body iron stores and 
ferritin mRNA expression in mucosal cells o f patients with IDA and GH.
5.2.2 Methods and Materials
(i) Subjects
This study was undertaken in accordance with the ethical committee at Aintree 
Hospital, Liverpool and had been approved by South Sefton ethical committee. Informed 
consent was obtained from all subjects who underwent peroral endoscopy after a 10 hour 
fast to obtain duodenal biopsies. The study was carried in 3 control volunteers, 3 patients 
with GH and 4 patients with IDA. Endoscopic small bowel tissues were obtained from 
patients who were undergoing routine endoscopy for dyspepsia at Aintree Hospital 
Liverpool. Control subjects (1 male and 2 female; age 23-43 years) had no history of 
disordered iron absorption. There were three male patients with GH aged between 54-69 
years. The diagnosis of GH was based on a liver biopsy showing raised parenchymal iron, 
a transferrin saturation o f more than 62% and a raised serum ferritin greater than 600 
mg/litre. All three patients had not been venesected prior to the study. There were 4 
patients with IDA (2 male, 2 female; age 42-58 years). The diagnosis o f IDA was based 
on a haemoglobin concentration o f less than 10 g/dl, a mean corpuscular volume of less 
than 76 f/1 and a serum ferritin of less than 10 mg/litre.
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(ii) Probes and gene cloning
The pFr and Pr3 clones for L (approximately 900 bp) and H subunits 
(approximately 850 bp) of human ferritin (a generous gift from Dr. Antonello 
Pietrangelo) in the vector PBR 322 was transformed into DH5 1-a competent cells 
(Promega, Biotech). This was undertaken as described in section 2.2.2 (Ü). Plasmid DNA 
was extracted using the large scale preparation method in caesium chloride-ethidium 
bromide in section 2.2.2 (iv-vii).
Human L and H-ferritin sequences are almost full-length complementary DNAs 
that have been shown to recognise specifically ferritin mRNA (Santoro et al 1986, 
Costanzo et al 1984) were removed from the plasmid using the restriction enzyme Pstl 
(Figure 2-8 and Figure 5-6a). A 28S rRNA probe containing a 26-base oligonucleotide 
which recognises human 28S rRNA (Barbu & Daultry 1989) was used as control. 
Labelling of cDNA's and oligonucleotide sequence with ^^dCTP, hybridisation/washing 
conditions for human ferritin probes and 28 S rRNA were as described in section 2.3.5.
5.2.3 Results
Iron status of the subjects in the present study have been summarised in Table 5-2. 
Densitometery readings of all the subjects for each group are shown in Table 5-3 and 
summarised in Figure 5-6b. In controls, IDA and GH, ferritin transcripts (both L and H) 
did not differ significantly in their respective crypt and villus cells (Figure 5-6b). 
However, ferritin L mRNA was significantly lower in both crypt (p<0.01) and villus cells 
(p<0.01) in patients with IDA compared to control subjects (Figure 5-6b). This was also 
observed for ferritin H mRNA being significantly lower in crypt (p<0.01) and villus cell 
(p<0.001). Contrary to expectations, patients with GH also had significantly lower L and 
H ferritin subunit transcripts in both crypt (p<0.01 for L-ferritin, p<0.001 for H-ferritin) 
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Table 5-2
Iron status of subjects studied






GH 1 57/M 14.3 97 2400
G H 2 54/M 14.8 93 2510
GH3 69/M 13.7 90 1730
IDA 1 53/M 9.2 10 7
IDA 2 45/M 8.4 6 9
IDAS 42/F 7.8 3 3
IDA 4 55/F 7.6 7 11
Control 1 43/F 13.2 39 36
Control 2 33/F 13.8 29 28
Control 3 40/M 14.6 42 42
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Ferritin expression in crypt and villus cell in subjects with disordered iron
metabolism (n=3 ± SEM for Con & IDA and n=4 ± SEM for IDA
(statistical significance as compared to control subjects)




* P < 0.05 
** P < 0.01 
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5 3  Immunohistochemical study o f  TfR expression in the intestinal mucosa 
o f  patients with iron deficiency anaemia and genetic haemochromatosis
53,1 Methods
(i) Subjects investigated
Duodenal biopsies were obtained from 3 subjects with GH, 4 subjects with IDA 
and 3 controls who underwent peroral endoscopy with dyspepsia. In addition there was a 
32 year o f female subject who was previously noted to have an IDA . She was prescribed 
ferrous sulphate (200 mg three times a day for 3 months). At the time of endoscopy, her 
serum ferritin was similar to control subjects.
r l
(ii) Immunohistochemistry
These were undertaken using the monoclonal antibody 0K T9 for detection of TfR 
(Sutherland et al 1981), obtained from Ortho Pharmaceuticals, Raritan, on duodenal 
biopsies in subjects with IDA, on iron supplements, control subjects and in GH as 
described in section 2.4.1. To ensure uniform and comparable conditions, cryostat 
sections (6 pm) from all patients were mounted in grid fashion on glass slides in 
duplicate for the antibody. As a negative control, incubations were undertaken without 
the first antibody. A subjective assessment o f the staining intensity for each group was 
made by 2 independent observers and graded from 0 (none), 1 (mild ), 2 (moderate) and 
3 (intense) staining.
5.3,2 Results
(i) Distribution and localisation o f  TfR staining in duodenal mucosal cells
There were differences in the TfR staining in the o f the duodenal mucosa between 
the groups studied (Figure 5-7 a-d). Receptor staining in the columnar villus epithelial 
cells was confined to the subnuclear and basolateral regions in control subjects, iron 




intense in the iron deficient subjects which was observed on the entire length of the villus 
architecture (Figure 5-7c). In a patient receiving iron supplements, staining was less 
intense than control and was mainly confined to cells in the basal villus architecture with 
decreasing receptor expression from crypt (+2) to villus tip (0) (Figure 5-7 d).
By contrast, in subjects with GH, intense staining for TfR (Figure 5-8) was 
observed in both crypt (3) and almost the entire length o f the villus architecture (2). Peris 
potassium ferricyanide staining in GH subjects reveal haemosiderin deposits in liver but 
not in duodenal tissues (Figure 5-9 a- b).
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Figure 5-7
TfR expression in duodenal mucosa in subjects with disordered iron metabolism 
(a) Control subjects (note reduced expression from crypt to villus, top left); (b) 
Negative control (top right); (c) Iron deficiency anaemia (note enhanced receptor 
expression up to the terminal villi, bottom left); (d) Effect of iron supplementation 
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Inmiunohistochemical studies on TfR expression confirmed the inverse 
relationship between receptor expression and body iron stores. However, in GH, TfR 
were not downregulated. Initially it was thought to represent a site specific defect 
(Lombard et al 1990) but this may just reflect enhanced enterocyte iron transfer to 
plasma.
In the present study a semi-quantitative analysis o f duodenal crypt and villus cells 
was undertaken to study ferritin mRNA expression in subjects with disordered iron 
metabolism. In IDA subjects, both L and H ferritin transcripts were reduced in the 
absorptive and the non absorptive cells. As cellular iron is diminished in IDA, ferritin 
expression may be expected to be is reduced as less protein will be required for iron 
storage and detoxification.
Trousseau (Trousseau 1865) was the first to describe iron overload in a diabetic 
patient who had bronze skin and a granular liver on post mortum in the later half o f the 
nineteenth century. Von Recklinghausen assigned the term 'haemochromatosis' to this 
condition in 1889. The hereditary nature o f the disease was only recognised by Seldon in 
1927 and it took half a century before the inheritance o f this condition was recognised to 
be autosomal recessive (Simon et al 1977). Recently, a Cys-282-Tyr mutation in the 
HLA-H region o f chromosome 6 was found to be associated with GH (Feder et al 1996). 
However to date, the precise role of HLA H in iron metabolism is currently not known.
Previous immunohistochemical and electron microscopy studies on ferritin 
expression in the duodenum of patients with GH have attempted to clarify the role of 
ferritin but with conflicting results. Two separate groups using similar techniques 
(Whittaker et al 1989, Francanzani et al 1989) failed to detect ferritin in the absorptive 
cells of the duodenum although ferritin was observed in cells o f the lamina propria. 




The site of the metabolic defect in GH remains unknown. In theory, this defect 
could be on the enterocyte (on the luminal surface, mucosal or both) or a more 
widespread disorder affecting the liver and the RE system. Since iron absorption is 
primarily controlled at the site o f absorption in the proximal intestine, a generalised 
membrane defect in the cells o f the RE and liver seems less likely. Previous physiological 
studies on iron metabolism seem to suggest that the defect may lie in both mucosal 
uptake and the release of iron to the portal circulation (Boender & Verloop 1969, Marx 
1979). To date, the most promising candidate protein to mediate enhanced mucosal iron 
uptake in GH is the 160 kDa iron binding protein (Teichman & Stremmel 1990) 
especially when it was revealed that the protein was inappropriately upregulated in  GH 
(Stremmel 1991). Further support for a mucosal defect is seen in a copper loading 
disorder (Menke disease), a condition not too dissimilar from GH where the abnormality 
has been localised to a defective membrane copper transporting ATPase (Davies 1993). 
On the other hand, iron kinetic studies in enterocytes o f GH subjects (McLaren et al 
1991) tended to suggest that mucosal transfer o f iron to the portal circulation may be the 
major determining factor. The reality is that neither has been definitely identified as the 
rate limiting step.
The present data revealing that both L and H-ferritin transcripts in GH subjects 
were significantly lower compared to control subjects is in agreement with a recent 
observation (Pietrangelo et al 1995) utilising insitu hybridisation techniques. In a 
previous study by the same group (Pietrangelo et al 1992), on whole small bowel 
endoscopic biopsies (containing both villus and crypt cells) ferritin transcripts were also 
inappropriately low in these subjects. Furthermore, ferritin excretion studies in GH also 
reveal lower faecal ferritin (both L and H) than expected for their body iron status 
(Skikne et al 1995). Therefore could the defect in GH be due to a failure o f the molecular 
mechanisms governing ferritin expression?. The molecular regulation o f ferritin 
expression is linked to the molecular regulation o f TfR which controls iron entry from
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plasma to target cells (section 1.3.7). This mechanism for controlling the availability of 
iron to target cells probably operates in the enterocyte since an inverse expression of 
these proteins in relation to body iron stores has also been demonstrated (Pietrangelo er al 
1992, Anderson et al 1990). However, this mechanism in the bowel is only likely to 
govern iron entry from plasma since TfR are only found on the basolateral side.
IRP activity (a reflector o f duodenal iron pool) and TfR expression has been 
studied by several investigators in the intestinal mucosa o f GH. TfR 'fail' to 
downregulate (Banerjee et al 1986, Lombard et al 1990) and IRP activity (Pietrangelo et 
al 1995) is increased in patients with GH both reflecting increase iron transfer from 
mucosa to plasma. Increased mucosal iron transfer to the portal circulation will render 
mucosal cells in GH relatively 'iron deficient' and may explain ferritin expression 
comparable or less than control subjects. This observation would tend to imply that 
enhanced iron-uptake by iron transport proteins at the luminal surface of the enterocyte 
e.g. Stremmel's iron binding protein (Stremmel & Teichman 1990) or Conrad's 
mobilferrin (Conrad et al 1990, 1993) being less likely candidates as these proteins will 
expand the iron storage compartment within the enterocyte unless it can be shown that 
these proteins are also capable o f mediating enhanced iron transfer to plasma.
In conclusion the results of the present study indicate that ferritin mRNA 
expression in IDA and GH were both reduced in the absorptive and the non absorptive 
cells o f the duodenum. It appears that reduction in mucosal ferritin GH is not due to a 
failure of the molecular mechanisms that control ferritin synthesis but rather, mucosal 
cells have enhanced iron transfer to plasma leading to raised body iron stores but 




6. Synopsis o f  thesis 
6J  General discussion
The control o f iron absorption is a carefully regulated biological process. It is able 
to respond by increasing iron absorption in the iron deficient state and to decrease 
absorption in the iron replete state. Iron absorption can be viewed to occur in several 
stages: (i) uptake of luminal iron onto mucosal cells (ii) iron transport across the 
enterocyte and (Üi) the release o f iron to the portal circulation. It is not always possible to 
separate these stages in absorption studies leading to conflicting results. Intestinal iron 
absorption needs to be a finely tuned process, because, unlike many other trace elements, 
there is no regulatory excretory mechanism for iron and iron homeostasis largely 
controlled by regulating absorption of dietary iron (McCane & Widdowson 1937). Iron 
excretion in human is limited to approximately 1 mg/day (Bothwell 1979) but excretion 
can be increased up to 4 mg/day with the principal loss in the gastrointestinal tract 
(Crosby et al 1963). This loss is balanced by a daily intake o f approximately equal 
amount in adults except in GH where iron absorption is inappropriately high but the 
mechanism for the apparent lack o f regulation remains a mystery.
6,1.1 Candidate proteins in iron metabolism
Studies on iron absorption have concentrated on mucosal proteins known to be 
involved in iron metabolism namely TfN, TfR and fenitin. These are not the only 
proteins implicated in mucosal iron metabolism. Others include the mucosal iron 
transport protein o f Teichmann & Stremmel (1990) and the transmembrane protein, 
mobliferrin working in conjunction with integrin (Conrad 1990, 1992). However, their 
precise role(s) in mucosal iron homeostasis remains unclear.
This thesis is primarily concerned with the effect o f body iron stores on mucosal 
iron proteins (namely ferritin and TfR) that are implicated in mucosal iron uptake. 
However, it is perhaps important to reiterate that there are other factors known to affect
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mucosal iron uptake. These factors have been discussed in Chapter 1 and are now
summarised below.
i. Non-haem iron vs haem iron with greater mucosal uptake of haem iron 
(30 % vs 10 %)
ii. Interactions between iron constituents in foods and the secretions of the gut 
such as gastric HCl which enhance, while bile and pancreatic secretions impede 
mucosal iron uptake.
iii. Nature of the iron constituents in foods e.g. dietary non~haem iron are more 
affected by luminal secretions than haem iron. Animal tissues (proteins) also 
promote mucosal uptake of non-haem iron.
iv. The interplay of promoting ligands like ascorbic acid and inhibitory ligands like 
phytates and calcium have a major influence on non-haem iron uptake in 
mucosal cells.
V. The proportion of haem iron and non-haem iron in a mixed meal since
non-haem iron uptake is influenced by the total iron contend in a meal whereas 
haem iron is relatively unaffected.
vi Mucins (high molecular glycoproteins) may have a role in promoting mucosal
iron uptake. Iron bound to gastric mucins enhances solubility where on 
approaching the duodenum, iron is released (due to the alkaline conditions), 
then passes to a transmemenbrane protein integrin, and eventually to 
mobileferrin.
vii. The mucosal cell itself may influence iron uptake since transplantation o f small 
intestine from iron deficient rats and iron loaded rats to isogenic iron deficient 
rats revealed significant changes in mucosal iron uptake.
viii. Internal factors such as body iron status, erythropoeitic activity and hypoxia 
also influence iron processing at the mucosal surface.
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ix Iron uptake by mucosal cells from plasma involves a receptor-ligand endocytic
mechanism via an ATP-ase where iron is released to the cell and apotransferrin is 
recycled to the plasma surface. This delivery of iron is dependant of receptor 
expression and iron saturation of plasma TfN.
X. The mechanism(s) governing iron transfer to the portal circulation, although
poorly understood, is an additional factor. In this respect, although TfN may 
normally play some role, it appears not to be essential. IRP may be important in 
performing this function,
xi. Iron supplied to cells control expression of ferritin and TfR. These mRNA's 
contain a sequence o f nucleotides forming a stem-loop structure, such that when 
bound by an iron binding protein, a cytoplasmic aconitase, (dependant on body 
iron stores) mediates translation o f these mRNA's.
xii. The ferritin heteropolymer is composed of subunits (L and H-rich) which have 
different iron uptake and iron retaining properties such that the isoferritin 
produced could have a role in influencing iron uptake onto the mucosal cell and 
iron export to plasma.
xiii. Migration of proliferating crypt to functional villus cells is another aspect that 
is conceivable important with a constitutive ratio o f ferritin transcripts being 
pre-determined in accordance to body iron status such that mucosal uptake 
of dietary iron is determined by time for cells to migrate to the villus tip and iron 
delivery to plasma dependant on the initial pre-determined constitutive ratio in 
the crypt cells
(i) Transferrin
Within mucosal cells in the gastrointestinal tract, most of the iron is bound to one
or two proteins, mucosal ferritin and mucosal TfN, a modified form o f plasma TfN




labelling pattern of these proteins in iron replete and iron deficient animals, suggested 
mucosal TfN to be the iron transport protein from mucosal cell to plasma. Mucosal 
ferritin was postulated to bind iron that was not transported to plasma which served as a 
reservoir o f iron for these cells (Savin & Cook 1980, Topham et al 1985). However, the 
transport role o f mucosal TfN has been contested because radioimmunoassay techniques 
have demonstrated TfN throughout the small intestine (Osterloh et al 1985, Johnson et al 
1983) whereas iron absorption in man occurs mainly in the duodenum and jejunum. 
Furthermore, studies utilising Northern hybridisation techniques (Pietrangelo et al 1992) 
have failed to demonstrate TfN mRNA in mucosal cells implying that TfN was not 
synthesised within the enterocytes and is probably derived elsewhere, most likely, from 
plasma via a mucosal endocytic mechanism (Anderson et al 1994).
(ii) Transferrin receptors
The role of TfR has also been the subject o f some controversy. Based on 
immunological and immunohistochemical studies (Parmely et al 1985, Banergee 
et al 1986, Anderson et al 1990) these receptors are embedded within cell membranes on 
the serosal surface of enterocytes, more specifically on the mucosal basolateral surface. 
These receptors are abundantly expressed in the proliferating crypt cells due their higher 
requirement for iron (Meissner & Leblond 1960) and there appears to be a gradient of 
receptor expression which diminishes with increasing distance up the villus architecture 
(Anderson et al 1990, Lombard et al 1990). TfR are unregulated in iron deficiency and 
downregulated in the iron replete states (Anderson et al 1990). It's role on the basolateral 
surface of enterocytes remains unclear with postulated functions that include (i) 
governing the release of mucosal iron to the portal circulation (ii) regulation of cell 
growth (iii) a role in "informing" the enterocytes regarding body iron stores and (iv) 




However, maintaining cellular functions and growth is the general accepted view for the 
role o f TfR.
(iii) Ferritin
The concept o f ferritin as regulator of iron entering the body was proposed some 
50 years ago, initially by Hahn et al., (1943) and later modified by Granick (1946) who 
proposed the "mucosal block" with mucosal cells having the ability to store iron which 
could be transferred to the body according to need. Mucosal ferritin is low in iron 
deficiency and is raised in secondary iron overload (Charlton et al 1963, 1965, Smith et 
al 1966). The "mucosal block" was challenged with the demonstration of ferritin 
synthesis in iron deficient animals supplemented with small doses o f iron (Brittin & 
Raval 1970, Richmond et al 1972) and the prospect of ferritin having a regulatory effect 
was largely discontinued. However, the "mucosal block" hypothesis was rekindled by the 
elucidation isoferritin profiles with different iron retention properties (Ariso et al 1978, 
Wagstaff e/ f l /1978, Jones et al 1978) with L-rich ferritin subunits mainly for iron storage 
and H-rich ferritin subunits subserving a 'housekeeping' function.
The “mucosal block” is not the only hypothesis to account for the relationship 
between iron absorption and body requirements. Others include plasma TfN iron turnover 
concept by Cavill (1975) and the Fletcher-Huehns concept (1968). The former proposes 
that the rate of tissue iron uptake from plasma and the labile iron pool in the various body 
compartments influenced mucosal iron absorption with enhanced mucosal absorption 
when uptake of plasma TfN iron was increased in the same way that the liver maintains 
blood glucose if  peripheral utilisation was high. Several studies have supported this 
hypothesis. Increased iron absorption occurs following exchange transfusion of 
reticulocytes in rodents (Finch et al 1982 , Raja et al 1988) but was not accompanied by a 
reduction in plasma iron nor an increase in iron binding capacity suggesting that iron 
delivered to the reticulocytes was derived from the labile iron pool in the various body
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compartments. However, several other studies have disputed this view (Levine et al 1972, 
Cox & Peters 1980). The Fletcher-Huehns hypothesis (1968) was introduced after invitro 
experiments revealed functional differences between the two binding sites o f TfN. It 
assumed the amount of circulating TfN with both binding sites occupied reflected body 
iron stores and this in turn, determined mucosal iron concentration in the small intestine. 
One site was suggested to give up it’s iron preferentially to red cell precursors and the 
other from the intestinal epithelium. In this way, the demands of the bone-marrow can 
affect intestinal iron uptake by regulating transfer of iron from the intestinal epithelium to 
plasma. However, with the passage of time, this concept has been disputed as no 
difference in the ability o f either site o f TfN to donate or receive iron has been 
demonstrated in invitro or invivo studies in man (Aisen & Brown 1975).
6,1.2 Mucosal block, lag period and 3-dimensional villus architecture
The concept o f pre-conditioning of crypt cells stems from previous physiological 
studies on iron absorption revealing a 'lag period' between changes in body iron stores 
and alterations in mucosal iron uptake. This Tag period’ (approximately 3 days in rats) 
correlated with the migration of cells in the ciypts of Lieberkuhn to the villus tip 
architecture. It was suggested, that, the behaviour of the mucosal cells may have been 
"conditioned" during their developmental period in the crypts, and, any cellular 
manipulation of the environment must be followed by a 'lag' period during which the 
"conditioned" cell must first move out to the their functional position on the villi. Upon 
migration to the villus tip, these cells determined the capacity of iron transfer to the body 
according to need. The mechanism(s) by which crypt cells are conditioned by body iron 
stores are poorly understood, but, I postulated that TfR at the basolateral surface of 






6,2 Summary o f  presented results
6.2.1 TfR
Immunohistochemical studies using OX 26, a monoclonal antibody to rat TfR, 
confirmed the established inverse relationship between TfR expression and body iron 
stores with enhanced receptor expression when body stores were low and diminished 
receptor expression when body iron stores became replete. It also confirmed previous 
studies (Banergee et al 1986, Anderson et al 1990) on greater TfR expression in 
proliferating crypt cells compared to villus cells.
This inverse relationship between body iron stores and receptor expression was 
again demonstrated on further manipulation o f the diet of these animals. In rats given 
carbonyl iron orally for 5 weeks, TfR expression was down-regulated and was virtually 
confined to the cells. On introducing an iron deficient diet to these animals, enhanced 
receptor expression was observed, initially in crypt cells and later in villus cells. 
Interestingly, this response was observed by day 1 from the change in diet where body 
stores were unlikely to change significantly suggesting that the mucosal cell itself may be 
responsive to changes in environmental iron. Conversely, in rats maintained on an iron 
deficient for 5 weeks, receptor expression was enhanced and extended right up to the 
terminal villus architecture. On introducing a carbonyl iron supplemented diet to these 
animals, TfR were down regulated, with diminished receptor expression, initially, in 
villus cells followed by crypt cells.
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Using an adapted method of separating crypt and villus in the rat model and 
Northern hybridisation techniques to examine L and H-rich ferritin subunit mRNA, I set 
out to examine this concept of the Tag period' and pre-conditioning o f the crypt cells by 
body iron stores with ferritin as the candidate protein for the mucosal block.
__________________________________  __  ___
Chapter 6
TfR expression was also examined in human duodenal mucosa in subjects with 
disordered iron metabolism. Using OKT9, a monoclonal antibody to human TfR, the 
reciprocal relationship between iron stores and TfR expression was also confirmed in 
human duodenal mucosal cells.
6.2.2 TfR mRNA
A 30-mer oligonucleotide probe was used to study TfR mRNA expression in 
animals with different iron stores. TfR transcripts also demonstrated the inverse 
relationship between body iron stores and receptor expression. The sequential studies on 
TfR expression in cell subpopulations have provided a semi-quantitative analysis which 
had not been previously reported. Furthermore, there was greater receptor mRNA 
expression in crypt cells than villus cells reflecting proliferating cells to have a higher 
requirement for iron. Similar changes have been observed for TfR mRNA expression in 
human but using whole endoscopic biopsies containing both crypt and villus cells 
(Pietrangelo et al 1992) and in mice (McKie et al 1996) with increase expression in iron 
deficiency and reduced expression in secondary iron overload
6.2.3 Liver ferritin
Ferritin mRNA expression in liver were also examined. The hybridisation signals 
for L-rich ferritin subunits tended to be stronger than H-rich ferritin subunit, implying 
that the predominant isoferritin in liver was L-ferritin.
In animals loaded with oral and parenteral iron, ferritin (L and H) expression 
tended to rise, although did not reach statistical significance when compared to controls. 
This observation was different from a previous study revealing a substantial increase in 
L-rich ferritin subimit but not H-rich ferritin subunit expression (Pietrangelo et al 1990). 
The reasons for these discrepancies were discussed in section 4.3.3.
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However, when animals maintained on a carbonyl iron supplemented diet and in 
animals receiving parenteral iron were switched to an iron deficient diet, there was a 
significant decrease in both L and H-rich subunit ferritin mRNA within 24 hours. 
Similarly, on changing animals fi*om an iron deficient diet to a diet enriched with 
carbonyl iron, a significant increase in liver ferritin transcription was observed for both L 
and H- rich ferritin subunits which was only observed at day 5 after the change in diet. 
These observations suggest that hepatocytes are also capable of 'responding' to changes 
dietary iron.
6.2.4 Mucosal ferritin
Ferritin mRNA expression were also examined in crypt and villus cells of the 
intestinal mucosa. Hybridisation signals for H-rich ferritin tended to be stronger than 
L-rich ferritin, implying that the predominant isoferritin within the enterocytes was 
H-rich ferritin subunits.
In animals loaded with carbonyl iron and parenteral iron, there was a tendency to 
transcribe an L-rich ferritin (although not statistically significant) in both villus and crypt 
cells compared to their respective controls. This was also observed in a recent similar 
study in mice, although intestinal cells were not segregated (McKie et al 1996). However, 
the L:H transcript ratios of these two groups in the present study (only significant in the 
parenteral group) do reflect that mucosal cells were capable o f responding to changes 
body iron.
In animals maintained on the iron deficient diet, there was a significant reduction 
in both L and H-subunit ferritin expression but confined to villus cells. A possible 
explanation for this is that in the iron deficient state, steady state ferritin transcripts may 
be lower (presumably due to diminished iron stores), perhaps an adaptive process to 




Span, have lower ferritin transcripts such that 'less iron' will be lost when these cells are 
shed into the gut lumen.
In animals maintained on a carbonyl iron supplemented diet and then switched to 
an iron deficient diet, a significant reduction in L-subunit ferritin mRNA expression was 
observed in both crypt and villus cells within 24 hours from the change in diet. However, 
H-subunit ferritin mRNA did not change significantly. Similar changes (observed within 
6 hours from the change in diet) were also observed in both crypt and villus cells in the 
parenteral iron group but both L and H-subunit mRNA were significantly reduced. These 
differences may be related to the mode of administration of iron (oral vs IP) and iron 
preparation (carbonyl iron vs iron sorbitol). The converse, however, was not observed, 
where both ferritin subunit mRNA remain unaltered (although there was a tendency 
towards a raised L:H transcript ratio) on changing animals maintained on an iron 
deficient diet to a carbonyl iron supplemented diet The reasons for these discrepancies 
have been discussed in section 4.4.6.
A number o f inferences can be drawn from these observations, (i) if  there was 
conditioning of crypt cells by body iron stores, this was not mediated through ferritin 
mRNA levels since a response in villus cell was observed within 24 hours from the 
change in diet, (ii) both absorptive and non-absorptive cells were capable of responding 
to changes in luminal iron, (iii) environmental iron scarcity may have an effect on the 
controlling mechanisms by affecting ferritin in the villus via a microcirculation effect, 
(iv) although body iron stores demonstrated a tendency to influence the production of 
specific ferritin transcripts in the mucosal cell, the mucosal cell itself may be more 
important in processing iron prior to major changes in iron stores. There is supportive 
evidence for this from several previous studies (Fairweather-Tait & Wright 1984, 




Several reports have suggested that TfR (Banerjee et al 1986, Lombard et al 
1990) and TfR mRNA (Pietrangelo et al 1992) are inappropriately expressed (failure to 
down-regulate) in mucosal cells o f patients with GH. Similarly, mucosal ferritin in 
subjects with GH have also been examined using radioimmunological and 
immunohistochemical techniques (Halliday et al 1978, Whittaker et al 1989, Fracanzani 
et al 1989). These studies demonstrated lower mucosal ferritin (both subunits) when 
compared to patients with secondary iron overload but comparable mucosal ferritin levels 
when compared to control subjects. Similar results have been obtained using Northern 
and insitu hybridisation techniques (Pietrangelo et al 1992, Pietrangelo et al 1995).
The present immunohistchemical study confirmed previous studies on the 
"inability" to down regulate o f TfR in GH (Baneijee et al 1986, Lombard et al 1990).
This is now thought to reflect enhanced iron transfer to the portal circulation rather than a 
site specific defect.
Examination of subpopulation of crypt and villus cells in the human small 1
*intestinal mucosa have not been described to date. I have addressed this by developing a 
method for separating subpopulations of these cells from endoscopic biopsies. The purity 
these cell subpopulations were confirmed by measuring 3H-thymidine incorporation for 
crypt cells and assaying alkaline phosphatase activity for villus cells. In addition, I have 
also demonstrated that sufficient RNA could be obtained to analyse specific mRNA 
transcripts utilising specific probes e.g. TfR (expression mainly in crypt cells) and 
sucrase-isomaltase (expression mainly in villus cells).
Ferritin expression in crypt and villus cells were also examined using this 
separation technique. Ferritin transcripts, demonstrated by Northern hybridisation were 
consistent to a recent study (published while my studies was undertaken) using insitu 
hybridisation (Pietrangelo et al 1995) with mucosal cells (both crypt and villus cells) in 




increase iron transport to plasma), it was concluded that ferritin expression was preserved 
in GH and also accounted for mucosal cells o f GH being relatively 'iron deficient' 
(Pietrangelo et al 1995).
6,3 Potential fo r future work and the future
Although there have been major advances in our understanding of mucosal iron 
absorption since the days o f Hahn, there are still major gaps in our understanding in iron 
metabolism. There is little data especially on the mechanism(s) on mucosal iron transfer 
to plasma, TfR seems to be the ideal candidate due to its location but is not technically 
feasible on kinetic considerations (Baker & Morgan 1994).
Clues in our understanding of mucosal iron uptake may lie in the elucidation of 
the defect in GH. There is much debate on the location of the defect. Is the defect on the 
mucosal side, the serosal site or both? At the mucosal surface o f the enterocyte, the most 
promising candidate is the 160 KD iron transport protein. However, to date, the gene for 
this mucosal iron transport protein has yet to be localised. Its concentration in the 
duodenum appears to be increased in iron deficiency and reduced in iron overload. 
Potentially, this protein could be responsible for increasing uptake o f iron at the luminal 
membrane of the enterocyte which would also result in a higher influx of iron into the 
cell. It remains to be shown if  this protein is also capable o f rapid removal of iron from 
the mucosal cell.
On the serosal side, the 90 KD iron regulating factor protein appears promising. It 
is conceivable that the regulatory mechanism involving the IRE-IRPl is abnormal in GH 
such that IRP's role as the physiological iron sensor is impaired. This will result in 
excessive transfer/release of iron to plasma. However, this has yet to be confirmed. 
Against this is the recent localisation of the gene for IRPl to chromosome 9 (Hentze 




elucidation of a second IRP (named IRP2), molecular weight o f 105 KD (Kim et al 
1994). The role o f this and possibly other IRP need to be addressed.
It has been suggested that Northern hybridisation may not be the most sensitive 
method of demonstrating changes in ferritin/TfrR mRNA expression who advocate the 
technique of solution hybridisation (White & Munro 1988). It may be worthwhile 
re-examining the hypothesis using this technique or more recent and sensitive techniques 
such as reverse transcriptase polymerase chain reaction (PT-PCR) and RNA protection 
assays. The alternative explanation from the current findings that environmental 
availability of iron may determine regulatory response in the mucosa rather than body 
iron stores warrants further investigation.
Ultimately, a key factor lies on chromosome 6, the site o f the haemochromatosis 
gene. The elucidation of the haemochromatosis gene product will lead to a better 
understanding o f the pathogenesis o f GH and therefore mucosal iron processing. The 
defect in GH may not be any of the proteins described so far especially with the recent 
identification of a Cys-282-Tyr mutation in the HLA H region of chromosome 6 
(Feder et al 1996). The precise role of HLA H in iron metabolism is not known. 
However, some clues may be inferred by the fact that it codes for a membrane protein for 
a binding site for microglobulin. Interestingly, a deficiency in p2 - microglobulin has 
been shown to be associated with iron overload in mice. Endocytosed vesicles 
(containing TfN and TfR) are also known to interact with HLA H proteins (Cresswell 
1985). It is conceivable that a 'faulty' or absent p^. microglobulin results in inappropriate 
mucosal iron uptake such that information regarding body iron stores have not been 
conveyed to the mucosal mechanism(s) controlling iron uptake. These are exciting and 
challenging avenues for future studies. It is perhaps pertinent to conclude that, the more 
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